Plants having enhanced yield-related traits and a method for making the same

ABSTRACT

The present invention concerns a method for enhancing yield-related traits in plants by modulating expression in a plant of one ore more nucleic acid(s) encoding at least two iSYT (interactor of SYT—synovial sarcoma translocation—) polypeptides. The present invention also concerns plants having modulated expression of a nucleic acid encoding at least two iSYT polypeptides, which plants have enhanced yield-related traits relative to corresponding wild type plants or other control plants. Nucleic acids encoding at least two iSYT polypeptides and constructs comprising the same useful in performing the methods of the invention are also disclosed. Also provided are constructs useful in the methods of the invention. The present invention also relates to an iSYT-based protein complex. The use of the complex to promote plant growth, and a method for stimulating the complex formation, by overexpressing at least two members of the complex, are also disclosed.

RELATED APPLICATIONS

This application is a divisional of patent application Ser. No. 13/060,881 filed Feb. 25, 2011, which is a national stage application (under 35 U.S.C. §371) of PCT/EP2009/061226, filed Aug. 31, 2009, which claims benefit of U.S. Provisional Application 61/190,543, filed Aug. 29, 2008. The entire content of each aforementioned application is hereby incorporated by reference in its entirety.

SUBMISSION OF SEQUENCE LISTING

The Sequence Listing associated with this application is filed in electronic format via EFS-Web and hereby incorporated by reference into the specification in its entirety. The name of the text file containing the Sequence Listing is Sequence_Listing_(—)074053_(—)0011_(—)01. The size of the text file is 2.031 KB, and the text file was created on Dec. 23, 2014.

The present invention relates generally to the field of molecular biology and concerns a method for enhancing yield-related traits in plants by modulating expression in a plant of one ore more nucleic acid(s) encoding at least two iSYT (interactor of SYT—synovial sarcoma translocation—) polypeptides. The present invention also concerns plants having modulated expression of a nucleic acid encoding at least two iSYT polypeptides, which plants have enhanced yield-related traits relative to corresponding wild type plants or other control plants. The Invention also provides hitherto unknown nucleic acids encoding at least two iSYT polypeptides, and constructs comprising the same, useful in performing the methods of the invention. The invention also provides constructs useful in the methods of the invention. Furthermore the present invention also relates to an iSYT-based protein complex. It further relates to the use of the complex to promote plant growth, and to a method for stimulating the complex formation, by overexpressing at least two members of the complex.

The ever-increasing world population and the dwindling supply of arable land available for agriculture fuels research towards increasing the efficiency of agriculture. Conventional means for crop and horticultural improvements utilise selective breeding techniques to identify plants having desirable characteristics. However, such selective breeding techniques have several drawbacks, namely that these techniques are typically labour intensive and result in plants that often contain heterogeneous genetic components that may not always result in the desirable trait being passed on from parent plants. Advances in molecular biology have allowed mankind to modify the germplasm of animals and plants. Genetic engineering of plants entails the isolation and manipulation of genetic material (typically in the form of DNA or RNA) and the subsequent introduction of that genetic material into a plant. Such technology has the capacity to deliver crops or plants having various improved economic, agronomic or horticultural traits.

The demand for more plant derived products has spectacularly increased. In the near future the challenge for agriculture will be to fulfill the growing demands for feed and food in a sustainable manner. Moreover plants start to play an important role as energy sources. To cope with these major challenges, a profound increase in plant yield will have to be achieved. Biomass production is a multi-factorial system in which a plethora of processes are fed into the activity of meristems that give rise to new cells, tissues, and organs. Although a considerable amount of research on yield performance is being performed little is known about the molecular networks underpinning yield (Van Camp, 2005). Many genes have been described in Arabidopsis thaliana that, when mutated or ectopically expressed, result in the formation of larger structures, such as leaves or roots. These so-called “intrinsic yield genes” are involved in many different processes whose interrelationship is mostly unknown.

A trait of particular economic interest is increased yield. Yield is normally defined as the measurable produce of economic value from a crop. This may be defined in terms of quantity and/or quality. Yield is directly dependent on several factors, for example, the number and size of the organs, plant architecture (for example, the number of branches), seed production, leaf senescence and more. Root development, nutrient uptake, stress tolerance and early vigour may also be important factors in determining yield. Optimizing the abovementioned factors may therefore contribute to increasing crop yield.

Seed yield is a particularly important trait, since the seeds of many plants are important for human and animal nutrition. Crops such as corn, rice, wheat, canola and soybean account for over half the total human caloric intake, whether through direct consumption of the seeds themselves or through consumption of meat products raised on processed seeds. They are also a source of sugars, oils and many kinds of metabolites used in industrial processes. Seeds contain an embryo (the source of new shoots and roots) and an endosperm (the source of nutrients for embryo growth during germination and during early growth of seedlings). The development of a seed involves many genes, and requires the transfer of metabolites from the roots, leaves and stems into the growing seed. The endosperm, in particular, assimilates the metabolic precursors of carbohydrates, oils and proteins and synthesizes them into storage macromolecules to fill out the grain.

Another important trait for many crops is early vigour. Improving early vigour is an important objective of modern rice breeding programs in both temperate and tropical rice cultivars. Long roots are important for proper soil anchorage in water-seeded rice. Where rice is sown directly into flooded fields, and where plants must emerge rapidly through water, longer shoots are associated with vigour. Where drill-seeding is practiced, longer mesocotyls and coleoptiles are important for good seedling emergence. The ability to engineer early vigour into plants would be of great importance in agriculture. For example, poor early vigour has been a limitation to the introduction of maize (Zea mays L.) hybrids based on Corn Belt germplasm in the European Atlantic.

A further important trait is that of improved abiotic stress tolerance. Abiotic stress is a primary cause of crop loss worldwide, reducing average yields for most major crop plants by more than 50% (Wang et al., Planta 218, 1-14, 2003). Abiotic stresses may be caused by drought, salinity, extremes of temperature, chemical toxicity and oxidative stress. The ability to improve plant tolerance to abiotic stress would be of great economic advantage to farmers worldwide and would allow for the cultivation of crops during adverse conditions and in territories where cultivation of crops may not otherwise be possible.

Crop yield may therefore be increased by optimising one of the above-mentioned factors.

Depending on the end use, the modification of certain yield traits may be favoured over others. For example for applications such as forage or wood production, or bio-fuel resource, an increase in the vegetative parts of a plant may be desirable, and for applications such as flour, starch or oil production, an increase in seed parameters may be particularly desirable. Even amongst the seed parameters, some may be favoured over others, depending on the application. Various mechanisms may contribute to increasing seed yield, whether that is in the form of increased seed size or increased seed number.

One approach to increasing yield (seed yield and/or biomass) in plants may be through modification of the inherent growth mechanisms of a plant, such as the cell cycle or various signalling pathways involved in plant growth or in defense mechanisms.

It has now been found that various yield-related traits may be enhanced in plants by modulating expression in a plant of one or more nucleic acid(s) encoding at least two iSYT polypeptides, selected from the group consisting of any of the polypeptides of Table A, homologues thereof, and fusions of the same.

One of the abovementioned “intrinsic yield genes”, AN3 (also known as GIF1 and herein also refer to as SYT—synovial sarcoma translocation polypeptide), was identified in search of GRF (growth regulating factor) interactors (Kim and Kende, 2004) and by analysis of narrow-leaf Arabidopsis mutants (Horiguchi et al., 2005). SYT is a homolog of the human SYT (synovial sarcoma translocation) protein and is encoded by a small gene family in the Arabidopsis genome. SYT is a transcription co-activator whose biological function, despite the implication of its chromosomal translocation in tumorigenesis, is still unclear (Clark et al., 1994; de Bruin et al., 1996). Using the yeast GAL4 system, SYT was shown to possess transactivation activity (Kim and Kende, 2004). This together with yeast two-hybrid and in vitro binding assays demonstrating interaction of SYT with several GRFs (Kim and Kende, 2004; Horiguchi et al., 2005), suggests a role of SYT as transcription co-activator of GRFs. GRF (growth regulating factor) genes occur in the genomes of all seed plants thus far examined and encode putative transcription factors that play a regulatory role in growth and development of leaves (Kim et al., 2003). In support of a GRF and SYT transcription activator and co-activator complex, grf and SYT mutants display similar phenotypes, and combinations of grf and SYT mutations showed a cooperative effect (Kim and Kende, 2004). The SYT mutant narrow-leaf phenotype is shown to result of a reduction in cell numbers. Moreover, ectopic expression of SYT resulted in transgenic plants with larger leaves consisting of more cells, indicating that SYT controls both cell number and organ size (Horiguchi et al., 2005). Although the function of SYT in plant growth regulation is not known, these results show that SYT fulfills the requirements of an “intrinsic yield gene”.

In our ambition to decipher the molecular network underpinning yield enhancement mechanism a genome-wide protein centred approach was undertaken to study SYT interacting proteins in Arabidopsis thaliana cell suspension cultures. The tandem affinity purification (TAP) technology combined with mass spectrometry (MS) based protein identification resulted in the isolation and identification of SYT interacting proteins that may function in the regulation of plant growth (iSYT). Surprisingly, we isolated several proteins belonging to multiprotein complexes. Moreover, many interactors were previously completely uncharacterized. Reports on few of the SYT interactors show that they are implicated in several developmental processes (Wagner & Meyerowitz, 2002; Meagher et al., 2005; Samowski et al., 2005; Hurtado et al., 2006; Kwon et al., 2006) but so far none of the identified (iSYT genes have been associated with stimulation of plant growth. Further surprising no specific combination of iSYT polypeptides useful to enhance yield related traits has previously been described.

SUMMARY

Surprisingly, it has now been found that modulating expression in a plant of one ore more nucleic acid(s) encoding at least two iSYT polypeptides wherein said iSYT polypeptide is selected from the group consisting of any of the polypeptides of Table A, homologues thereof, and fusions of the same, promotes plant growth and gives plants having enhanced yield-related traits relative to control plants.

According one embodiment, there is provided a method for enhancing yield-related traits in plants relative to control plants, comprising modulating expression in a plant of one or more nucleic acid(s) encoding at least two iSYT polypeptides wherein said iSYT polypeptide is selected from the group consisting of any of the polypeptides of Table A, homologues thereof, and fusions of the same.

DEFINITIONS Polypeptide(s)/Protein(s)

The terms “polypeptide” and “protein” are used interchangeably herein and refer to amino acids in a polymeric form of any length, linked together by peptide bonds.

Polynucleotide(s)/Nucleic Acid(s)/Nucleic Acid Sequence(s)/Nucleotide Sequence(s)

The terms “polynucleotide(s)”, “nucleic acid sequence(s)”, “nucleotide sequence(s)”, “nucleic acid(s)”, “nucleic acid molecule” are used interchangeably herein and refer to nucleotides, either ribonucleotides or deoxyribonucleotides or a combination of both, in a polymeric unbranched form of any length.

Recombinant DNA

“Recombinant DNA” means a DNA molecule that is made by combination of two otherwise separated segments of DNA, e.g., by chemical synthesis or by the manipulation of isolated segments of nucleic acids by genetic engineering techniques. Recombinant DNA can include exogenous DNA or simply a manipulated native DNA. Recombinant DNA for expressing a protein in a plant is typically provided as an expression cassette which has a promoter that is active in plant cells operably linked to DNA encoding a protein of interest.

Homologue(s)

“Homologues” of a protein encompass peptides, oligopeptides, polypeptides, proteins and enzymes having amino acid substitutions, deletions and/or insertions relative to the unmodified protein in question and having similar biological and functional activity as the unmodified protein from which they are derived.

A deletion refers to removal of one or more amino acids from a protein.

An insertion refers to one or more amino acid residues being introduced into a predetermined site in a protein. Insertions may comprise N-terminal and/or C-terminal fusions as well as intra-sequence insertions of single or multiple amino adds. Generally, insertions within the amino acid sequence will be smaller than N- or C-terminal fusions, of the order of about 1 to 10 residues. Examples of N- or C-terminal fusion proteins or peptides include the binding domain or activation domain of a transcriptional activator as used in the yeast two-hybrid system, phage coat proteins, (histidine)-6-tag, glutathione S-transferase-tag, protein A, maltose-binding protein, dihydrofolate reductase, Tag*100 epitope, c-myc epitope, FLAG-epitope, lacZ, CMP (calmodulin-binding peptide), HA epitope, protein C epitope and VSV epitope.

A substitution refers to replacement of amino acids of the protein with other amino acids having similar properties (such as similar hydrophobicity, hydrophilicity, antigenicity, propensity to form or break α-helical structures or β-sheet structures). Amino add substitutions are typically of single residues, but may be clustered depending upon functional constraints placed upon the polypeptide; insertions will usually be of the order of about 1 to 10 amino acid residues. The amino acid substitutions are preferably conservative amino acid substitutions. Conservative substitution tables are well known in the art (see for example Creighton (1984) Proteins. W.H. Freeman and Company (Eds) and Table 1 below).

TABLE 1 Examples of conserved amino acid substitutions Residue Conservative Substitutions Ala Ser Arg Lys Asn Gln; His Asp Glu Gln Asn Cys Ser Glu Asp Gly Pro His Asn; Gln Ile Leu, Val Leu Ile; Val Lys Arg; Gln Met Leu; Ile Phe Met; Leu; Tyr Ser Thr; Gly Thr Ser; Val Trp Tyr Tyr Trp; Phe Val Ile; Leu

Amino acid substitutions, deletions and/or insertions may readily be made using peptide synthetic techniques well known in the art, such as solid phase peptide synthesis and the like, or by recombinant DNA manipulation. Methods for the manipulation of DNA sequences to produce substitution, insertion or deletion variants of a protein are well known in the art. For example, techniques for making substitution mutations at predetermined sites in DNA are well known to those skilled in the art and include M13 mutagenesis, T7-Gen in vitro mutagenesis (USB, Cleveland, Ohio), QuickChange Site Directed mutagenesis (Stratagene, San Diego, Calif.), PCR-mediated site-directed mutagenesis or other site-directed mutagenesis protocols.

Derivatives

“Derivatives” include peptides, oligopeptides, polypeptides which may, compared to the amino acid sequence of the naturally-occurring form of the protein, such as the protein of interest, comprise substitutions of amino acids with non-naturally occurring amino acid residues, or additions of non-naturally occurring amino acid residues. “Derivatives” of a protein also encompass peptides, oligopeptides, polypeptides which comprise naturally occurring altered (glycosylated, acylated, prenylated, phosphorylated, myristoylated, sulphated etc.) or non-naturally altered amino acid residues compared to the amino acid sequence of a naturally-occurring form of the polypeptide. A derivative may also comprise one or more non-amino acid substituents or additions compared to the amino acid sequence from which it is derived, for example a reporter molecule or other ligand, covalently or non-covalently bound to the amino acid sequence, such as a reporter molecule which is bound to facilitate its detection, and non-naturally occurring amino acid residues relative to the amino acid sequence of a naturally-occurring protein. Furthermore, “derivatives” also include fusions of the naturally-occurring form of the protein with tagging peptides such as FLAG, HIS6 or thioredoxin (for a review of tagging peptides, see Terpe, Appl. Microbiol. Biotechnol. 60, 523-533, 2003).

Orthologue(s)/Paralogue(s)

Orthologues and paralogues encompass evolutionary concepts used to describe the ancestral relationships of genes. Paralogues are genes within the same species that have originated through duplication of an ancestral gene; orthologues are genes from different organisms that have originated through speculation, and are also derived from a common ancestral gene.

Domain, Motif/Consensus Sequence/Signature

The term “domain” refers to a set of amino acids conserved at specific positions along an alignment of sequences of evolutionarily related proteins. While amino acids at other positions can vary between homologues, amino acids that are highly conserved at specific positions indicate amino acids that are likely essential in the structure, stability or function of a protein. Identified by their high degree of conservation in aligned sequences of a family of protein homologues, they can be used as identifiers to determine if any polypeptide in question belongs to a previously identified polypeptide family.

The term “motif” or “consensus sequence” or “signature” refers to a short conserved region in the sequence of evolutionarily related proteins. Motifs are frequently highly conserved parts of domains, but may also include only part of the domain, or be located outside of conserved domain (if all of the amino acids of the motif fall outside of a defined domain).

Specialist databases exist for the identification of domains, for example, SMART (Schultz et al. (1998) Proc. Natl. Acad. Sci. USA 95, 5857-5864; Letunic et al. (2002) Nucleic Acids Res 30, 242-244), InterPro (Mulder et al., (2003) Nucl. Acids. Res. 31, 315-318), Prosite (Bucher and Bairoch (1994), A generalized profile syntax for biomolecular sequences motifs and its function in automatic sequence interpretation. (In) ISMB-94; Proceedings 2nd International Conference on Intelligent Systems for Molecular Biology. Altman R., Brutlag D., Karp P., Lathrop R., Searls D., Eds., pp 53-61, AAAI Press, Menlo Park; Hulo et al., Nucl. Acids. Res. 32:D134-D137, (2004)), or Pfam (Bateman et al., Nucleic Acids Research 30(1): 276-280 (2002)). A set of tools for in silico analysis of protein sequences is available on the ExPASy proteomics server (Swiss Institute of Bioinformatics (Gasteiger et al., ExPASy: the proteomics server for in-depth protein knowledge and analysis, Nucleic Acids Res. 31:3784-3788(2003)). Domains or motifs may also be Identified using routine techniques, such as by sequence alignment.

Methods for the alignment of sequences for comparison are well known in the art, such methods include GAP, BESTFIT, BLAST, FASTA and TFASTA. GAP uses the algorithm of Needleman and Wunsch ((1970) J Mol Biol 48: 443-453) to find the global (i.e. spanning the complete sequences) alignment of two sequences that maximizes the number of matches and minimizes the number of gaps. The BLAST algorithm (Altschul et al. (1990) J Mol Biol 215: 403-10) calculates percent sequence identity and performs a statistical analysis of the similarity between the two sequences. The software for performing BLAST analysis is publicly available through the National Centre for Biotechnology Information (NCBI). Homologues may readily be identified using, for example, the ClustalW multiple sequence alignment algorithm (version 1.83), with the default pairwise alignment parameters, and a scoring method in percentage. Global percentages of similarity and identity may also be determined using one of the methods available in the MatGAT software package (Campanella et al., BMC Bioinformatics. 2003 Jul. 10; 4:29. MatGAT: an application that generates similarity/identity matrices using protein or DNA sequences.). Minor manual editing may be performed to optimise alignment between conserved motifs, as would be apparent to a person skilled in the art. Furthermore, instead of using full-length sequences for the identification of homologues, specific domains may also be used. The sequence identity values may be determined over the entire nucleic acid or amino acid sequence or over selected domains or conserved motif(s), using the programs mentioned above using the default parameters. For local alignments, the Smith-Waterman algorithm is particularly useful (Smith T F, Waterman M S (1981) J. Mol. Biol 147(1);195-7).

Reciprocal BLAST

Typically, this involves a first BLAST involving BLASTing a query sequence (for example using any of the sequences listed in Table A of the Examples section) against any sequence database, such as the publicly available NCBI database. BLASTN or TBLASTX (using standard default values) are generally used when starting from a nucleotide sequence, and BLASTP or TBLASTN (using standard default values) when starting from a protein sequence. The BLAST results may optionally be filtered. The full-length sequences of either the filtered results or non-filtered results are then BLASTed back (second BLAST) against sequences from the organism from which the query sequence is derived. The results of the first and second BLASTs are then compared. A paralogue is identified if a high-ranking hit from the first blast is from the same species as from which the query sequence is derived, a BLAST back then ideally results in the query sequence amongst the highest hits; an orthologue is identified if a high-ranking hit in the first BLAST is not from the same species as from which the query sequence is derived, and preferably results upon BLAST back in the query sequence being among the highest hits.

High-ranking hits are those having a low E-value. The lower the E-value, the more significant the score (or in other words the lower the chance that the hit was found by chance). Computation of the E-value is well known in the art. In addition to E-values, comparisons are also scored by percentage identity. Percentage identity refers to the number of identical nucleotides (or amino acids) between the two compared nucleic acid (or polypeptide) sequences over a particular length. In the case of large families, ClustalW may be used, followed by a neighbour joining tree, to help visualize clustering of related genes and to identify orthologues and paralogues.

Hybridisation

The term “hybridisation” as defined herein is a process wherein substantially homologous complementary nucleotide sequences anneal to each other. The hybridisation process can occur entirely in solution, i.e. both complementary nucleic acids are in solution. The hybridisation process can also occur with one of the complementary nucleic acids immobilised to a matrix such as magnetic beads, Sepharose beads or any other resin. The hybridisation process can furthermore occur with one of the complementary nucleic acids immobilised to a solid support such as a nitro-cellulose or nylon membrane or immobilised by e.g. photolithography to, for example, a siliceous glass support (the latter known as nucleic acid arrays or microarrays or as nucleic acid chips). In order to allow hybridisation to occur, the nucleic acid molecules are generally thermally or chemically denatured to melt a double strand into two single strands and/or to remove hairpins or other secondary structures from single stranded nucleic acids.

The term “stringency” refers to the conditions under which a hybridisation takes place. The stringency of hybridisation is influenced by conditions such as temperature, salt concentration, ionic strength and hybridisation buffer composition. Generally, low stringency conditions are selected to be about 30° C. lower than the thermal melting point (T_(m)) for the specific sequence at a defined ionic strength and pH. Medium stringency conditions are when the temperature is 20° C. below T_(m), and high stringency conditions are when the temperature is 10° C. below T_(m). High stringency hybridisation conditions are typically used for isolating hybridising sequences that have high sequence similarity to the target nucleic acid sequence. However, nucleic acids may deviate in sequence and still encode a substantially identical polypeptide, due to the degeneracy of the genetic code. Therefore medium stringency hybridisation conditions may sometimes be needed to identify such nucleic acid molecules.

The Tm is the temperature under defined ionic strength and pH, at which 50% of the target sequence hybridises to a perfectly matched probe. The T_(m) is dependent upon the solution conditions and the base composition and length of the probe. For example, longer sequences hybridise specifically at higher temperatures. The maximum rate of hybridisation is obtained from about 16° C. up to 32° C. below T_(m). The presence of monovalent cations in the hybridisation solution reduce the electrostatic repulsion between the two nucleic acid strands thereby promoting hybrid formation; this effect is visible for sodium concentrations of up to 0.4M (for higher concentrations, this effect may be ignored). Formamide reduces the melting temperature of DNA-DNA and DNA-RNA duplexes with 0.6 to 0.7° C. for each percent formamide, and addition of 50% formamide allows hybridisation to be performed at 30 to 45° C., though the rate of hybridisation will be lowered. Base pair mismatches reduce the hybridisation rate and the thermal stability of the duplexes. On average and for large probes, the Tm decreases about 1° C. per % base mismatch. The Tm may be calculated using the following equations, depending on the types of hybrids:

1) DNA-DNA Hybrids (Meinkoth and Wahl, Anal. Biochem., 138: 267-284, 1984):

T_(m)=81.5° C.+16.6×log₁₀[Na⁺]^(a)+0.41×%[G/C ^(b)]−500×[L^(c)]⁻¹−0.61×% formamide

2) DNA-RNA or RNA-RNA Hybrids:

Tm=79.8+18.5(log₁₀[Na]^(a))+0.58(% G/C ^(b))+11.8(% G/C ^(b))²−820/L ^(c)

3) oligo-DNA or oligo-RNA^(d) hybrids:

For <20 nucleotides: T_(m)=2 (I_(n))

For 20-35 nucleotides: T_(m)=22+1.46 (I_(n))

^(a) or for other monovalent cation, but only accurate in the 0.01-0.4 M range. ^(b) only accurate for % GC in the 30% to 75% range. ^(c) L=length of duplex in base pairs. ^(d) oligo, oligonucleotide; I_(n)=effective length of primer=2×(no. of G/C)+(no. of A/T).

Non-specific binding may be controlled using any one of a number of known techniques such as, for example, blocking the membrane with protein containing solutions, additions of heterologous RNA, DNA, and SDS to the hybridisation buffer, and treatment with Rnase. For non-homologous probes, a series of hybridizations may be performed by varying one of (i) progressively lowering the annealing temperature (for example from 68° C. to 42° C.) or (ii) progressively lowering the formamide concentration (for example from 50% to 0%). The skilled artisan is aware of various parameters which may be altered during hybridisation and which will either maintain or change the stringency conditions.

Besides the hybridisation conditions, specificity of hybridisation typically also depends on the function of post-hybridisation washes. To remove background resulting from non-specific hybridisation, samples are washed with dilute salt solutions. Critical factors of such washes include the ionic strength and temperature of the final wash solution: the lower the salt concentration and the higher the wash temperature, the higher the stringency of the wash. Wash conditions are typically performed at or below hybridisation stringency. A positive hybridisation gives a signal that is at least twice of that of the background. Generally, suitable stringent conditions for nucleic acid hybridisation assays or gene amplification detection procedures are as set forth above. More or less stringent conditions may also be selected. The skilled artisan is aware of various parameters which may be altered during washing and which will either maintain or change the stringency conditions.

For example, typical high stringency hybridisation conditions for DNA hybrids longer than 50 nucleotides encompass hybridisation at 65° C. in 1×SSC or at 42° C. in 1×SSC and 50% formamide, followed by washing at 65° C. in 0.3×SSC. Examples of medium stringency hybridisation conditions for DNA hybrids longer than 50 nucleotides encompass hybridisation at 50° C. in 4×SSC or at 40° C. in 6×SSC and 50% formamide, followed by washing at 50° C. in 2×SSC. The length of the hybrid is the anticipated length for the hybridising nucleic acid. When nucleic acids of known sequence are hybridised, the hybrid length may be determined by aligning the sequences and identifying the conserved regions described herein. 1×SSC is 0.15M NaCl and 15 mM sodium citrate; the hybridisation solution and wash solutions may additionally include 5×Denhardt's reagent, 0.5-1.0% SDS, 100 μg/mil denatured, fragmented salmon sperm DNA, 0.5% sodium pyrophosphate.

For the purposes of defining the level of stringency, reference can be made to Sambrook et al. (2001) Molecular Cloning: a laboratory manual, 3^(rd) Edition, Cold Spring Harbor Laboratory Press, CSH, New York or to Current Protocols in Molecular Biology, John Wiley & Sons, N.Y. (1989 and yearly updates).

Splice Variant

The term “splice variant” as used herein encompasses variants of a nucleic acid sequence in which selected introns and/or exons have been excised, replaced, displaced or added, or in which introns have been shortened or lengthened. Such variants will be ones in which the biological activity of the protein is substantially retained; this may be achieved by selectively retaining functional segments of the protein. Such splice variants may be found in nature or may be manmade. Methods for predicting and isolating such splice variants are well known in the art (see for example Foissac and Schiex (2005) BMC Bioinformatics 6:25).

Allelic Variant

Alleles or allelic variants are alternative forms of a given gene, located at the same chromosomal position. Allelic variants encompass Single Nucleotide Polymorphisms (SNPs), as well as Small Insertion/Deletion Polymorphisms (INDELs). The size of INDELs is usually less than 100 bp. SNPs and INDELs form the largest set of sequence variants in naturally occurring polymorphic strains of most organisms.

Endogenous Gene

Reference herein to an “endogenous” gene not only refers to the gene in question as found in a plant in its natural form (i.e., without there being any human intervention), but also refers to that same gene (or a substantially homologous nucleic acid/gene) in an isolated form subsequently (re)introduced into a plant (a transgene). For example, a transgenic plant containing such a transgene may encounter a substantial reduction of the transgene expression and/or substantial reduction of expression of the endogenous gene. The isolated gene may be isolated from an organism or may be manmade, for example by chemical synthesis.

Gene Shuffling/Directed Evolution

Gene shuffling or directed evolution consists of iterations of DNA shuffling followed by appropriate screening and/or selection to generate variants of nucleic acids or portions thereof encoding proteins having a modified biological activity (Castle et al., (2004) Science 304(5674): 1151-4; U.S. Pat. Nos. 5,811,238 and 6,395,547).

Construct

Additional regulatory elements may include transcriptional as well as translational enhancers. Those skilled in the art will be aware of terminator and enhancer sequences that may be suitable for use in performing the invention. An intron sequence may also be added to the 5′ untranslated region (UTR) or in the coding sequence to increase the amount of the mature message that accumulates in the cytosol, as described in the definitions section. Other control sequences (besides promoter, enhancer, silencer, intron sequences, 3′UTR and/or 5′UTR regions) may be protein and/or RNA stabilizing elements. Such sequences would be known or may readily be obtained by a person skilled in the art.

The genetic constructs of the invention may further include an origin of replication sequence that is required for maintenance and/or replication in a specific cell type. One example is when a genetic construct is required to be maintained in a bacterial cell as an episomal genetic element (e.g. plasmid or cosmid molecule). Preferred origins of replication include, but are not limited to, the f1-ori and colE1.

For the detection of the successful transfer of the nucleic acid sequences as used in the methods of the invention and/or selection of transgenic plants comprising these nucleic acids, it is advantageous to use marker genes (or reporter genes). Therefore, the genetic construct may optionally comprise a selectable marker gene. Selectable markers are described in more detail in the “definitions” section herein. The marker genes may be removed or excised from the transgenic cell once they are no longer needed. Techniques for marker removal are known in the art, useful techniques are described above in the definitions section.

Regulatory Element/Control Sequence/Promoter

The terms “regulatory element”, “control sequence” and “promoter” are all used interchangeably herein and are to be taken in a broad context to refer to regulatory nucleic acid sequences capable of effecting expression of the sequences to which they are ligated. The term “promoter” typically refers to a nucleic acid control sequence located upstream from the transcriptional start of a gene and which is involved in recognising and binding of RNA polymerase and other proteins, thereby directing transcription of an operably linked nucleic acid. Encompassed by the aforementioned terms are transcriptional regulatory sequences derived from a classical eukaryotic genomic gene (including the TATA box which is required for accurate transcription initiation, with or without a CCAAT box sequence) and additional regulatory elements (i.e. upstream activating sequences, enhancers and silencers) which alter gene expression in response to developmental and/or external stimuli, or in a tissue-specific manner. Also included within the term is a transcriptional regulatory sequence of a classical prokaryotic gene, in which case it may include a—35 box sequence and/or—10 box transcriptional regulatory sequences. The term “regulatory element” also encompasses a synthetic fusion molecule or derivative that confers, activates or enhances expression of a nucleic acid molecule in a cell, tissue or organ.

A “plant promoter” comprises regulatory elements, which mediate the expression of a coding sequence segment in plant cells. Accordingly, a plant promoter need not be of plant origin, but may originate from viruses or micro-organisms, for example from viruses which attack plant cells. The “plant promoter” can also originate from a plant cell, e.g. from the plant which is transformed with the nucleic acid sequence to be expressed in the inventive process and described herein. This also applies to other “plant” regulatory signals, such as “plant” terminators. The promoters upstream of the nucleotide sequences useful in the methods of the present invention can be modified by one or more nucleotide substitution(s), insertion(s) and/or deletion(s) without interfering with the functionality or activity of either the promoters, the open reading frame (ORF) or the 3′-regulatory region such as terminators or other 3′ regulatory regions which are located away from the ORF. It is furthermore possible that the activity of the promoters is increased by modification of their sequence, or that they are replaced completely by more active promoters, even promoters from heterologous organisms. For expression in plants, the nucleic acid molecule must, as described above, be linked operably to or comprise a suitable promoter which expresses the gene at the right point in time and with the required spatial expression pattern.

For the identification of functionally equivalent promoters, the promoter strength and/or expression pattern of a candidate promoter may be analysed for example by operably linking the promoter to a reporter gene and assaying the expression level and pattern of the reporter gene in various tissues of the plant. Suitable well-known reporter genes include for example beta-glucuronidase or beta-galactosidase. The promoter activity is assayed by measuring the enzymatic activity of the beta-glucuronidase or beta-galactosidase. The promoter strength and/or expression pattern may then be compared to that of a reference promoter (such as the one used in the methods of the present invention). Alternatively, promoter strength may be assayed by quantifying mRNA levels or by comparing mRNA levels of the nucleic acid used in the methods of the present invention, with mRNA levels of housekeeping genes such as 18S rRNA, using methods known in the art, such as Northern blotting with densitometric analysis of autoradiograms, quantitative real-time PCR or RT-PCR (Heid et al., 1996 Genome Methods 6: 986-994). Generally by “weak promoter” is intended a promoter that drives expression of a coding sequence at a low level. By “low level” is intended at levels of about 1/10,000 transcripts to about 11100,000 transcripts, to about 1/500,0000 transcripts per cell. Conversely, a “strong promoter” drives expression of a coding sequence at high level, or at about 1/10 transcripts to about 1/100 transcripts to about 1/1000 transcripts per cell. Generally, by “medium strength promoter” is intended a promoter that drives expression of a coding sequence at a lower level than a strong promoter, in particular at a level that is in all instances below that obtained when under the control of a 35S CaMV promoter.

Operably Linked

The term “operably linked” as used herein refers to a functional linkage between the promoter sequence and the gene of interest, such that the promoter sequence is able to initiate transcription of the gene of interest.

Constitutive Promoter

A “constitutive promoter” refers to a promoter that is transcriptionally active during most, but not necessarily all, phases of growth and development and under most environmental conditions, in at least one cell, tissue or organ. Table 2a below gives examples of constitutive promoters.

TABLE 2a Examples of constitutive promoters Gene Source Reference Actin McElroy et al, Plant Cell, 2: 163-171, 1990 HMGP WO 2004/070039 CAMV 35S Odell et al, Nature, 313: 810-812, 1985 CaMV 19S Nilsson et al., Physiol. Plant. 100: 456-462, 1997 GOS2 de Pater et al, Plant J Nov; 2(6): 837-44, 1992, WO 2004/065596 Ubiquitin Christensen et al, Plant Mol. Biol. 18: 675-689, 1992 Rice cyclophilin Buchholz et al, Plant Mol Biol. 25(5): 837-43, 1994 Maize H3 histone Lepetit et al, Mol. Gen. Genet. 231: 276-285, 1992 Alfalfa H3 Wu et al. Plant Mol. Biol. 11: 641-649, 1988 histone Actin 2 An et al, Plant J. 10(1); 107-121, 1996 34S FMV Sanger et al., Plant. Mol. Biol., 14, 1990: 433-443 Rubisco small U.S. Pat. No. 4,962,028 subunit OCS Leisner (1988) Proc Natl Acad Sci USA 85(5): 2553 SAD1 Jain et al., Crop Science, 39 (6), 1999: 1696 SAD2 Jain et al., Crop Science, 39 (6), 1999: 1696 nos Shaw et al. (1984) Nucleic Acids Res. 12(20): 7831-7846 V-ATPase WO 01/14572 Super promoter WO 95/14098 G-box proteins WO 94/12015

Ubiquitous Promoter

A ubiquitous promoter is active in substantially all tissues or cells of an organism.

Developmentally-Regulated Promoter

A developmentally-regulated promoter is active during certain developmental stages or in parts of the plant that undergo developmental changes.

Inducible Promoter

An inducible promoter has induced or increased transcription initiation in response to a chemical (for a review see Gatz 1997, Annu. Rev. Plant Physiol. Plant Mol. Biol., 48:89-108), environmental or physical stimulus, or may be “stress-inducible”, i.e. activated when a plant is exposed to various stress conditions, or a “pathogen-inducible” i.e. activated when a plant is exposed to exposure to various pathogens.

Organ-Specific/Tissue-Specific Promoter

An organ-specific or tissue-specific promoter is one that is capable of preferentially initiating transcription in certain organs or tissues, such as the leaves, roots, seed tissue etc. For example, a “root-specific promoter” is a promoter that is transcriptionally active predominantly in plant roots, substantially to the exclusion of any other parts of a plant, whilst still allowing for any leaky expression in these other plant parts. Promoters able to initiate transcription in certain cells only are referred to herein as “cell-specific”.

Examples of root-specific promoters are listed in Table 2b below:

TABLE 2b Examples of root-specific promoters Gene Source Reference RCc3 Plant Mol Biol. 1995 January; 27(2): 237-48 Arabidopsis PHT1 Kovama et al., 2005; Mudge et al. (2002, Plant J. 31: 341) Medicago phosphate Xiao et al., 2006 transporter Arabidopsis Pyk10 Nitz et al. (2001) Plant Sci 161(2): 337-346 root-expressible genes Tingey et al., EMBO J. 6: 1, 1987. tobacco auxin- Van der Zaal et al., Plant Mol. Biol. 16, inducible gene 983, 1991. β-tubulin Oppenheimer, et al., Gene 63: 87, 1988. tobacco root- Conkling, et al., Plant Physiol. 93: 1203, 1990. specific genes B. napus G1-3b gene U.S. Pat. No. 5,401,836 SbPRP1 Suzuki et al., Plant Mol. Biol. 21: 109-119, 1993. LRX1 Baumberger et al. 2001, Genes & Dev. 15: 1128 BTG-26 Brassica US 20050044585 napus LeAMT1 (tomato) Lauter et al. (1996, PNAS 3: 8139) The LeNRT1-1 Lauter et al. (1996, PNAS 3: 8139) (tomato) class I patatin Liu et al., Plant Mol. Biol. 153: 386-395, 1991. gene (potato) KDC1 (Daucus Downey et al. (2000, J. Biol. Chem. 275: 39420) carota) TobRB7 gene W Song (1997) PhD Thesis, North Carolina State University, Raleigh, NC USA OsRAB5a (rice) Wang et al. 2002, Plant Sci. 163: 273 ALF5 (Arabidopsis) Diener et al. (2001, Plant Cell 13: 1625) NRT2; 1Np (N. Quesada et al. (1997, Plant Mol. Biol. 34: 265) plumbaginifolia)

A seed-specific promoter is transcriptionally active predominantly in seed tissue, but not necessarily exclusively in seed tissue (in cases of leaky expression). The seed-specific promoter may be active during seed development and/or during germination. The seed specific promoter may be endosperm/aleurone/embryo specific. Examples of seed-specific promoters (endosperm/aleurone/embryo specific) are shown in Table 2c to Table 2f below. Further examples of seed-specific promoters are given in Qing Qu and Takaiwa (Plant Biotechnol. J. 2, 113-125, 2004), which disclosure is incorporated by reference herein as if fully set forth.

TABLE 2c Examples of seed-specific promoters Gene source Reference seed-specific genes Simon et al., Plant Mol. Biol. 5: 191, 1985; Scofield et al., J. Biol. Chem. 262: 12202, 1987.; Baszczynski et al., Plant Mol. Biol. 14: 633, 1990. Brazil Nut albumin Pearson et al., Plant Mol. Biol. 18: 235-245, 1992. legumin Ellis et al., Plant Mol. Biol. 10: 203-214, 1988. glutelin (rice) Takaiwa et al., Mol. Gen. Genet. 208: 15-22, 1986; Takaiwa et al., FEBS Letts. 221: 43-47, 1987. zein Matzke et al Plant Mol Biol, 14(3): 323-32 1990 napA Stalberg et al, Planta 199: 515-519, 1996. wheat LMW and HMW Mol Gen Genet 216: 81-90, 1989; NAR 17: 461-2, 1989 glutenin-1 wheat SPA Albani et al, Plant Cell, 9: 171-184, 1997 wheat α, β, γ-gliadins EMBO J. 3: 1409-15, 1984 barley Itr1 promoter Diaz et al. (1995) Mol Gen Genet 248(5): 592-8 barley B1, C, D, hordein Theor Appl Gen 98: 1253-62, 1999; Plant J 4: 343-55, 1993; Mol Gen Genet 250: 750-60, 1996 barley DOF Mena et al, The Plant Journal, 116(1): 53-62, 1998 blz2 EP99106056.7 synthetic promoter Vicente-Carbajosa et al., Plant J. 13: 629-640, 1998. rice prolamin NRP33 Wu et al, Plant Cell Physiology 39(8) 885-889, 1998 rice a-globulin Glb-1 Wu et al, Plant Cell Physiology 39(8) 885-889, 1998 rice OSH1 Sato et al, Proc. Natl. Acad. Sci. USA, 93: 8117-8122, 1996 rice α-globulin REB/OHP-1 Nakase et al. Plant Mol. Biol. 33: 513-522, 1997 rice ADP-glucose pyrophos- Trans Res 6: 157-68, 1997 phorylase maize ESR gene family Plant J 12: 235-46, 1997 sorghum α-kafirin DeRose et al., Plant Mol. Biol 32: 1029-35, 1996 KNOX Postma-Haarsma et al, Plant Mol. Biol. 39: 257-71, 1999 rice oleosin Wu et al, J. Biochem. 123: 386, 1998 sunflower oleosin Cummins et al., Plant Mol. Biol. 19: 873-876, 1992 PRO0117, putative rice 40S WO 2004/070039 ribosomal protein PRO0136, rice alanine unpublished aminotransferase PRO0147, trypsin inhibitor unpublished ITR1 (barley) PRO0151, rice WSI18 WO 2004/070039 PRO0175, rice RAB21 WO 2004/070039 PRO005 WO 2004/070039 PRO0095 WO 2004/070039 α-amylase (Amy32b) Lanahan et al, Plant Cell 4: 203-211, 1992; Skriver et al, Proc Natl Acad Sci USA 88: 7266-7270, 1991 cathepsin β-like gene Cejudo et al, Plant Mol Biol 20: 849-856, 1992 Barley Ltp2 Kalla et al., Plant J. 6: 849-60, 1994 Chi26 Leah et al., Plant J. 4: 579-89, 1994 Maize B-Peru Selinger et al., Genetics 149; 1125-38, 1998

TABLE 2d examples of endosperm-specific promoters Gene source Reference glutelin (rice) Takaiwa et al. (1986) Mol Gen Genet 208: 15-22; Takaiwa et al. (1987) FEBS Letts. 221: 43-47 zein Matzke et al., (1990) Plant Mol Biol 14(3): 323-32 wheat LMW Colot et al. (1989) Mol Gen Genet 216: 81-90, and HMW Anderson et al. (1989) NAR 17: 461-2 glutenin-1 wheat SPA Albani et al. (1997) Plant Cell 9: 171-184 wheat gliadins Rafalski et al. (1984) EMBO 3: 1409-15 barley Itr1 Diaz et al. (1995) Mol Gen Genet 248(5): 592-8 promoter barley B1, C, D, Cho et al. (1999) Theor Appl Genet 98: 1253-62; hordein Muller et al. (1993) Plant J 4: 343-55; Sorenson et al. (1996) Mol Gen Genet 250: 750-60 barley DOF Mena et al, (1998) Plant J 116(1): 53-62 blz2 Onate et al. (1999) J Biol Chem 274(14): 9175-82 synthetic promoter Vicente-Carbajosa et al. (1998) Plant J 13: 629-640 rice prolamin Wu et al, (1998) Plant Cell Physiol 39(8) 885-889 NRP33 rice globulin Wu et al. (1998) Plant Cell Physiol 39(8) 885-889 Glb-1 rice globulin Nakase et al. (1997) Plant Molec Biol 33: 513-522 REB/OHP-1 rice ADP-glucose Russell et al. (1997) Trans Res 6: 157-68 pyrophosphorylase maize ESR Opsahl-Ferstad et al. (1997) Plant J 12: 235-46 gene family sorghum kafirin DeRose et al. (1996) Plant Mol Biol 32: 1029-35

TABLE 2e Examples of embryo specific promoters: Gene source Reference rice OSH1 Sato et al, Proc. Natl. Acad. Sci. USA, 93: 8117-8122, 1996 KNOX Postma-Haarsma et al, Plant Mol. Biol. 39: 257-71, 1999 PRO0151 WO 2004/070039 PRO0175 WO 2004/070039 PRO005 WO 2004/070039 PRO0095 WO 2004/070039

TABLE 2f Examples of aleurone-specific promoters: Gene source Reference α-amylase Lanahan et al, Plant Cell 4: 203-211, 1992; (Amy32b) Skriver et al, Proc Natl Acad Sci USA 88: 7266-7270, 1991 cathepsin β-like gene Cejudo et al, Plant Mol Biol 20: 849-856, 1992 Barley Ltp2 Kalla et al., Plant J. 6: 849-60, 1994 Chi26 Leah et al., Plant J. 4: 579-89, 1994 Maize B-Peru Selinger et al., Genetics 149; 1125-38, 1998

A green tissue-specific promoter as defined herein is a promoter that is transcriptionally active predominantly in green tissue, substantially to the exclusion of any other parts of a plant, whilst still allowing for any leaky expression in these other plant parts.

Examples of green tissue-specific promoters which may be used to perform the methods of the invention are shown in Table 2g below.

TABLE 2g Examples of green tissue-specific promoters Gene Expression Reference Maize Orthophosphate dikinase Leaf specific Fukavama et al., 2001 Maize Phosphoenolpyruvate Leaf specific Kausch et al., 2001 carboxylase Rice Phosphoenolpyruvate Leaf specific Liu et al., 2003 carboxylase Rice small subunit Rubisco Leaf specific Nomura et al., 2000 rice beta expansin EXBP9 Shoot specific WO 2004/070039 Pigeonpea small subunit Rubisco Leaf specific Panguluri et al., 2005 Pea RBCS3A Leaf specific

Another example of a tissue-specific promoter is a meristem-specific promoter, which is transcriptionally active predominantly in meristematic tissue, substantially to the exclusion of any other parts of a plant, whilst still allowing for any leaky expression in these other plant parts. Examples of green meristem-specific promoters which may be used to perform the methods of the invention are shown in Table 2h below.

TABLE 2h Examples of meristem-specific promoters Gene source Expression pattern Reference rice OSH1 Shoot apical meristem, Sato et al. (1996) from embryo globular Proc. Natl. Acad. Sci. stage to seedling stage USA, 93: 8117-8122 Rice metallothionein Meristem specific BAD87835.1 WAK1 & WAK 2 Shoot and root apical Wagner & Kohorn meristems, and in ex- (2001) Plant Cell panding leaves and sepals 13(2): 303-318

Terminator

The term “terminator” encompasses a control sequence which is a DNA sequence at the end of a transcriptional unit which signals 3′ processing and polyadenylation of a primary transcript and termination of transcription. The terminator can be derived from the natural gene, from a variety of other plant genes, or from T-DNA. The terminator to be added may be derived from, for example, the nopaline synthase or octopine synthase genes, or alternatively from another plant gene, or less preferably from any other eukaryotic gene.

Selectable Marker (Gene)/Reporter Gene

“Selectable marker”, “selectable marker gene” or “reporter gene” includes any gene that confers a phenotype on a cell in which it is expressed to facilitate the identification and/or selection of cells that are transfected or transformed with a nucleic acid construct of the invention. These marker genes enable the identification of a successful transfer of the nucleic acid molecules via a series of different principles. Suitable markers may be selected from markers that confer antibiotic or herbicide resistance, that introduce a new metabolic trait or that allow visual selection. Examples of selectable marker genes include genes conferring resistance to antibiotics (such as nptII that phosphorylates neomycin and kanamycin, or hpt, phosphorylating hygromycin, or genes conferring resistance to, for example, bleomycin, streptomycin, tetracyclin, chloramphenicol, ampicillin, gentamycin, geneticin (G418), spectinomycin or blasticidin), to herbicides (for example bar which provides resistance to Basta®; aroA or gox providing resistance against glyphosate, or the genes conferring resistance to, for example, imidazolinone, phosphinothricin or sulfonylurea), or genes that provide a metabolic trait (such as manA that allows plants to use mannose as sole carbon source or xylose isomerase for the utilisation of xylose, or antinutritive markers such as the resistance to 2-deoxyglucose). Expression of visual marker genes results in the formation of colour (for example β-glucuronidase, GUS or β-galactosidase with its coloured substrates, for example X-Gal), luminescence (such as the luciferin/luceferase system) or fluorescence (Green Fluorescent Protein, GFP, and derivatives thereof). This list represents only a small number of possible markers. The skilled worker is familiar with such markers. Different markers are preferred, depending on the organism and the selection method.

It is known that upon stable or transient integration of nucleic acids into plant cells, only a minority of the cells takes up the foreign DNA and, if desired, integrates it into its genome, depending on the expression vector used and the transfection technique used. To identify and select these integrants, a gene coding for a selectable marker (such as the ones described above) is usually introduced into the host cells together with the gene of interest. These markers can for example be used in mutants in which these genes are not functional by, for example, deletion by conventional methods. Furthermore, nucleic acid molecules encoding a selectable marker can be introduced into a host cell on the same vector that comprises the sequence encoding the polypeptides of the invention or used in the methods of the invention, or else in a separate vector. Cells which have been stably transfected with the introduced nucleic acid can be identified for example by selection (for example, cells which have integrated the selectable marker survive whereas the other cells die).

Since the marker genes, particularly genes for resistance to antibiotics and herbicides, are no longer required or are undesired in the transgenic host cell once the nucleic acids have been introduced successfully, the process according to the invention for introducing the nucleic acids advantageously employs techniques which enable the removal or excision of these marker genes. One such a method is what is known as co-transformation. The co-transformation method employs two vectors simultaneously for the transformation, one vector bearing the nucleic acid according to the invention and a second bearing the marker gene(s). A large proportion of transformants receives or, in the case of plants, comprises (up to 40% or more of the transformants), both vectors. In case of transformation with Agrobacteria, the transformants usually receive only a part of the vector, i.e. the sequence flanked by the T-DNA, which usually represents the expression cassette. The marker genes can subsequently be removed from the transformed plant by performing crosses. In another method, marker genes integrated into a transposon are used for the transformation together with desired nucleic acid (known as the Ac/Ds technology). The transformants can be crossed with a transposase source or the transformants are transformed with a nucleic acid construct conferring expression of a transposase, transiently or stable. In some cases (approx. 10%), the transposon jumps out of the genome of the host cell once transformation has taken place successfully and is lost. In a further number of cases, the transposon jumps to a different location. In these cases the marker gene must be eliminated by performing crosses. In microbiology, techniques were developed which make possible, or facilitate, the detection of such events. A further advantageous method relies on what is known as recombination systems; whose advantage is that elimination by crossing can be dispensed with. The best-known system of this type is what is known as the Cre/lox system. Cre1 is a recombinase that removes the sequences located between the loxP sequences. If the marker gene is integrated between the loxP sequences, it is removed once transformation has taken place successfully, by expression of the recombinase. Further recombination systems are the HIN/HIX, FLP/FRT and REP/STB system (Tribble et al., J. Biol. Chem., 275, 2000: 22255-22267; Velmurugan et al., J. Cell Biol., 149, 2000: 553-566). A site-specific integration into the plant genome of the nucleic acid sequences according to the invention is possible. Naturally, these methods can also be applied to microorganisms such as yeast, fungi or bacteria.

Transgenic/Transgene/Recombinant

For the purposes of the invention, “transgenic”, “transgene” or “recombinant” means with regard to, for example, a nucleic acid sequence, an expression cassette, gene construct or a vector comprising the nucleic acid sequence or an organism transformed with the nucleic acid sequences, expression cassettes or vectors according to the invention, all those constructions brought about by recombinant methods in which either

-   -   (a) the nucleic acid sequences encoding proteins useful in the         methods of the invention, or     -   (b) genetic control sequence(s) which is operably linked with         the nucleic acid sequence according to the invention, for         example a promoter, or     -   (c) a) and b)         are not located in their natural genetic environment or have         been modified by recombinant methods, it being possible for the         modification to take the form of, for example, a substitution,         addition, deletion, inversion or insertion of one or more         nucleotide residues. The natural genetic environment is         understood as meaning the natural genomic or chromosomal locus         in the original plant or the presence in a genomic library. In         the case of a genomic library, the natural genetic environment         of the nucleic acid sequence is preferably retained, at least in         part. The environment flanks the nucleic acid sequence at least         on one side and has a sequence length of at least 50 bp,         preferably at least 500 bp, especially preferably at least 1000         bp, most preferably at least 5000 bp. A naturally occurring         expression cassette—for example the naturally occurring         combination of the natural promoter of the nucleic acid         sequences with the corresponding nucleic acid sequence encoding         a polypeptide useful in the methods of the present invention, as         defined above—becomes a transgenic expression cassette when this         expression cassette is modified by non-natural, synthetic         (“artificial”) methods such as, for example, mutagenic         treatment. Suitable methods are described, for example, in U.S.         Pat. No. 5,565,350 or WO 00/15815.

A transgenic plant for the purposes of the invention is thus understood as meaning, as above, that the nucleic acids used in the method of the invention are not at their natural locus in the genome of said plant, it being possible for the nucleic acids to be expressed homologously or heterologously. However, as mentioned, transgenic also means that, while the nucleic acids according to the invention or used in the inventive method are at their natural position in the genome of a plant, the sequence has been modified with regard to the natural sequence, and/or that the regulatory sequences of the natural sequences have been modified. Transgenic is preferably understood as meaning the expression of the nucleic acids according to the invention at an unnatural locus in the genome, i.e. homologous or, preferably, heterologous expression of the nucleic acids takes place. Preferred transgenic plants are mentioned herein.

Modulation

The term “modulation” means in relation to expression or gene expression, a process in which the expression level is changed by said gene expression in comparison to the control plant, the expression level may be increased or decreased. The original, unmodulated expression may be of any kind of expression of a structural RNA (rRNA, tRNA) or mRNA with subsequent translation. The term “modulating the activity” shall mean any change of the expression of the inventive nucleic acid sequences or encoded proteins, which leads to increased yield and/or increased growth of the plants.

Expression

The term “expression” or “gene expression” means the transcription of a specific gene or specific genes or specific genetic construct. The term “expression” or “gene expression” in particular means the transcription of a gene or genes or genetic construct into structural RNA (rRNA, tRNA) or mRNA with or without subsequent translation of the latter into a protein. The process includes transcription of DNA and processing of the resulting mRNA product.

Increased Expression/Overexpression

The term “increased expression” or “overexpression” as used herein means any form of expression that is additional to the original wild-type expression level.

Methods for increasing expression of genes or gene products are well documented in the art and include, for example, overexpression driven by appropriate promoters, the use of transcription enhancers or translation enhancers. Isolated nucleic acids which serve as promoter or enhancer elements may be introduced in an appropriate position (typically upstream) of a non-heterologous form of a polynucleotide so as to upregulate expression of a nucleic acid encoding the polypeptide of interest. For example, endogenous promoters may be altered in vivo by mutation, deletion, and/or substitution (see, Kmiec, U.S. Pat. No. 5,565,350; Zarling at al., WO9322443), or isolated promoters may be introduced into a plant cell in the proper orientation and distance from a gene of the present invention so as to control the expression of the gene.

If polypeptide expression is desired, it is generally desirable to include a polyadenytation region at the 3′-end of a polynucleotide coding region. The polyadenylation region can be derived from the natural gene, from a variety of other plant genes, or from T-DNA. The 3′ end sequence to be added may be derived from, for example, the nopaline synthase or octopine synthase genes, or alternatively from another plant gene, or less preferably from any other eukaryotic gene.

An intron sequence may also be added to the 5′ untranslated region (UTR) or the coding sequence of the partial coding sequence to increase the amount of the mature message that accumulates in the cytosol. Inclusion of a spilceable intron in the transcription unit in both plant and animal expression constructs has been shown to increase gene expression at both the mRNA and protein levels up to 1000-fold (Buchman and Berg (1988) Mol. Cell biol. 8: 4395-4405; Callis et al. (1987) Genes Dev 1:1183-1200). Such intron enhancement of gene expression is typically greatest when placed near the 5′ end of the transcription unit. Use of the maize introns Adh1-S intron 1, 2, and 6, the Bronze-1 intron are known in the art. For general information see: The Maize Handbook, Chapter 116, Freeling and Walbot, Eds., Springer, N.Y. (1994).

Decreased Expression

Reference herein to “decreased expression” or “reduction or substantial elimination” of expression is taken to mean a decrease in endogenous gene expression and/or polypeptide levels and/or polypeptide activity relative to control plants. The reduction or substantial elimination is in increasing order of preference at least 10%, 20%, 30%, 40% or 50%, 60%, 70%, 80%, 85%, 90%, or 95%, 96%, 97%, 98%, 99% or more reduced compared to that of control plants.

For the reduction or substantial elimination of expression an endogenous gene in a plant, a sufficient length of substantially contiguous nucleotides of a nucleic acid sequence is required. In order to perform gene silencing, this may be as little as 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10 or fewer nucleotides, alternatively this may be as much as the entire gene (including the 5′ and/or 3′ UTR, either in part or in whole). The stretch of substantially contiguous nucleotides may be derived from the nucleic acid encoding the protein of interest (target gene), or from any nucleic acid capable of encoding an orthologue, paralogue or homologue of the protein of interest. Preferably, the stretch of substantially contiguous nucleotides is capable of forming hydrogen bonds with the target gene (either sense or antisense strand), more preferably, the stretch of substantially contiguous nucleotides has, in increasing order of preference, 50%, 60%, 70%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100% sequence identity to the target gene (either sense or antisense strand). A nucleic acid sequence encoding a (functional) polypeptide is not a requirement for the various methods discussed herein for the reduction or substantial elimination of expression of an endogenous gene.

This reduction or substantial elimination of expression may be achieved using routine tools and techniques. A preferred method for the reduction or substantial elimination of endogenous gene expression is by introducing and expressing in a plant a genetic construct into which the nucleic acid (in this case a stretch of substantially contiguous nucleotides derived from the gene of interest, or from any nucleic acid capable of encoding an orthologue, paralogue or homologue of any one of the protein of interest) is cloned as an inverted repeat (in part or completely), separated by a spacer (non-coding DNA).

In such a preferred method, expression of the endogenous gene is reduced or substantially eliminated through RNA-mediated silencing using an inverted repeat of a nucleic acid or a part thereof (in this case a stretch of substantially contiguous nucleotides derived from the gene of interest, or from any nucleic acid capable of encoding an orthologue, paralogue or homologue of the protein of interest), preferably capable of forming a hairpin structure. The inverted repeat is cloned in an expression vector comprising control sequences. A non-coding DNA nucleic acid sequence (a spacer, for example a matrix attachment region fragment (MAR), an intron, a polylinker, etc.) is located between the two inverted nucleic acids forming the inverted repeat. After transcription of the inverted repeat, a chimeric RNA with a self-complementary structure is formed (partial or complete). This double-stranded RNA structure is referred to as the hairpin RNA (hpRNA). The hpRNA is processed by the plant into siRNAs that are incorporated into an RNA-induced silencing complex (RISC). The RISC further cleaves the mRNA transcripts, thereby substantially reducing the number of mRNA transcripts to be translated into polypeptides. For further general details see for example, Grierson et al. (1998) WO 98/53083; Waterhouse et al. (1999) WO 99/53050).

Performance of the methods of the invention does not rely on introducing and expressing in a plant a genetic construct into which the nucleic acid is cloned as an inverted repeat, but any one or more of several well-known “gene silencing” methods may be used to achieve the same effects.

One such method for the reduction of endogenous gene expression is RNA-mediated silencing of gene expression (downregulation). Silencing in this case is triggered in a plant by a double stranded RNA sequence (dsRNA) that is substantially similar to the target endogenous gene. This dsRNA is further processed by the plant into about 20 to about 26 nucleotides called short interfering RNAs (siRNAs). The siRNAs are incorporated into an RNA-induced silencing complex (RISC) that cleaves the mRNA transcript of the endogenous target gene, thereby substantially reducing the number of mRNA transcripts to be translated into a polypeptide. Preferably, the double stranded RNA sequence corresponds to a target gene.

Another example of an RNA silencing method involves the introduction of nucleic acid sequences or parts thereof (in this case a stretch of substantially contiguous nucleotides derived from the gene of interest, or from any nucleic acid capable of encoding an orthologue, paralogue or homologue of the protein of interest) in a sense orientation into a plant. “Sense orientation” refers to a DNA sequence that is homologous to an mRNA transcript thereof. Introduced into a plant would therefore be at least one copy of the nucleic acid sequence. The additional nucleic acid sequence will reduce expression of the endogenous gene, giving rise to a phenomenon known as co-suppression. The reduction of gene expression will be more pronounced if several additional copies of a nucleic acid sequence are introduced into the plant, as there is a positive correlation between high transcript levels and the triggering of co-suppression.

Another example of an RNA silencing method involves the use of antisense nucleic acid sequences. An “antisense” nucleic acid sequence comprises a nucleotide sequence that is complementary to a “sense” nucleic acid sequence encoding a protein, i.e. complementary to the coding strand of a double-stranded cDNA molecule or complementary to an mRNA transcript sequence. The antisense nucleic acid sequence is preferably complementary to the endogenous gene to be silenced. The complementarity may be located in the “coding region” and/or in the “non-coding region” of a gene. The term “coding region” refers to a region of the nucleotide sequence comprising codons that are translated into amino acid residues. The term “non-coding region” refers to 5′ and 3′ sequences that flank the coding region that are transcribed but not translated into amino acids (also referred to as 5′ and 3′ untranslated regions).

Antisense nucleic acid sequences can be designed according to the rules of Watson and Crick base pairing. The antisense nucleic acid sequence may be complementary to the entire nucleic acid sequence (in this case a stretch of substantially contiguous nucleotides derived from the gene of interest, or from any nucleic acid capable of encoding an orthologue, paralogue or homologue of the protein of interest), but may also be an oligonucleotide that is antisense to only a part of the nucleic acid sequence (including the mRNA 5′ and 3′ UTR). For example, the antisense oligonucleotide sequence may be complementary to the region surrounding the translation start site of an mRNA transcript encoding a polypeptide. The length of a suitable antisense oligonucleotide sequence is known in the art and may start from about 50, 45, 40, 35, 30, 25, 20, 15 or 10 nucleotides in length or less. An antisense nucleic acid sequence according to the invention may be constructed using chemical synthesis and enzymatic ligation reactions using methods known in the art. For example, an antisense nucleic acid sequence (e.g., an antisense oligonucleotide sequence) may be chemically synthesized using naturally occurring nucleotides or variously modified nucleotides designed to increase the biological stability of the molecules or to increase the physical stability of the duplex formed between the antisense and sense nucleic acid sequences, e.g., phosphorothioate derivatives and acridine substituted nucleotides may be used. Examples of modified nucleotides that may be used to generate the antisense nucleic acid sequences are well known in the art. Known nucleotide modifications include methylation, cyclization and ‘caps’ and substitution of one or more of the naturally occurring nucleotides with an analogue such as inosine. Other modifications of nucleotides are well known in the art.

The antisense nucleic acid sequence can be produced biologically using an expression vector into which a nucleic acid sequence has been subcloned in an antisense orientation (i.e., RNA transcribed from the inserted nucleic acid will be of an antisense orientation to a target nucleic acid of interest). Preferably, production of antisense nucleic acid sequences in plants occurs by means of a stably integrated nucleic acid construct comprising a promoter, an operably linked antisense oligonucleotide, and a terminator.

The nucleic acid molecules used for silencing in the methods of the invention (whether introduced into a plant or generated in situ) hybridize with or bind to mRNA transcripts and/or genomic DNA encoding a polypeptide to thereby inhibit expression of the protein, e.g., by inhibiting transcription and/or translation. The hybridization can be by conventional nucleotide complementarity to form a stable duplex, or, for example, in the case of an antisense nucleic acid sequence which binds to DNA duplexes, through specific interactions in the major groove of the double helix. Antisense nucleic acid sequences may be introduced into a plant by transformation or direct injection at a specific tissue site.

Alternatively, antisense nucleic acid sequences can be modified to target selected cells and then administered systemically. For example, for systemic administration, antisense nucleic acid sequences can be modified such that they specifically bind to receptors or antigens expressed on a selected cell surface, e.g., by linking the antisense nucleic acid sequence to peptides or antibodies which bind to cell surface receptors or antigens. The antisense nucleic acid sequences can also be delivered to cells using the vectors described herein.

According to a further aspect, the antisense nucleic acid sequence is an a-anomeric nucleic acid sequence. An a-anomeric nucleic add sequence forms specific double-stranded hybrids with complementary RNA in which, contrary to the usual b-units, the strands run parallel to each other (Gaultier et al. (1987) Nucl Ac Res 15: 6625-6641). The antisense nucleic acid sequence may also comprise a 2′-o-methylribonucleotide (Inoue et al. (1987) Nucl Ac Res 15, 6131-6148) or a chimeric RNA-DNA analogue (Inoue et al. (1987) FEBS Lett. 215, 327-330).

The reduction or substantial elimination of endogenous gene expression may also be performed using ribozymes. Ribozymes are catalytic RNA molecules with ribonuclease activity that are capable of cleaving a single-stranded nucleic acid sequence, such as an mRNA, to which they have a complementary region. Thus, ribozymes (e.g., hammerhead ribozymes (described in Haselhoff and Gerlach (1988) Nature 334, 585-591) can be used to catalytically cleave mRNA transcripts encoding a polypeptide, thereby substantially reducing the number of mRNA transcripts to be translated into a polypeptide. A ribozyme having specificity for a nucleic acid sequence can be designed (see for example: Cech et al. U.S. Pat. No. 4,987,071; and Cech et al. U.S. Pat. No. 5,116,742). Alternatively, mRNA transcripts corresponding to a nucleic acid sequence can be used to select a catalytic RNA having a specific ribonuclease activity from a pool of RNA molecules (Bartel and Szostak (1993) Science 261, 1411-1418). The use of ribozymes for gene silencing in plants is known in the art (e.g., Atkins et al. (1994) WO 94/00012; Lenne et al. (1995) WO 95/03404; Lutziger et al. (2000) WO 00/00619; Prinsen et al. (1997) WO 97/13865 and Scott et al. (1997) WO 97/38116).

Gene silencing may also be achieved by insertion mutagenesis (for example, T-DNA insertion or transposon insertion) or by strategies as described by, among others, Angell and Baulcombe ((1999) Plant J 20(3): 357-62), (Amplicon VIGS WO 98/36083), or Baulcombe (WO 99/15682).

Gene silencing may also occur if there is a mutation on an endogenous gene and/or a mutation on an isolated gene/nucleic acid subsequently introduced into a plant. The reduction or substantial elimination may be caused by a non-functional polypeptide. For example, the polypeptide may bind to various interacting proteins; one or more mutation(s) and/or truncation(s) may therefore provide for a polypeptide that is still able to bind Interacting proteins (such as receptor proteins) but that cannot exhibit its normal function (such as signalling ligand).

A further approach to gene silencing is by targeting nucleic acid sequences complementary to the regulatory region of the gene (e.g., the promoter and/or enhancers) to form triple helical structures that prevent transcription of the gene in target cells. See Helene, C., Anticancer Drug Res. 6, 569-84, 1991; Helene et al., Ann. N.Y. Acad. Sc. 660, 27-36 1992; and Maher, L. J. Bioassays 14, 807-15, 1992.

Other methods, such as the use of antibodies directed to an endogenous polypeptide for inhibiting its function in planta, or interference in the signalling pathway in which a polypeptide is involved, will be well known to the skilled man. In particular, it can be envisaged that manmade molecules may be useful for inhibiting the biological function of a target polypeptide, or for interfering with the signalling pathway in which the target polypeptide is involved.

Alternatively, a screening program may be set up to identify in a plant population natural variants of a gene, which variants encode polypeptides with reduced activity. Such natural variants may also be used for example, to perform homologous recombination.

Artificial and/or natural microRNAs (miRNAs) may be used to knock out gene expression and/or mRNA translation. Endogenous miRNAs are single stranded small RNAs of typically 19-24 nucleotides long. They function primarily to regulate gene expression and/l or mRNA translation. Most plant microRNAs (miRNAs) have perfect or near-perfect complementarity with their target sequences. However, there are natural targets with up to five mismatches. They are processed from longer non-coding RNAs with characteristic fold-back structures by double-strand specific RNases of the Dicer family. Upon processing, they are incorporated in the RNA-induced silencing complex (RISC) by binding to its main component, an Argonaute protein. MiRNAs serve as the specificity components of RISC, since they base-pair to target nucleic acids, mostly mRNAs, in the cytoplasm. Subsequent regulatory events include target mRNA cleavage and destruction and/or translational inhibition. Effects of miRNA overexpression are thus often reflected in decreased mRNA levels of target genes.

Artificial microRNAs (amiRNAs), which are typically 21 nucleotides in length, can be genetically engineered specifically to negatively regulate gene expression of single or multiple genes of interest. Determinants of plant microRNA target selection are well known in the art. Empirical parameters for target recognition have been defined and can be used to aid in the design of specific amiRNAs, (Schwab et al., Dev. Cell 8, 517-527, 2005). Convenient tools for design and generation of amiRNAs and their precursors are also available to the public (Schwab et al., Plant Cell 18, 1121-1133, 2006).

For optimal performance, the gene silencing techniques used for reducing expression in a plant of an endogenous gene requires the use of nucleic acid sequences from monocotyledonous plants for transformation of monocotyledonous plants, and from dicotyledonous plants for transformation of dicotyledonous plants. Preferably, a nucleic acid sequence from any given plant species is introduced into that same species. For example, a nucleic acid sequence from rice is transformed into a rice plant. However, it is not an absolute requirement that the nucleic acid sequence to be introduced originates from the same plant species as the plant in which it will be introduced. It is sufficient that there is substantial homology between the endogenous target gene and the nucleic acid to be introduced.

Described above are examples of various methods for the reduction or substantial elimination of expression in a plant of an endogenous gene. A person skilled in the art would readily be able to adapt the aforementioned methods for silencing so as to achieve reduction of expression of an endogenous gene in a whole plant or in parts thereof through the use of an appropriate promoter, for example.

Transformation

The term “introduction” or “transformation” as referred to herein encompasses the transfer of an exogenous polynucleotide into a host cell, irrespective of the method used for transfer. Plant tissue capable of subsequent clonal propagation, whether by organogenesis or embryogenesis, may be transformed with a genetic construct of the present invention and a whole plant regenerated there from. The particular tissue chosen will vary depending on the clonal propagation systems available for, and best suited to, the particular species being transformed. Exemplary tissue targets include leaf disks, pollen, embryos, cotyledons, hypocotyls, megagametophytes, callus tissue, existing meristematic tissue (e.g., apical meristem, axillary buds, and root meristems), and induced meristem tissue (e.g., cotyledon meristem and hypocotyl meristem). The polynucleotide may be transiently or stably introduced into a host cell and may be maintained non-integrated, for example, as a plasmid. Alternatively, it may be integrated into the host genome. The resulting transformed plant cell may then be used to regenerate a transformed plant in a manner known to persons skilled in the art.

The transfer of foreign genes into the genome of a plant is called transformation. Transformation of plant species is now a fairly routine technique. Advantageously, any of several transformation methods may be used to introduce the gene of interest into a suitable ancestor cell. The methods described for the transformation and regeneration of plants from plant tissues or plant cells may be utilized for transient or for stable transformation. Transformation methods include the use of liposomes, electroporation, chemicals that increase free DNA uptake, injection of the DNA directly into the plant, particle gun bombardment, transformation using viruses or pollen and microprojection. Methods may be selected from the calcium/polyethylene glycol method for protoplasts (Krens, F. A. et al., (1982) Nature 296, 72-74; Negrutiu I at al. (1987) Plant Mol Biol 8: 363-373); electroporation of protoplasts (Shillito R. D. at al. (1985) Bio/Technol 3. 1099-1102); microinjection into plant material (Crossway A et al., (1986) Mol. Gen Genet 202: 179-185); DNA or RNA-coated particle bombardment (Klein T M at al., (1987) Nature 327: 70) infection with (non-integrative) viruses and the like. Transgenic plants, including transgenic crop plants, are preferably produced via Agrobacterium-mediated transformation. An advantageous transformation method is the transformation in planta. To this end, it is possible, for example, to allow the agrobacteria to act on plant seeds or to inoculate the plant meristem with agrobacteria. It has proved particularly expedient in accordance with the invention to allow a suspension of transformed agrobacteria to act on the intact plant or at least on the flower primordia. The plant is subsequently grown on until the seeds of the treated plant are obtained (Clough and Bent, Plant J. (1998) 16, 735-743). Methods for Agrobacterium-mediated transformation of rice include well known methods for rice transformation, such as those described in any of the following: European patent application EP 1198985 A1, Aldemita and Hodges (Planta 199: 612-617, 1996); Chan et a (Plant Mol Biol 22 (3): 491-506, 1993), Hiel at al. (Plant J 6 (2): 271-282, 1994), which disclosures are incorporated by reference herein as if fully set forth. In the case of corn transformation, the preferred method is as described in either Ishida et al. (Nat. Biotechnol 14(6): 745-50, 1996) or Frame et al. (Plant Physiol 129(1): 13-22, 2002), which disclosures are incorporated by reference herein as if fully set forth. Said methods are further described by way of example in B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, eds. S. D. Kung and R. Wu, Academic Press (1993) 128-143 and in Potrykus Annu. Rev. Plant Physiol. Plant Molec. Biol. 42 (1991) 205-225). The nucleic acids or the construct to be expressed is preferably cloned into a vector, which is suitable for transforming Agrobacterium tumefaciens, for example pBin19 (Bevan et al., Nucl. Acids Res. 12 (1984) 8711). Agrobacteria transformed by such a vector can then be used in known manner for the transformation of plants, such as plants used as a model, like Arabidopsis (Arabidopsis thaliana is within the scope of the present invention not considered as a crop plant), or crop plants such as, by way of example, tobacco plants, for example by immersing bruised leaves or chopped leaves in an agrobacterial solution and then culturing them in suitable media. The transformation of plants by means of Agrobacterium tumefaciens is described, for example, by Höfgen and Willmitzer in Nucl. Acid Res. (1988) 16, 9877 or is known inter alia from F. F. White, Vectors for Gene Transfer in Higher Plants; in Transgenic Plants, Vol. 1, Engineering and Utilization, eds. S. D. Kung and R. Wu, Academic Press, 1993, pp. 15-38.

In addition to the transformation of somatic cells, which then have to be regenerated into intact plants, it is also possible to transform the cells of plant meristems and in particular those cells which develop into gametes. In this case, the transformed gametes follow the natural plant development, giving rise to transgenic plants. Thus, for example, seeds of Arabidopsis are treated with agrobacteria and seeds are obtained from the developing plants of which a certain proportion is transformed and thus transgenic [Feldman, K A and Marks M D (1987). Mol Gen Genet 208:274-289; Feldmann K (1992). In: C Koncz, N-H Chua and J Shell, eds, Methods in Arabidopsis Research. Word Scientific, Singapore, pp. 274-289]. Alternative methods are based on the repeated removal of the inflorescences and incubation of the excision site in the center of the rosette with transformed agrobacteria, whereby transformed seeds can likewise be obtained at a later point in time (Chang (1994). Plant J. 5: 551-558; Katavic (1994). Mol Gen Genet, 245: 363-370). However, an especially effective method is the vacuum infiltration method with its modifications such as the “floral dip” method. In the case of vacuum infiltration of Arabidopsis, intact plants under reduced pressure are treated with an agrobacterial suspension [Bechthold, N (1993). C R Acad Sci Paris Life Sci, 316; 1194-1199], while in the case of the “floral dip” method the developing floral tissue is incubated briefly with a surfactant-treated agrobacterial suspension [Cough, S J and Bent A F (1998) The Plant J. 16, 735-743]. A certain proportion of transgenic seeds are harvested in both cases, and these seeds can be distinguished from non-transgenic seeds by growing under the above-described selective conditions. In addition the stable transformation of plastids is of advantages because plastids are inherited maternally is most crops reducing or eliminating the risk of transgene flow through pollen. The transformation of the chloroplast genome is generally achieved by a process which has been schematically displayed in Klaus et al., 2004 [Nature Biotechnology 22 (2), 225-229]. Briefly the sequences to be transformed are cloned together with a selectable marker gene between flanking sequences homologous to the chloroplast genome. These homologous flanking sequences direct site specific integration into the plastome. Plastidal transformation has been described for many different plant species and an overview is given in Bock (2001) Transgenic plastids in basic research and plant biotechnology. J Mol Biol. 2001 Sep. 21; 312 (3):425-38 or Maliga, P (2003) Progress towards commercialization of plastid transformation technology. Trends Biotechnol. 21, 20-28. Further biotechnological progress has recently been reported in form of marker free plastid transformants, which can be produced by a transient co-integrated maker gene (Klaus et al., 2004, Nature Biotechnology 22(2), 225-229).

The genetically modified plant cells can be regenerated via all methods with which the skilled worker is familiar. Suitable methods can be found in the abovementioned publications by S. D. Kung and R. Wu, Potrykus or Höfgen and Willmitzer.

Generally after transformation, plant cells or cell groupings are selected for the presence of one or more markers which are encoded by plant-expressible genes co-transferred with the gene of interest, following which the transformed material is regenerated into a whole plant. To select transformed plants, the plant material obtained in the transformation is, as a rule, subjected to selective conditions so that transformed plants can be distinguished from untransformed plants. For example, the seeds obtained in the above-described manner can be planted and, after an initial growing period, subjected to a suitable selection by spraying. A further possibility consists in growing the seeds, if appropriate after sterilization, on agar plates using a suitable selection agent so that only the transformed seeds can grow into plants. Alternatively, the transformed plants are screened for the presence of a selectable marker such as the ones described above.

Following DNA transfer and regeneration, putatively transformed plants may also be evaluated, for instance using Southern analysis, for the presence of the gene of interest, copy number and/or genomic organisation. Alternatively or additionally, expression levels of the newly introduced DNA may be monitored using Northern and/or Western analysis, both techniques being well known to persons having ordinary skill in the art.

The generated transformed plants may be propagated by a variety of means, such as by clonal propagation or classical breeding techniques. For example, a first generation (or T1) transformed plant may be selfed and homozygous second-generation (or T2) transformants selected, and the T2 plants may then further be propagated through classical breeding techniques. The generated transformed organisms may take a variety of forms. For example, they may be chimeras of transformed cells and non-transformed cells; clonal transformants (e.g., all cells transformed to contain the expression cassette); grafts of transformed and untransformed tissues (e.g., in plants, a transformed rootstock grafted to an untransformed scion).

T-DNA Activation Tagging

T-DNA activation tagging (Hayashi et al. Science (1992) 1350-1353), involves insertion of T-DNA, usually containing a promoter (may also be a translation enhancer or an intron), in the genomic region of the gene of interest or 10 kb up- or downstream of the coding region of a gene in a configuration such that the promoter directs expression of the targeted gene. Typically, regulation of expression of the targeted gene by its natural promoter is disrupted and the gene falls under the control of the newly introduced promoter. The promoter is typically embedded in a T-DNA. This T-DNA is randomly inserted into the plant genome, for example, through Agrobacterium infection and leads to modified expression of genes near the inserted T-DNA. The resulting transgenic plants show dominant phenotypes due to modified expression of genes close to the introduced promoter.

Tilling

The term “TILLING” is an abbreviation of “Targeted Induced Local Lesions in Genomes” and refers to a mutagenesis technology useful to generate and/or identify nucleic acids encoding proteins with modified expression and/or activity. TILLING also allows selection of plants carrying such mutant variants. These mutant variants may exhibit modified expression, either in strength or in location or in timing (if the mutations affect the promoter for example). These mutant variants may exhibit higher activity than that exhibited by the gene in its natural form. TILLING combines high-density mutagenesis with high-throughput screening methods. The steps typically followed in TILLING are: (a) EMS mutagenesis (Redei G P and Koncz C (1992) In Methods in Arabidopsis Research, Koncz C, Chua N H, Schell J, eds. Singapore, World Scientific Publishing Co, pp. 16-82; Feldmann et al., (1994) In Meyerowitz E M, Somerville C R, eds, Arabidopsis. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., pp 137-172; Lightner J and Caspar T (1998) In J Martinez-Zapater, J Salinas, eds, Methods on Molecular Biology, Vol. 82. Humana Press, Totowa, N.J., pp 91-104); (b) DNA preparation and pooling of individuals; (c) PCR amplification of a region of interest; (d) denaturation and annealing to allow formation of heteroduplexes; (e) DHPLC, where the presence of a heteroduplex in a pool is detected as an extra peak in the chromatogram; (f) identification of the mutant individual; and (g) sequencing of the mutant PCR product. Methods for TILLING are well known in the art (McCallum et al., (2000) Nat Biotechnol 18: 455-457; reviewed by Stemple (2004) Nat Rev Genet 5(2): 145-50).

Homologous Recombination

Homologous recombination allows introduction in a genome of a selected nucleic acid at a defined selected position. Homologous recombination is a standard technology used routinely in biological sciences for lower organisms such as yeast or the moss Physcomitrella. Methods for performing homologous recombination in plants have been described not only for model plants (Offringa et al. (1990) EMBO J 9(10): 3077-84) but also for crop plants, for example rice (Terada et al. (2002) Nat Biotech 20(10): 1030-4; lida and Terada (2004) Curr Opin Biotech 15(2): 132-8), and approaches exist that are generally applicable regardless of the target organism (Miller et al, Nature Biotechnol. 25, 778-785, 2007).

Yield Related Traits

Yield related traits comprise one or more of yield, biomass, seed yield, early vigour, greenness index, increased growth rate, improved agronomic traits (such as Improved Water Use Efficiency (WUE), Nitrogen Use Efficiency (NUE), etc.).

Yield

The term “yield” in general means a measurable produce of economic value, typically related to a specified crop, to an area, and to a period of time. Individual plant parts directly contribute to yield based on their number, size and/or weight, or the actual yield is the yield per square meter for a crop and year, which is determined by dividing total production (includes both harvested and appraised production) by planted square meters. The term “yield” of a plant may relate to vegetative biomass (root and/or shoot biomass), to reproductive organs, and/or to propagules (such as seeds) of that plant.

Taking corn as an example, a yield increase may be manifested as one or more of the following: increase in the number of plants established per square meter, an increase in the number of ears per plant, an increase in the number of rows, number of kernels per row, kernel weight, thousand kernel weight, ear length/diameter, increase in the seed filling rate (which is the number of filled seeds divided by the total number of seeds and multiplied by 100), among others. Taking rice as an example, a yield increase may manifest itself as an increase in one or more of the following: number of plants per square meter, number of panicles per plant, panicle length, number of spikelets per panicle, number of flowers (florets) per panicle, increase in the seed filling rate (which is the number of filled seeds divided by the total number of seeds and multiplied by 100), increase in thousand kernel weight, among others. In rice, submergence tolerance may also result in increased yield.

Early Vigour

“Early vigour” refers to active healthy well-balanced growth especially during early stages of plant growth, and may result from increased plant fitness due to, for example, the plants being better adapted to their environment (i.e. optimizing the use of energy resources and partitioning between shoot and root). Plants having early vigour also show increased seedling survival and a better establishment of the crop, which often results in highly uniform fields (with the crop growing in uniform manner, i.e. with the majority of plants reaching the various stages of development at substantially the same time), and often better and higher yield. Therefore, early vigour may be determined by measuring various factors, such as thousand kernel weight, percentage germination, percentage emergence, seedling growth, seedling height, root length, root and shoot biomass and many more.

Increased Growth Rate

The increased growth rate may be specific to one or more parts of a plant (including seeds), or may be throughout substantially the whole plant. Plants having an increased growth rate may have a shorter life cycle. The life cycle of a plant may be taken to mean the time needed to grow from a dry mature seed up to the stage where the plant has produced dry mature seeds, similar to the starting material. This life cycle may be influenced by factors such as speed of germination, early vigour, growth rate, greenness index, flowering time and speed of seed maturation. The increase in growth rate may take place at one or more stages in the life cycle of a plant or during substantially the whole plant life cycle. Increased growth rate during the early stages in the life cycle of a plant may reflect enhanced vigour. The increase in growth rate may alter the harvest cycle of a plant allowing plants to be sown later and/or harvested sooner than would otherwise be possible (a similar effect may be obtained with earlier flowering time). If the growth rate is sufficiently increased, it may allow for the further sowing of seeds of the same plant species (for example sowing and harvesting of rice plants followed by sowing and harvesting of further rice plants all within one conventional growing period). Similarly, if the growth rate is sufficiently increased, it may allow for the further sowing of seeds of different plants species (for example the sowing and harvesting of corn plants followed by, for example, the sowing and optional harvesting of soybean, potato or any other suitable plant). Harvesting additional times from the same rootstock in the case of some crop plants may also be possible. Altering the harvest cycle of a plant may lead to an increase in annual biomass production per square meter (due to an increase in the number of times (say in a year) that any particular plant may be grown and harvested). An increase in growth rate may also allow for the cultivation of transgenic plants in a wider geographical area than their wild-type counterparts, since the territorial limitations for growing a crop are often determined by adverse environmental conditions either at the time of planting (early season) or at the time of harvesting (late season). Such adverse conditions may be avoided if the harvest cycle is shortened. The growth rate may be determined by deriving various parameters from growth curves, such parameters may be: T-Mid (the time taken for plants to reach 50% of their maximal size) and T-90 (time taken for plants to reach 90% of their maximal size), amongst others.

Stress Resistance

An increase in yield and/or growth rate occurs whether the plant is under non-stress conditions or whether the plant is exposed to various stresses compared to control plants. Plants typically respond to exposure to stress by growing more slowly. In conditions of severe stress, the plant may even stop growing altogether. Mild stress on the other hand is defined herein as being any stress to which a plant is exposed which does not result in the plant ceasing to grow altogether without the capacity to resume growth. Mild stress in the sense of the invention leads to a reduction in the growth of the stressed plants of less than 40%, 35%, 30% or 25%, more preferably less than 20% or 15% in comparison to the control plant under non-stress conditions. Due to advances in agricultural practices (irrigation, fertilization, pesticide treatments) severe stresses are not often encountered in cultivated crop plants. As a consequence, the compromised growth induced by mild stress is often an undesirable feature for agriculture. Mild stresses are the everyday biotic and/or abiotic (environmental) stresses to which a plant is exposed. Abiotic stresses may be due to drought or excess water, anaerobic stress, salt stress, chemical toxicity, oxidative stress and hot, cold or freezing temperatures. The abiotic stress may be an osmotic stress caused by a water stress (particularly due to drought), salt stress, oxidative stress or an ionic stress. Biotic stresses are typically those stresses caused by pathogens, such as bacteria, viruses, fungi, nematodes and insects.

In particular, the methods of the present invention may be performed under non-stress conditions or under conditions of mild drought to give plants having increased yield relative to control plants. As reported in Wang et al. (Planta (2003) 218: 1-14), abiotic stress leads to a series of morphological, physiological, biochemical and molecular changes that adversely affect plant growth and productivity. Drought, salinity, extreme temperatures and oxidative stress are known to be interconnected and may induce growth and cellular damage through similar mechanisms. Rabbani et al. (Plant Physiol (2003) 133: 1755-1767) describes a particularly high degree of “cross talk” between drought stress and high-salinity stress. For example, drought and/or salinisation are manifested primarily as osmotic stress, resulting in the disruption of homeostasis and ion distribution in the cell. Oxidative stress, which frequently accompanies high or low temperature, salinity or drought stress, may cause denaturing of functional and structural proteins. As a consequence, these diverse environmental stresses often activate similar cell signalling pathways and cellular responses, such as the production of stress proteins, up-regulation of anti-oxidants, accumulation of compatible solutes and growth arrest. The term “non-stress” conditions as used herein are those environmental conditions that allow optimal growth of plants. Persons skilled in the art are aware of normal soil conditions and climatic conditions for a given location. Plants with optimal growth conditions, (grown under non-stress conditions) typically yield in increasing order of preference at least 97%, 95%, 92%, 90%, 87%, 85%, 83%, 80%, 77% or 75% of the average production of such plant in a given environment. Average production may be calculated on harvest and/or season basis. Persons skilled in the art are aware of average yield productions of a crop.

Nutrient deficiency may result from a lack of nutrients such as nitrogen, phosphates and other phosphorous-containing compounds, potassium, calcium, magnesium, manganese, iron and boron, amongst others.

The term salt stress is not restricted to common salt (NaCl), but may be any one or more of: NaCl, KCl, LiCl, MgCl₂, CaCl₂, amongst others.

Increase/Improve/Enhance

The terms “increase”, “improve” or “enhance” are interchangeable and shall mean in the sense of the application at least a 3%, 4%, 5%, 6%, 7%, 8%, 9% or 10%, preferably at least 15% or 20%, more preferably 25%, 30%, 35% or 40% more yield and/or growth in comparison to control plants as defined herein.

Seed Yield

Increased seed yield may manifest itself as one or more of the following: a) an increase in seed biomass (total seed weight) which may be on an individual seed basis and/or per plant and/or per square meter; b) increased number of flowers per plant; c) increased number of (filled) seeds; d) increased seed filling rate (which is expressed as the ratio between the number of filled seeds divided by the total number of seeds); e) increased harvest index, which is expressed as a ratio of the yield of harvestable parts, such as seeds, divided by the total biomass; and f) increased thousand kernel weight (TKW), which is extrapolated from the number of filled seeds counted and their total weight. An increased TKW may result from an increased seed size and/or seed weight, and may also result from an increase in embryo and/or endosperm size.

An increase in seed yield may also be manifested as an increase in seed size and/or seed volume. Furthermore, an increase in seed yield may also manifest itself as an increase in seed area and/or seed length and/or seed width and/or seed perimeter. Increased yield may also result in modified architecture, or may occur because of modified architecture.

Greenness Index

The “greenness index” as used herein is calculated from digital images of plants. For each pixel belonging to the plant object on the image, the ratio of the green value versus the red value (in the RGB model for encoding color) is calculated. The greenness index is expressed as the percentage of pixels for which the green-to-red ratio exceeds a given threshold. Under normal growth conditions, under salt stress growth conditions, and under reduced nutrient availability growth conditions, the greenness index of plants is measured in the last imaging before flowering. In contrast, under drought stress growth conditions, the greenness index of plants is measured in the first imaging after drought.

Marker Assisted Breeding

Such breeding programmes sometimes require introduction of allelic variation by mutagenic treatment of the plants, using for example EMS mutagenesis; alternatively, the programme may start with a collection of allelic variants of so called “natural” origin caused unintentionally. Identification of allelic variants then takes place, for example, by PCR. This is followed by a step for selection of superior allelic variants of the sequence in question and which give increased yield. Selection is typically carried out by monitoring growth performance of plants containing different allelic variants of the sequence in question. Growth performance may be monitored in a greenhouse or in the field. Further optional steps include crossing plants in which the superior allelic variant was identified with another plant. This could be used, for example, to make a combination of interesting phenotypic features.

Use as Probes in (Gene Mapping)

Use of nucleic acids encoding the protein of interest for genetically and physically mapping the genes requires only a nucleic acid sequence of at least 15 nucleotides in length. These nucleic acids may be used as restriction fragment length polymorphism (RFLP) markers. Southern blots (Sambrook J, Fritsch E F and Maniatis T (1989) Molecular Cloning, A Laboratory Manual) of restriction-digested plant genomic DNA may be probed with the ISYT-LIKE-encoding nucleic acids. The resulting banding patterns may then be subjected to genetic analyses using computer programs such as MapMaker (Lander et al. (1987) Genomics 1: 174-181) in order to construct a genetic map. In addition, the nucleic acids may be used to probe Southern blots containing restriction endonuclease-treated genomic DNAs of a set of individuals representing parent and progeny of a defined genetic cross. Segregation of the DNA polymorphisms is noted and used to calculate the position of the iSYT-like polypeptide-encoding nucleic acid in the genetic map previously obtained using this population (Botstein et al. (1980) Am. J. Hum. Genet. 32:314-331).

The production and use of plant gene-derived probes for use in genetic mapping is described in Bernatzky and Tanksley (1986) Plant Mol. Biol. Reporter 4: 37-41. Numerous publications describe genetic mapping of specific cDNA clones using the methodology outlined above or variations thereof. For example, F2 intercross populations, backcross populations, randomly mated populations, near isogenic lines, and other sets of individuals may be used for mapping. Such methodologies are well known to those skilled in the art.

The nucleic acid probes may also be used for physical mapping (i.e., placement of sequences on physical maps; see Hoheisel et al. In: Non-mammalian Genomic Analysis: A Practical Guide, Academic press 1996, pp. 319-346, and references cited therein).

In another embodiment, the nucleic acid probes may be used in direct fluorescence in situ hybridisation (FISH) mapping (Trask (1991) Trends Genet. 7:149-154). Although current methods of FISH mapping favour use of large clones (several kb to several hundred kb; see Laan et al. (1995) Genome Res. 5:13-20), improvements in sensitivity may allow performance of FISH mapping using shorter probes.

A variety of nucleic acid amplification-based methods for genetic and physical mapping may be carried out using the nucleic acids. Examples include allele-specific amplification (Kazazian (1989) J. Lab. Clin. Med 11:95-96), polymorphism of PCR-amplified fragments (CAPS; Sheffield et al. (1993) Genomics 16:325-332), allele-specific ligation (Landegren et al. (1988) Science 241:1077-1080), nucleotide extension reactions (Sokolov (1990) Nucleic Acid Res. 18:3671), Radiation Hybrid Mapping (Walter et al. (1997) Nat. Genet. 7:22-28) and Happy Mapping (Dear and Cook (1989) Nucleic Acid Res. 17:6795-6807). For these methods, the sequence of a nucleic acid is used to design and produce primer pairs for use in the amplification reaction or in primer extension reactions. The design of such primers is well known to those skilled in the art. In methods employing PCR-based genetic mapping, it may be necessary to identify DNA sequence differences between the parents of the mapping cross in the region corresponding to the instant nucleic acid sequence. This, however, is generally not necessary for mapping methods.

Plant

The term “plant” as used herein encompasses whole plants, ancestors and progeny of the plants and plant parts, including seeds, shoots, stems, leaves, roots (including tubers), flowers, and tissues and organs, wherein each of the aforementioned comprise the gene/nucleic acid of interest. The term “plant” also encompasses plant cells, suspension cultures, callus tissue, embryos, meristematic regions, gametophytes, sporophytes, pollen and microspores, again wherein each of the aforementioned comprises the gene/nucleic acid of interest.

Plants that are particularly useful in the methods of the invention include all plants which belong to the superfamily Viridiplantae, in particular monocotyledonous and dicotyledonous plants including fodder or forage legumes, ornamental plants, food crops, trees or shrubs selected from the list comprising Acer spp., Actinidia spp., Abelmoschus spp., Agave sisalana, Agropyron spp., Agrostis stolonifera, Allium spp., Amaranthus spp., Ammophila arenaria, Ananas comosus, Annona spp., Apium graveolens, Arachis spp, Artocarpus spp., Asparagus officinalis, Avena spp. (e.g. Avena sativa, Avena fatua, Avena byzantina, Avena fatua var. sativa, Avena hybrida), Averrhoa carambola, Bambusa sp., Benincasa hispida, Bertholletia excelsea, Beta vulgaris, Brassica spp. (e.g. Brassica napus, Brassica rapa ssp. [canola, oilseed rape, turnip rape]), Cadaba farinosa, Camellia sinensis, Canna indica, Cannabis sativa, Capsicum spp., Carex elata, Carica papaya, Carissa macrocarpa, Carya spp., Carthamus tinctorius, Castanea spp., Celba pentandra, Cichorlum endvia, Cinnamomum spp., Citrullus lanatus, Citrus spp., Cocos spp., Coffea spp., Colocasia esculenta, Cola spp., Corchorus sp., Coriandrum sativum, Corylus spp., Crataegus spp., Crocus sativus, Cucurbita spp., Cucumis spp., Cynara spp., Daucus carota, Desmodium spp., Dimocarpus longan, Dioscorea spp., Diospyros spp., Echinochloa spp., Elaeis (e.g. Elaeis guineensis, Elaeis oleifera), Eleusine coracana, Eragrostis tef, Erianthus sp., Erioborya japonica, Eucalyptus sp., Eugenia uniflora, Fagopyrum spp., Fagus spp., Festuca arundinacea, Ficus carica, Fortunella spp., Fragaria spp., Ginkgo biloba, Glycine spp. (e.g. Glycine max, Soja hispida or Soja max), Gossypium hirsutum, Helianthus spp. (e.g. Helianthus annuus), Hemerocallis fulva, Hibiscus spp., Hordeum spp. (e.g. Hordeum vulgare), Ipomoea batatas, Juglans spp., Lactuca sativa, Lathyrus spp., Lens culinaris, Linum usitatissimum, Litchi chinensis, Lotus spp., Luffa acutangula, Lupinus spp., Luzula sylvatica, Lycopersicon spp. (e.g. Lycopersicon esculentum, Lycopersicon lycopersicum, Lycopersicon pyriforme), Macrotyloma spp., Malus spp., Malpighia emarginata, Mammea americana, Mangifera indica, Manihot spp., Manilkara zapota, Medicago sativa, Melilotus spp., Mentha spp., Miscanthus sinensis, Momordica spp., Morus nigra, Musa spp., Nicotiana spp., Olea spp., Opuntia spp., Ornithopus spp., Oryza spp. (e.g. Oryza sativa, Oryza latifolia), Panicum miliaceum, Panicum virgatum, Passiflora edulis, Pastninaca sativa, Pennisetum sp., Persea spp., Peroselinum crispum, Phalaris arundinacea, Phaseolus spp., Phleum pretense, Phoenix spp., Phragmites australis, Physalis spp., Pinus spp., Pistacia vera, Pisum spp., Poe spp., Populus spp., Prosopis spp., Prunus spp., Psidium spp., Punica granatum, Pyrus communis, Quercus spp., Raphanus sativus, Rheum rharbararum, Ribes spp., Ricinus communis, Rubus spp., Saccharum spp., Salix sp., Sambucus spp., Secale cereale, Sesamum spp., Sinapis sp., Solanum spp. (e.g. Solanum tuberosum, Solanum integrifolium or Solanum lycopersicum), Sorghum bicolor, Spinacia spp., Syzygium spp., Tagetes spp., Tamarindus indica, Theobroma cacao, Triflium spp., Tripsacum dactyloides, Triticosecale rimpaui, Triticum spp. (e.g. Triticum aestivum, Triticum durum, Tritium turgidum, Triticum hybernum, Triticum macha, Triticum sativum, Triticum monococcum or Triticum vulgare), Tropaeolum minus, Tropaeolum majus, Vaccinium spp., Vicia spp., Vigna spp., Viola odorata, Vitis spp., Zee mays, Zizania palustris, Ziziphus spp., amongst others.

Control Plant(s) The choice of suitable control plants is a routine part of an experimental setup and may include corresponding wild type plants or corresponding plants without the gene of interest. The control plant is typically of the same plant species or even of the same variety as the plant to be assessed. The control plant may also be a nullizygote of the plant to be assessed. Nullizygotes are individuals missing the transgene by segregation. A “control plant” as used herein refers not only to whole plants, but also to plant parts, including seeds and seed parts.

DETAILED DESCRIPTION OF THE INVENTION

Surprisingly, it has now been found that modulating expression in a plant of one or more nucleic acid(s) encoding at least two iSYT polypeptides selected from the group consisting of any of the polypeptides of Table A, homologues thereof and fusions of the same gives plants having enhanced yield-related traits relative to control plants. According to a first embodiment, the present invention provides a method for enhancing yield-related traits in plants relative to control plants, comprising modulating expression in a plant of one or more nucleic acid(s) encoding at least two iSYT polypeptides selected from the group consisting of any of the polypeptides of Table A, homologues thereof and fusions of the same and optionally selecting for plants having enhanced yield-related traits.

A preferred method for modulating, increasing or decreasing expression of a nucleic acid encoding at least two iSYT polypeptides selected from the group consisting of any of the polypeptides of Table A, homologues thereof and fusions of the same is by introducing and expressing in a plant a nucleic acid encoding a iSYT-like polypeptide.

Any reference hereinafter to a “protein useful in the methods of the invention” is taken to mean an iSYT polypeptide, homologue thereof or fusions of the same as defined herein. Any reference hereinafter to a “nucleic acid useful in the methods of the invention” is taken to mean a nucleic acid capable of encoding such an iSYT polypeptide, homologue thereof or fusions of the same. The nucleic acid to be introduced into a plant (and therefore useful in performing the methods of the invention) is any nucleic acid encoding the type of protein which will now be described, hereafter also named “iSYT nucleic acid” or “iSYT gene”.

An “iSYT polypeptide” as defined herein refers to any of the polypeptide of Table A and maybe represented by the corresponding amino acid sequence as provided in the sequence listing. Further description of an iSYT polypeptide is provided in Table B.

An “iSYT-like polypeptide” as defined herein refers to any polypeptide selected from the group consisting of any of the polypeptides of Table A, homologues thereof and fusions of the same. Polypeptides useful in the methods of the invention are iSYT polypeptides as well as iSYT-like polypeptides.

A fusion of iSYT and/or iSYT-like polypeptides is preferably encoded by a nucleic acid which may be constructed using well known recombinant DNA techniques (Sambrook J, Fritsch E F and Manlatis T (1989) Molecular Cloning, A Laboratory Manual). For example the protein fusion may comprise a fusion of the entire iSYT and/or iSYT-like polypeptides or of only a portion of the same, for example the N-terminal or the C-terminal portion. Preferably the portion comprises one or more of the conserved domain corresponding to the domains of Tables C1 to C20 of the corresponding iSYT polypeptide.

Concerning SYT

SYT as defined herein refers to the polypeptide encoded by the AN3 (ANGUSTIFOLIA 3) gene of Arabidopsis thaliana. Alternative names for the AN3 gene are GIF1 gene and SYT1 gene. The genomic locus and the AGI reference of the SYT gene is AT59g28640.

The terms “SYT”, “SYT1” and “AN3” as used herein are interchangeable.

A “SYT polypeptide” as referred herein is represented by the sequence:

(SEQ ID NO: 671) MQQHLMQMQPMMAGYYPSNVTSDHIQQYLDENSKLILKIVESQNSGKLSE CAENQARLQRNLMYLAAIADSQPQPPSVHSQYGSAGGGMIQGEGGSHYLQ QQQATQQQQMTQQSLMAARSSMLYAQQQQQQQPYATLQHQQLHHSQLGMS SSSGGGGSSGLHILQGEAGGFHDFGRGKPEMGSGGGGEGRGGSSGDGGET LYLKSSDDGN

A “SYT Polypeptide” useful in the methods of the invention is preferably encoded by the following nucleic acid:

(SEQ ID NO: 672) ATGCAACAGCACCTGATGCAGATGCAGCCCATGATGGCTGGTTACTACC CCAGCAATGTTACCTCTGATCATATCCAACAGTACTTGGACGAAAACAA ATCGTTGATTCTGAAGATTGTTGAGTCTCAAAACTCTGGAAAGCTTAGC GAATGCGCCGAGAATCAAGCAAGGCTTCAACGCAACCTAATGTACCTAG CTGCAATAGCAGATTCTCAGCCTCAGCCACCAAGTGTGCATAGCCAGTA TGGATCTGCTGGTGGTGGGATGATTCAGGGAGAAGGAGGGTCACACTAT TTGCAGCAGCAACAAGCGACTCAACAGCAACAGATGACTCAGCAGTCTC TAATGGCGGCTCGATCTTCAATGTTGTATGCTCAGCAACAGCAGCAGCA GCAGCCTTACGCGACGCTTCAGCATCAGCAATTGCACCATAGCCAGCTT GGAATGAGCTCGAGCAGCGGAGGAGGAGGAAGCAGTGGTCTCCATATCC TTCAGGGAGAGGCTGGTGGGTTTCATGATTTTGGCCGTGGGAAGCCGGA AATGGGAAGTGGTGGTGGCGGTGAAGGCAGAGGAGGAAGTTCAGGGGAT GGTGGAGAAACCCTTTACTTGAAATCATCAGATGATGGGAATTGA

Alternatively or additionally, the term “SYT polypeptide or homologue thereof” as defined herein refers to a polypeptide comprising an SNH domain having in increasing order of preference at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% sequence identity to the SNH domain of SEQ ID NO: 670.

SEQ ID NO: 670: IQQYLDENKSLILKIVESQNSGKLSECAENQARLQRNLMYLAAIAD

Preferred homologues of a SYT polypeptide useful in the methods of the invention are listed in Table A2.

Preferably the methods of the invention concern a homologue of a SYT polypeptide derived from a crop plant more preferably, in increasing order of preference from corn, sugar cane, soybean, wheat, cotton and canola.

Additionally or alternatively, the homologue of a SYT polypeptide useful in the method in the invention has in increasing order of preference at least 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% overall sequence identity to the amino acid represented by any one of the polypeptide sequences of Table A2 or of the SYT Polypeptide. The overall sequence identity is determined using a global alignment algorithm, such as the Needleman Wunsch algorithm in the program GAP (GCG Wisconsin Package, Accelrys), preferably with default parameters and preferably with sequences of mature proteins (i.e. without taking into account secretion signals or transit peptides). Compared to overall sequence identity, the sequence identity will generally be higher when only conserved domains or motifs are considered.

Preferably an iSYT, a homologue thereof or a fusion of the same useful in the methods of the invention comprises a domain having in increasing order of preference at least 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity to the amino acid sequence of one or more of the conserved domain located at specific amino acid coordinates of an iSYT polypeptide according to Tables C1 to C20, preferably to the domain identified in the HMMSmart database.

For Example, a homologue of the iSYT AT1G05370 polypeptide useful in the methods of the invention comprises a domain having in increasing order of preference at least 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity to the amino acid sequence of any one or more of the conserved domains according to Table C1, preferably to the domain SM00516 located at amino acid coordinates 86-229 of the iSYT AT1G05370 polypeptide.

Preferred homologues of an iSYT polypeptide useful in the methods of the invention are given in Tables A1 to A26.

Additionally or alternatively, the homologue of a iSYT polypeptide useful in the method in the invention has in increasing order of preference at least 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% overall sequence identity to the amino acid represented by any one of the polypeptide sequences selected from the group consisting of the polypeptides of Table A and Tables A1 to A26. The overall sequence identity is determined using a global alignment algorithm, such as the Needleman Wunsch algorithm in the program GAP (GCG Wisconsin Package, Accelrys), preferably with default parameters and preferably with sequences of mature proteins (i.e. without taking into account secretion signals or transit peptides). Compared to overall sequence identity, the sequence identity will generally be higher when only conserved domains or motifs are considered.

Preferably the methods of the invention concern a homologue of an iSYT polypeptide derived from a crop plant more preferably, in increasing order of preference from corn, sugar cane, soybean, wheat, cotton and canola.

The terms “domain”. “signature” and “motif” are defined in the “definitions” section herein.

In one embodiment preferred combinations of two iSYT polypeptide whose expression is to be modulated according the methods of the invention are provided on Table 3. In another further preferred embodiment homologues of such iSYT polypeptides are combined, more preferably from a monocotyledonous plant, more preferably from rice or corn plants.

TABLE 3 Combinations of two iSYT polypeptides. iSYT iSYT Combination polypeptide 1 ortholog of polypeptide 2 ortholog of Combi1 (AT5G28640) (AT1G18450) Combi2 (AT5G28640) (AT3G60830) Combi3 (AT5G28640) (AT2G46020) Combi4 (AT5G28640) (AT2G28290) Combi5 (AT5G28640) (AT1G21700) Combi6 (AT5G28640) (AT5G14170) Combi7 (AT5G28640) (AT1G23900) Combi8 (AT5G28640) (AT2G18876) Combi9 (AT5G28640) (AT4G27550) Combi10 (AT5G28640) (AT1G65980) Combi11 (AT5G28640) (AT1G05370) Combi12 (AT5G28640) (AT4G35550) Combi13 (AT5G28640) (AT4G21540) Combi14 (AT5G28640) (AT1G20670) Combi15 (AT2G46020) (AT2G28290) Combi16 (AT5g23690) (AT3G60830) Combi17 (AT3G60830) (AT1G18450) Combi18 (AT4g17330) (AT2G46020) Combi19 Poptr_importin beta AT5G53480 Poptr_importin alpha AT3g06720 Combi20 Zeama_SYT1 AT5G28640 Zeama_SWIB/MDM2/CHC1 AT5G14170 like protein Combi21 Zeama_SYT1 AT5G28640 Zeama_hypothetical AT5G17510 protein, heme binding Combi22 Zeama_SYT1 AT5G28640 Poptr_ARP7 AT3G60830 Combi23 Poptr_ARP7 AT3G60830 Poptr_ARP4 AT1G18450

Encompassed on Table 4 are the corresponding orthologoues iSYT-like polypeptides originating from poplar or corn cells.

Another aspect of the invention is an isolated AN3-based protein complex, comprising at least the proteins AN3p and one or more of the proteins selected from the group encoded by AT4G16143, AT1 G09270, AT3G06720, AT5G53480, AT3G60830, AT1 G18450, AT2G46020, AT2G28290, AT1G21700, AT5G14170, AT4G17330, AT4G27550, AT1G65980, AT5G55210. AT3G15000, AT4G35550, AT1G20670, AT1G08730, AT5G13030, AT2G18876, AT5G17510, AT1G05370, AT4G21540, AT1 G23900 and AT5G23690 (genes listed in Table A). Preferably, said AN3-based protein complex comprises at least the proteins AN3p and one or more proteins selected from the group consisting of ARP4 (AT1G18450), ARP7 (AT3G06830), SNF2 (AT2G46020), SYD (AT2G28290), SWI3C (AT1G21700) and SWP73B (AT5G14170). Even more preferably, said AN3-based protein complex comprises at least AN3p. an actin related protein selected from the group consisting of ARP4 and ARP7, an ATPase selected from the group consisting of SNF2 (BRM) and SYD and a SWIRM domain containing protein. Preferably, said SWIRM domain containing protein is SWI3C. An AN3-based protein complex as used here means that AN3p is interacting, directly or indirectly, with the other proteins of the complex. A direct interaction is an interaction where at least one domain of AN3p interacts with one or more domains or the interaction partner. An indirect interaction is an interaction where AN3p itself is not interacting with the interacting protein by one of its domains, but where said interacting protein is interacting with a protein that is directly or indirectly interacting with AN3p.

A further aspect of the invention is the use of a protein complex according to the invention to promote plant growth. Preferably, said use is an overexpression of the protein complex, by overexpressing at least two members of the protein complex. Promotion of plant growth, as used here, is an increase in plant biomass in plants where the protein complex is used, compared with the same plant where the complex is not used, grown under the same conditions, except for the conditions needed for the use of the complex, if any. Such conditions may be, as a non limited example, the addition of one or more compounds to induce one or more promoters of one or more genes encoding a protein of the complex. Alternatively, the same plant is an untransformed parental plant, grown under the same conditions as the transformed plant, wherein the complex is used. Preferably, promotion of plant growth results in an increased yield. This yield can be a total increase in plant biomass, or a partial increase of yield, such as, but not limited to seed yield, leave yield or root yield.

Still another aspect of the invention is a method to promote AN3-based protein complex formation, by simultaneous overexpression of at least two proteins of the complex. Proteins of the complex, beside AN3p itself, are listed in table A. Preferably, said overexpression is an overexpression of AN3p and one or more proteins selected from the group consisting of ARP4 (AT1G18450), ARP7 (AT3G60830). SNF2 (AT2G46020), SYD (AT2G28290), SWI3C (AT1G21700) and SWP73B (AT5G14170). Even more preferably, said overexpression is an overexpression of at least AN3p, an actin related protein selected from the group consisting of ARP4 and ARP7, an ATPase selected from the group consisting of SNF2 (BRM) and SYD and a SWIRM domain containing protein. Preferably, said SWIRM domain containing protein is SWI3C.

Methods for obtaining overexpression are known to the person skilled in the art, and comprise, but are not limited to placing the gene encoding the protein to be overexpressed after a strong promoter such as the Cauliflower Mosaic Virus 35S promoter. Simultaneous overexpression as used here means that there is an overlap in timeframe for all the proteins to be overexpressed, whereby the level of said proteins is increased when compared to a non-overexpressed control. It does not necessarily mean that all genes should be induced at the same moment. Depending upon the turnover of the messenger RNA and/or the protein, one gene may be induced before or after another, as long as there is an overlap in time where both proteins are present in a concentration that is higher than the normal (non-overexpressed) concentration.

In addition, two or three iSYT-like polypeptides, when expressed in rice according to the methods of the present invention as outlined in the Examples section, give plants having increased yield related traits, selected from increased aboveground biomass or increased seed yield.

The present invention is illustrated by transforming plants with the nucleic acid sequences comprising the gene encoding the combinations of the polypeptides of Table 4.

However, performance of the invention is not restricted to these sequences; the methods of the invention may advantageously be performed using any iSYT-like-encoding nucleic acid or iSYT-like polypeptide as defined herein.

Examples of nucleic acids encoding iSYT-like polypeptides are given in Table A an Tables A2 to A26 of the Examples section herein. Such nucleic acids are useful in performing the methods of the invention. The amino acid sequences given in Tables A2 to A26 of the Examples section are example sequences of orthologues and paralogues of the iSYT polypeptide of Table A, the terms “orthologues” and “paralogues” being as defined herein. Further orthologues and paralogues may readily be identified by performing a so-called reciprocal blast search as described in the definitions section; where the query sequence is SEQ ID NO: 1 or SEQ ID NO: 2, the second BLAST (back-BLAST) would be against Arabidopsis thaliana sequences.

The invention also provides hitherto unknown iSYT-encoding nucleic acids and iSYT polypeptides useful for conferring enhanced yield-related traits in plants relative to control plants.

According to a further embodiment of the present invention, there is therefore provided an isolated nucleic acid molecule selected from:

-   -   (i) a nucleic acid represented by any one of the polynucleotides         of Tables A2 to A26;     -   (ii) the complement of a nucleic acid of (i);     -   (iii) a nucleic acid encoding an iSYT-like polypeptide having in         increasing order of preference at least 50%, 51%, 52%, 53%, 54%,         55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%,         68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%,         81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%,         94%, 95%, 96%, 97%, 98% 99% or 100% sequence identity to the         amino acid sequence of any of the polypeptides of Table A2 to         A26 and further preferably conferring enhanced yield-related         traits relative to control plants.     -   (iv) a nucleic acid molecule which hybridizes with a nucleic         acid molecule of (i) to (iii) under high stringency         hybridization conditions and preferably confers enhanced         yield-related traits relative to control plants.

According to a further embodiment of the present invention, there is also provided an isolated polypeptide selected from:

-   -   (i) an amino acid sequence represented by any one of the         polypeptides of Tables A2 to A26;     -   (ii) an amino acid sequence having, in increasing order of         preference, at least 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%,         58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%,         71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%,         84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%,         97%, 98%, or 99% sequence identity to the amino acid sequence of         any of the sequences of the polypeptide of Table A2 to A26 and         further preferably conferring enhanced yield-related traits         relative to control plants.     -   (iii) derivatives of any of the amino acid sequences given         in (i) or (ii) above.         Nucleic acid variants may also be useful in practicing the         methods of the invention. Examples of such variants include         nucleic acids encoding homologues and derivatives of any one of         the amino acid sequences given in Table A of the Examples         section, the terms “homologue” and “derivative” being as defined         herein. Also useful in the methods of the invention are nucleic         acids encoding homologues and derivatives of orthologues or         paralogues of any one of the amino acid sequences given in Table         A of the Examples section. Homologues and derivatives useful in         the methods of the present invention have substantially the same         biological and functional activity as the unmodified protein         from which they are derived. Further variants useful in         practising the methods of the invention are variants in which         codon usage is optimised or in which miRNA target sites are         removed.

Further nucleic acid variants useful in practising the methods of the invention include portions of nucleic acids encoding iSYT-like polypeptides, nucleic acids hybridising to nucleic acids encoding iSYT-like polypeptides, splice variants of nucleic acids encoding iSYT-like polypeptides, allelic variants of nucleic acids encoding iSYT-like polypeptides and variants of nucleic acids encoding iSYT-like polypeptides obtained by gene shuffling. The terms hybridising sequence, splice variant, allelic variant and gene shuffling are as described herein.

Nucleic acids encoding iSYT-LIKE polypeptides need not be full-length nucleic acids, since performance of the methods of the invention does not rely on the use of full-length nucleic acid sequences. According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a portion of any one of the nucleic acid sequences given in Table A of the Examples section, or a portion of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in Table A of the Examples section wherein the nucleic acid encodes two or three iSYT polypeptides.

A portion of a nucleic acid may be prepared, for example, by making one or more deletions to the nucleic acid. The portions may be used in isolated form or they may be fused to other coding (or non-coding) sequences in order to, for example, produce a protein that combines several activities. When fused to other coding sequences, the resultant polypeptide produced upon translation may be bigger than that predicted for the protein portion.

Portions useful in the methods of the invention, encode a iSYT-like polypeptide as defined herein, and have substantially the same biological activity as the amino acid sequences given in Table A of the Examples section. Preferably, the portion is a portion of any one of the nucleic acids given in Table A of the Examples section, or is a portion of a nucleic acid encoding an orthologue or paralogue of any one of the amino acid sequences given in Table A of the Examples section. Preferably the portion is at least 100, 200, 300, 400, 500, 550, 600, 650, 700, 750, 800, 850, 900, 950, 1000 consecutive nucleotides in length, the consecutive nucleotides being of any one of the nucleic acid sequences given in Table A of the Examples section, or of a nucleic acid encoding an orthologue or paralogue of any one of the amino acid sequences given in Table A of the Examples section. Most preferably the portion is a portion of the nucleic acid of SEQ ID NO: 1.

Another nucleic acid variant useful in the methods of the invention is a nucleic acid capable of hybridising, under reduced stringency conditions, preferably under stringent conditions, with a nucleic acid encoding a iSYT-LIKE polypeptide as defined herein, or with a portion as defined herein.

Hybridising sequences useful in the methods of the invention encode an iSYT-LIKE polypeptide as defined herein, having substantially the same biological activity as the amino acid sequences given in Table A of the Examples section. Preferably, the hybridising sequence is callable of hybridising to the complement of any one of the nucleic acids given in Table A of the Examples section, or to a portion of any of these sequences, a portion being as defined above, or the hybridising sequence is capable of hybridising to the complement of a nucleic acid encoding an orthologue or paralogue of any one of the amino acid sequences given in Table A of the Examples section. Most preferably, the hybridising sequence is capable of hybridising to the complement of a nucleic acid encoding any of the polypeptide of Table A and Table A2 to A6.

Another nucleic acid variant useful in the methods of the invention is a splice variant encoding a iSYT-LIKE polypeptide as defined hereinabove, a splice variant being as defined herein.

According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a splice variant of two or three nucleic acid sequences given in Table A or Tables A2 to A26 of the Examples section, or a splice variant of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in Table A of the Examples section.

Another nucleic acid variant useful in performing the methods of the invention is an allelic variant of a nucleic acid encoding an iSYT-LIKE polypeptide as defined hereinabove, an allelic variant being as defined herein.

According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant of two or three allelic variant of any one of the nucleic acids given in Table A or Tables A2 to A26 of the Examples section, or comprising Introducing and expressing in a plant an allelic variant of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in Table A of the Examples section.

Gene shuffling or directed evolution may also be used to generate variants of nucleic acids encoding iSYT-LIKE polypeptides as defined above; the term “gene shuffling” being as defined herein.

According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a variant of any one of the nucleic acid sequences given in Table A or Tables A2 to A26 of the Examples section, or comprising introducing and expressing in a plant a variant of a nucleic acid encoding two or three orthologue, paralogue or homologue of any of the amino acid sequences given in Table A or Tables A2 to A26 of the Examples section, which variant nucleic acid is obtained by gene shuffling.

Furthermore, nucleic acid variants may also be obtained by site-directed mutagenesis. Several methods are available to achieve site-directed mutagenesis, the most common being PCR based methods (Current Protocols in Molecular Biology. Wiley Eds.).

Nucleic acids encoding iSYT-like polypeptides may be derived from any natural or artificial source. The nucleic acid may be modified from its native form in composition and/or genomic environment through deliberate human manipulation. Preferably the iSYT-LIKE polypeptide-encoding nucleic acid is from a plant, further preferably from a monocotyledonous plant, most preferably the nucleic acid is from Zea mays or from Oryza sativa.

Performance of the methods of the invention gives plants having enhanced yield-related traits. In particular performance of the methods of the invention gives plants having increased yield, especially increased seed yield relative to control plants. The terms “yield” and “seed yield” are described in more detail in the “definitions” section herein.

Reference herein to enhanced yield-related traits is taken to mean an increase early vigour and/or in biomass (weight) of one or more parts of a plant, which may include aboveground (harvestable) parts and/or (harvestable) parts below ground. In particular, such harvestable parts are seeds, and performance of the methods of the invention results in plants having increased seed yield relative to the seed yield of control plants.

A preferred method for modulating (increasing or decreasing) expression of any two or three nucleic acids encoding the corresponding two or three iSYT-like polypeptides is by introducing and expressing in a plant: (i) a nucleic acid sequence encoding a first iSYT-like polypeptide; and (ii) a nucleic acid sequence encoding a second iSYT-like polypeptide. Therefore, according to the present invention, there is provided a method for enhancing yield-related traits in plants, which method comprises introducing and expressing in a plant:

-   -   (i) any two or three nucleic acids encoding the corresponding         two or three iSYT-like polypeptides; or     -   (ii) two or three nucleic acids, each encoding a single         iSYT-like polypeptide; or     -   (iii) a nucleic acid according to (i) and a nucleic according to         (ii),         wherein said iSYT-like polypeptide is selected from the group         consisting of any of the polypeptides of Table A, homologues         thereof and fusions of the same.

Methods for introducing and expressing two or more transgenes (also called gene stacking) in transgenic plants are well known in the art (see for example, a review by Halpin (2005) Plant Biotech J (3): 141-155. Gene stacking can proceed by interactive steps, where two or more transgenes can be sequentially introduced into a plant by crossing a plant containing one transgene with individuals harbouring other transgenes or, alternatively, by re-transforming (or super-transforming) a plant containing one transgene with new genes.

According to the present invention, there is provided a method for enhancing yield-related traits in plants, which method comprises sequentially introducing and expressing in a plant:

-   -   (i) any two or three nucleic acids encoding the corresponding         two or three iSYT-like polypeptides; or     -   (ii) two or three nucleic acids, each encoding a single         iSYT-like polypeptide; or     -   (iii) a nucleic acid according to (i) and a nucleic according to         (ii).         wherein said iSYT-like polypeptide is selected from the group         consisting of any of the polypeptides of Table A, homologues         thereof and fusions of the same.

Preferably, the nucleic acid sequences of (i), (ii) and (iii) are sequentially introduced and expressed by crossing. A crossing is performed between a female parent plant comprising an introduced and expressed isolated nucleic acid sequence encoding one or two iSYT-like polypeptides, and a male parent plant also comprising an introduced and expressed isolated nucleic acid sequence encoding one or two iSYT-like polypeptides, and preferably selecting in the progeny for the presence and expression of both transgenes. Therefore, according to the present invention, there is provided a method for enhancing yield-related traits in plants, by crossing a female parent plant comprising an introduced and expressed isolated nucleic acid sequence encoding one or two iSYT-like polypeptides, and a male parent plant comprising an introduced and expressed isolated nucleic acid sequence encoding one or two iSYT-like polypeptides, and preferably selecting in the progeny for the presence and expression of at least two of the introduced transgenes encoding the corresponding iSYT-like polypeptides, wherein said plants have enhanced yield-related traits relative to the parent plants, or to any other control plants as defined herein.

Alternatively the nucleic acid sequences of (i), (ii) and (ii) are sequentially introduced and expressed by re-transformation. Re-transformation is performed by introducing and expressing a nucleic acid sequence encoding one or two iSYT-like polypeptides, plant part, or plant cell comprising a introduced and expressed nucleic acid sequence encoding a second one or two iSYT-like polypeptides, and preferably by selecting in the progeny for the presence and expression of both transgenes. Therefore, according to the present invention, there is provided a method for enhancing yield-related traits in plants, by re-transformation performed by introducing and expressing a nucleic acid sequence encoding one or two iSYT-like polypeptides into a plant, plant part, or plant cell comprising an introduced and expressed nucleic acid sequence encoding a second one or two iSYT-like polypeptide, and by preferably selecting in the progeny for the presence and expression of both transgenes, wherein said plants have enhanced yield-related traits relative to the plants having increased expression of one of:

-   -   (i) any two or three nucleic acids encoding the corresponding         two or three iSYT-like polypeptides; or     -   (ii) two or three nucleic acids, each encoding a single         iSYT-like polypeptide; or     -   (iii) a nucleic acid according to (i) and a nucleic according to         (ii),         wherein said iSYT-like polypeptide is selected from the group         consisting of any of the polypeptides of Table A, homologues         thereof and fusions of the same.

Alternatively, gene stacking can occur via simultaneous transformation, or co-transformation, which is faster and can be used in a whole range of well known transformation techniques, preferably as described herein.

Alternatively, gene stacking can occur via simultaneous transformation, or co-transformation, which is faster and can be used in a whole range of transformation techniques, as described in the “definition” section herein.

When direct genetic transformation is considered, using physical or chemical delivery systems (e.g., microprojectile bombardment, PEG, electroporation, liposome, glass needles, etc.), the transgenes (at least two) can also be present in a number of conformations, but essentially do not need to be comprised in a vector capable of being replicated in Agrobacteria or viruses, intermediates of the genetic transformation. The two transgenes can be comprised in one or more nucleic acid molecules, but simultaneously used for the genetic transformation process.

According to the present invention, there is provided a method for enhancing yield-related traits in plants, which method comprises simultaneously introducing and expressing in a plant: (i) a nucleic acid sequence encoding one or two iSYT-like polypeptides; and (ii) a nucleic acid sequence encoding a second iSYT-like polypeptide, which plants have enhanced yield-related traits relative to plants having increased expression of one of:

-   -   (i) any two or three nucleic acids encoding the corresponding         two or three iSYT-like polypeptides; or     -   (ii) two or three nucleic acids, each encoding a single         iSYT-like polypeptide; or     -   (iii) a nucleic acid according to (i) and a nucleic according to         (ii),         wherein said iSYT-like polypeptide is selected from the group         consisting of any of the polypeptides of Table A, homologues         thereof and fusions of the same.

The nucleic acid sequences of (i), (ii) and (iii) that are simultaneously introduced and expressed, are comprised in one or more nucleic acid molecules. Therefore, according to the present invention is provided increasing yield-related traits in plants, which method comprises simultaneously introducing and expressing in a plant

-   -   (i) any two or three nucleic acids encoding the corresponding         two or three iSYT-like polypeptides; or     -   (ii) two or three nucleic acids, each encoding a single         iSYT-like polypeptide; or     -   (iii) a nucleic acid according to (i) and a nucleic according to         (ii),         wherein said iSYT-like polypeptide is selected from the group         consisting of any of the polypeptides of Table A, homologues         thereof and fusions of the same.

The invention also provides genetic constructs and vectors to facilitate introduction and/or expression (de novo introduced or increased the already existing expression) in plants of any two or three nucleic acids encoding the corresponding combination of two or three iSYT-like polypeptides. The gene constructs may be inserted into vectors, which may be commercially available, suitable for transforming into plants and for expression of the gene of interest in the transformed cells. The invention also provides use of a gene construct as defined herein in the methods of the invention.

More specifically, the present invention provides a construct comprising:

-   -   (a) any two or three nucleic acids encoding the corresponding         two or three iSYT-like polypeptides as defined above;     -   (b) one or more control sequences capable of increasing         expression of the nucleic acid sequence of (a) and of (b); and         optionally     -   (c) a transcription termination sequence.

The nucleic acid sequence of (a) is preferably a nucleic acid molecule comprising a nucleic acid sequence encoding combinations of two or three iSYT-like polypeptides, preferably those combinations listed in Table 3. The nucleic acid sequences encoding the iSYT polypeptides in maybe fused to each other or separated by coding or non-coding DNA, such as promoters, introns, subcellular targeting signal, or stuffed DNA such as the MARs (Matrix attachment Regions) regions.

The term “control sequence” and “termination sequence” are as defined herein. Preferred control sequence of a construct useful in the methods of the invention are provided in Table 4, preferably as represented by SEQ ID NO: 665 to SEQ ID NO: 669.

Preferably, one of the control sequences of a construct is a constitutive promoter. An example of a constitutive promoter is a GOS2 promoter, preferably a rice GOS2 promoter, more preferably a GOS2 promoter as represented by SEQ ID NO: 664.

TABLE 4 Preferred promoters SEQ ID Promoter name Source organism NO GOS2 Oryza sativa 665 HMGB Oryza sativa 666 ScBV Sugarcane bacilliform virus 667 ScBV-METI Sugarcane bacilliform virus 668 with intron ZmUBI Zea mays 669

In one preferred construct, a single control sequence is used to drive the expression of the nucleic acid sequence encoding two or three iSYT-like polypeptides, preferably those combinations as listed in Table 3.

The present invention also provides for a mixture of constructs useful for example, for simultaneous introduction and expression in plants of two or three nucleic acid sequence encoding an iSYT-like polypeptide as defined above; wherein at least one construct comprises:

-   -   (a) a nucleic acid sequence nucleic acid sequence encoding an         iSYT-like polypeptide as defined above;     -   (b) one or more control sequences capable of driving expression         of the nucleic acid sequence of (a); and optionally     -   (c) a transcription termination sequence,         and wherein at least one other construct comprises:     -   (d) a nucleic acid sequence nucleic acid sequence encoding an         iSYT-like polypeptide as defined above;     -   (e) one or more control sequences capable of driving expression         of the nucleic acid sequence of (d); and optionally     -   (f) a transcription termination sequence.

Preferably, one of the control sequences of a construct is a constitutive promoter. An example of a constitutive promoter is a GOS2 promoter, preferably a rice GOS2 promoter, more preferably a GOS2 promoter as represented by SEQ ID NO: 664

The invention also provides for the use of a construct comprising: (a) any two or three nucleic acids encoding the corresponding two or three iSYT-like polypeptides as defined above, or of a mixture of constructs as described above, in a method for making plants having enhanced yield-related traits relative to plants having increased expression of one of the nucleic acids encoding the corresponding two or three iSYT-like polypeptides which increased yield-related traits are one or more of: (i) increased early vigour; (ii) increased aboveground biomass or root biomass; (ii) increased total seed yield per plant; (iv) increased seed filling rate; (v) increased number of (filled) seeds; (vi) increased harvest index; or (vii) increased thousand kernel weight (TKW).

The invention also provides for plants, plant parts or plant cells transformed with a construct comprising any two or three nucleic acids encoding the corresponding two or three iSYT-like polypeptides as defined above or with a mixture of constructs as defined above.

Plants are transformed with one or more vectors comprising any of the nucleic acid sequences described above. The skilled artisan is well aware of the genetic elements that must be present on the vector in order to successfully transform, select and propagate host cells containing the sequence of interest. The sequence of interest is operably linked to one or more control sequences (at least to a promoter).

Advantageously, any type of promoter, whether natural or synthetic, may be used to increase expression of the nucleic acid sequence. A constitutive promoter is particularly useful in the methods.

Other organ-specific promoters, for example for preferred expression in leaves, stems, tubers, meristems, seeds (embryo and/or endosperm), are useful in performing the methods of the invention. See the “Definitions” section herein for definitions of the various promoter types.

The present invention provides a method for enhancing yield-related traits especially seed yield of plants, relative to control plants, which method comprises modulating expression in a plant of a nucleic acid encoding a iSYT-LIKE polypeptide as defined herein.

Since the transgenic plants according to the present invention have increased yield (yield related traits), it is likely that these plants exhibit an increased growth rate (during at least part of their life cycle), relative to the growth rate of control plants at a corresponding stage in their life cycle.

According to a preferred feature of the present invention, performance of the methods of the invention gives plants having an increased growth rate relative to control plants. Therefore, according to the present invention, there is provided a method for increasing the growth rate of plants, which method comprises modulating expression in a plant of a nucleic acid encoding a iSYT-like polypeptide as defined herein.

Performance of the methods of the invention gives plants grown under non-stress conditions or under mild drought conditions increased yield relative to control plants grown under comparable conditions. Therefore, according to the present invention, there is provided a method for increasing yield in plants grown under non-stress conditions or under mild drought conditions, which method comprises modulating expression in a plant of a nucleic acid encoding an iSYT-like polypeptide.

Performance of the methods of the invention gives plants grown under conditions of nutrient deficiency, particularly under conditions of nitrogen deficiency, increased yield relative to control plants grown under comparable conditions. Therefore, according to the present invention, there is provided a method for increasing yield in plants grown under conditions of nutrient deficiency, which method comprises modulating expression in a plant of a nucleic acid encoding an iSYT-like polypeptide.

Performance of the methods of the invention gives plants grown under conditions of salt stress, increased yield relative to control plants grown under comparable conditions. Therefore, according to the present invention, there is provided a method for increasing yield in plants grown under conditions of salt stress, which method comprises modulating expression in a plant of a nucleic acid encoding an iSYT-Like polypeptide.

The invention also provides genetic constructs and vectors to facilitate introduction and/or expression in plants of nucleic acids encoding iSYT-Like polypeptides. The gene constructs may be inserted into vectors, which may be commercially available, suitable for transforming into plants and suitable for expression of the gene of interest in the transformed cells. The invention also provides use of a gene construct as defined herein in the methods of the invention.

As mentioned above, a preferred method for modulating expression of a nucleic acid encoding a iSYT-Like polypeptide is by introducing and expressing in a plant a nucleic acid encoding a iSYT-Like polypeptide; however the effects of performing the method, i.e. enhancing yield-related traits may also be achieved using other well known techniques, including but not limited to T-DNA activation tagging, TILLING, homologous recombination. A description of these techniques is provided in the definitions section.

The present invention clearly extends to any plant cell or plant produced by any of the methods described herein, and to all plant parts and propagules thereof. The present invention encompasses plants or parts thereof (including seeds) obtainable by the methods according to the present invention. The plants or parts thereof comprise a nucleic acid transgene encoding a iSYT-Like polypeptide as defined above. The present invention extends further to encompass the progeny of a primary transformed or transfected cell, tissue, organ or whole plant that has been produced by any of the aforementioned methods, the only requirement being that progeny exhibit the same genotypic and/or phenotypic characteristic(s) as those produced by the parent in the methods according to the invention.

The invention also includes host cells containing an isolated nucleic acid encoding an iSYT-like polypeptide as defined hereinabove. Preferred host cells according to the invention are plant cells. Host plants for the nucleic acids or the vector used in the method according to the invention, the expression cassette or construct or vector are, in principle, advantageously all plants, which are capable of synthesizing the polypeptides used in the inventive method.

The methods of the invention are advantageously applicable to any plant. Plants that are particularly useful in the methods of the invention include all plants which belong to the superfamily Viridiplantae, in particular monocotyledonous and dicotyledonous plants including fodder or forage legumes, ornamental plants, food crops, trees or shrubs. According to a preferred embodiment of the present invention, the plant is a crop plant. Examples of crop plants include soybean, sunflower, canola, alfalfa, rapeseed, linseed, cotton, tomato, potato and tobacco. Further preferably, the plant is a monocotyledonous plant. Examples of monocotyledonous plants include sugarcane. More preferably the plant is a cereal. Examples of cereals include rice, maize, wheat, barley, millet, rye, triticale, sorghum, emmer, spelt, secale, einkom, teff, milo and oats.

The invention also extends to harvestable parts of a plant such as, but not limited to seeds, leaves, fruits, flowers, stems, roots, rhizomes, tubers and bulbs, which harvestable parts comprise a recombinant nucleic acid encoding an iSYT-like polypeptide. The invention furthermore relates to products derived, preferably directly derived, from a harvestable part of such a plant, such as dry pellets or powders, oil, fat and fatty acids, starch or proteins.

The present invention also encompasses use of nucleic acids encoding iSYT-like polypeptides as described herein and use of these iSYT-like polypeptides in enhancing any of the aforementioned yield-related traits in plants. For example, nucleic acids encoding iSYT-like polypeptide described herein, or the iSYT-like polypeptides themselves, may find use in breeding programmes in which a DNA marker is identified which may be genetically linked to a iSYT-like polypeptide-encoding gene. The nucleic acids/genes, or the iSYT-like polypeptides themselves may be used to define a molecular marker. This DNA or protein marker may then be used in breeding programmes to select plants having enhanced yield-related traits as defined hereinabove in the methods of the invention. Furthermore, allelic variants of a iSYT-like polypeptide-encoding nucleic acid/gene may find use in marker-assisted breeding programmes. Nucleic acids encoding iSYT-like polypeptides may also be used as probes for genetically and physically mapping the genes that they are a part of, and as markers for traits linked to those genes. Such information may be useful in plant breeding in order to develop lines with desired phenotypes.

Items

The present invention will now be described in reference to the embodiments of the following items:

-   1. A method for enhancing yield-related traits in a plant relative     to control plants, comprising modulating expression in a plant of:     -   (i) any two or three nucleic acids encoding the corresponding         two or three iSYT-like polypeptides; or     -   (ii) two or three nucleic acids, each encoding a single         iSYT-like polypeptide; or     -   (iii) a nucleic acid according to (i) and a nucleic according to         (ii),     -   wherein said iSYT-like polypeptide is selected from the group         consisting of any of the polypeptides of Table A, homologues         thereof and fusions of the same. -   2. A method according to item 1 wherein at least one of the     polypeptides is a synovial sarcoma translocation (SYT) polypeptide     or a homologue thereof, said SYT polypeptide or homologue thereof     preferably comprising an SNH domain having in increasing order of     preference at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%,     85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% sequence     identity to the SNH domain of SEQ ID NO: 670     (IQQYLDENKSLILKIVESQNSGKLSECAENQARLQRNL MYLAAIAD). -   3. A method according to item 1 or 2 wherein said nucleic acids     encode the corresponding polypeptides selected from the group     consisting of the polypeptides listed in Table 3. -   4. Method according to any one of items 1 to 3, wherein said     modulated expression is effected by introducing and expressing in a     plant said nucleic acids. -   5. Method according to any one of items 1 to 4, wherein said nucleic     acids is selected from the group consisting of the nucleic acids     encoding any the proteins listed in Table A and Tables A2 to Table     A26, or is a portion of such a nucleic acid, or a nucleic acid     capable of hybridising with such a nucleic acid. -   6. Method according to any one of items 1 to 5, wherein said nucleic     acids encode an orthologue or paralogue of any of the proteins given     in Table A. -   7. Method according to any preceding item, wherein said enhanced     yield-related traits comprise increased yield, preferably increased     biomass and/or increased seed yield relative to control plants. -   8. Method according to any preceding item, wherein said enhanced     yield-related traits are obtained under non-stress conditions. -   9. Method according to any preceding item, wherein said enhanced     yield-related traits are obtained under conditions of drought     stress, salt stress or nitrogen deficiency. -   10. Method according to any one of items 4 to 9, wherein said one or     more said nucleic acids are operably linked to a plant promoter,     preferably to a constitutive promoter, more preferably to a GOS2     promoter, most preferably to a GOS2 promoter from rice. -   11. Method according to any one of items 1 to 10, wherein said one     or more said nucleic acids is of plant origin, preferably from a     dicotyledonous plant, further preferably from the family     Brasslcaceae, more preferably from the genus Arabidopsis, most     preferably from Arabidopsis thaliana. -   12. Plant or part thereof, including seeds, obtainable by a method     according to any one of items 1 to 11, wherein said plant or part     thereof comprises any two or three nucleic acids encoding the     corresponding two or three polypeptides selected from the group     consisting of the polypeptides listed in Table A, homologues thereof     and fusions of the same. -   13. Construct comprising:     -   (i) Any two or three nucleic acids encoding the corresponding         two or three polypeptides selected from the group consisting of         any of the polypeptides listed in of Table A or homologues         thereof and fusions of the same;     -   (ii) one or more control sequences capable of driving expression         of the nucleic acid sequence of (i), preferably a plant         promoter, more preferably a constitutive promoter, even more         preferably a GOS2 promoter, most preferably a GOS2 promoter from         rice; and optionally     -   (iii) a transcription termination sequence. -   14. Construct according to item 12, wherein said nucleic acid of (i)     encodes two or three polypeptides selected from the group consisting     of the polypeptides listed in Table 3. -   15. Use of a construct according to item 13 or 14 in a method for     making plants having increased yield, particularly increased biomass     and/or increased seed yield relative to control plants. -   16. Plant, plant part or plant cell transformed with a construct     according to item 13 or 14. -   17. Method for the production of a transgenic plant having increased     yield, particularly increased biomass and/or increased seed yield     relative to control plants, comprising:     -   (i) introducing and expressing in a plant any two or three         nucleic acids encoding the corresponding polypeptides selected         from the group consisting of any of the polypeptides of Table A         or homologues thereof and fusions of the same; and     -   (ii) cultivating the plant cell under conditions promoting plant         growth and development. -   18. Transgenic plant having increased yield, particularly increased     biomass and/or increased seed yield, relative to control plants,     resulting from modulated expression of any two or three nucleic     acids encoding the corresponding polypeptides selected from the     group consisting of any of the polypeptides of Table A or homologues     thereof and fusions of the same, or a transgenic plant cell derived     from said transgenic plant. -   19. Transgenic plant according to item 12, 16 or 18, or a transgenic     plant cell derived thereof, wherein said plant is a crop plant or a     monocot or a cereal, such as rice, maize, wheat, barley, millet,     rye, triticale, sorghum emmer, spelt, secale, einkom, teff, milo and     oats. -   20. Harvestable parts of a plant according to item 19, wherein said     harvestable parts are preferably shoot biomass and/or seeds. -   21. Products derived from a plant according to item 18 or 19 and/or     from harvestable parts of a plant according to item 20. -   22. Construct according to item 12, wherein said nucleic acid of (i)     encodes two polypeptides selected from the group consisting of the     combinations of Table 3. -   23. Use of a construct according to item 13 or 14 in a method for     making plants having increased yield, particularly increased biomass     and/or increased seed yield relative to control plants. -   24. Plant, plant part or plant cell transformed with a construct     according to item 13 or 14. -   25. Method for the production of a transgenic plant having increased     yield, particularly increased biomass and/or increased seed yield     relative to control plants, comprising:     -   (iii) introducing and expressing in a plant one or more         (isolated) nucleic acids encoding at least one, preferably two,         three, four, five, six, seven, eight, nine, ten or more         polypeptides selected from the group consisting of any of the         polypeptides of Table A, homologues thereof and fusions of the         same; and     -   (iv) cultivating the plant cell under conditions promoting plant         growth and development. -   26. Transgenic plant having increased yield, particularly increased     biomass and/or increased seed yield, relative to control plants,     resulting from modulated expression of one or more (isolated)     nucleic acids encoding at least one, preferably two, three, four,     five, six, seven, eight, nine, ten or more polypeptides selected     from the group consisting of any of the polypeptides of Table A,     homologues thereof and fusions of the same, or a transgenic plant     cell derived from said transgenic plant. -   27. Transgenic plant according to item 12, 16 or 18, or a transgenic     plant cell derived thereof, wherein said plant is a crop plant or a     monocot or a cereal, such as rice, maize, wheat, barley, millet,     rye, triticale, sorghum emmer, spelt, secale, einkom, teff, milo and     oats. -   28. Harvestable parts of a plant according to item 19, wherein said     harvestable parts are preferably shoot biomass and/or seeds. -   29. Products derived from a plant according to item 18 or 19 and/or     from harvestable parts of a plant according to item 20. -   30. Use of any two or three nucleic acids encoding two or three     polypeptides selected from the group consisting of any of the     polypeptides of Table A, homologues thereof and fusions of the same     in increasing yield, particularly in increasing seed yield and/or     shoot biomass in plants, relative to control plants. -   31. An isolated AN3-based protein complex, comprising at least the     proteins AN3p and one or more of the proteins selected from the     group encoded by AT4G16143, AT1G09270, AT3G06720, AT5G53480,     AT3G60830. AT1G18450, AT2G46020, AT2G28290, AT1G21700, AT5G14170,     AT4G17330, AT4G27550, AT1G65980, AT5G55210, AT3G15000, AT4G35550,     AT1G20670, AT1G08730, AT5G13030, AT2G18876, AT5G17510, AT1G05370,     AT4G21540, AT1G23900 and AT5G23690. -   32. An isolated AN3-based protein complex comprises at least the     proteins AN3p and one or more proteins selected from the group     consisting of ARP4 (AT1G18450), ARP7 (AT3G60830), SNF2 (AT2G46020),     SYD (AT2G28290), SWI3C (AT1G21700) and SWP73B (AT5G14170). -   33. An isolated AN3-based protein complex according to item 2,     whereby said protein complex comprises at least AN3p, an actin     related protein selected from the group consisting of ARP4 and ARP7,     an ATPase selected from the group consisting of SNF2 (BRM) and SYD     and a SWIRM domain containing protein. -   34. An isolated AN3-based protein complex according to item 3,     whereby said SWIRM domain containing protein is SWI3C -   35. The use of a protein complex according to any of the preceding     items to promote plant growth. -   36. A method to promote AN3-based protein complex formation by     simultaneous overexpression of at least two proteins of the complex.

DESCRIPTION OF FIGURES

The present invention will now be described with reference to the following figures in which:

FIG. 1. Expression analysis of GS-tagged GFP and AN3 in transgenic cell suspension cultures.

The total protein extract of 2-day-old wild-type and N- and C-terminal GS-tagged GFP and AN3 overexpressing cultures (60 μg) was separated by 12% SDS-PAGE and immunoblotted.

For detection of GS-tagged proteins, blots were incubated with human blood plasma followed by incubation with anti-human IgG coupled to horseradish peroxidase. Protein gel blots were developed by Chemiluminiscent detection. The expected recombinant molecular masses for GS-tagged GFP and AN3 are 52.8 kDa and 43.5 kDa, respectively (indicated with a black dot).

FIG. 2. Analysis of the TAP protein eluates.

GS-tagged protein complexes were purified from transgenic plant cell suspension cultures, precipitated with TCA (25%, v/v), separated on 4-12% NuPAGE gels, and visualized with colloidal Coomassie G-250 staining. Bait proteins are indicated with a dot.

FIG. 3. represents the binary vector used for introducing and expressing in Oryza sativa of a iSYT-Like-encoding nucleic acid under the control of a plant promoter.

EXAMPLES

The present invention will now be described with reference to the following examples, which are by way of illustration alone. The following examples are not intended to completely define or otherwise limit the scope of the invention.

DNA manipulation: unless otherwise stated, recombinant DNA techniques are performed according to standard protocols described in (Sambrook (2001) Molecular Cloning: a laboratory manual, 3rd Edition Cold Spring Harbor Laboratory Press, CSH, New York) or in Volumes 1 and 2 of Ausubel et al. (1994), Current Protocols in Molecular Biology, Current Protocols. Standard materials and methods for plant molecular work are described in Plant Molecular Biology Labfax (1993) by R. D. D. Croy, published by BIOS Scientific Publications Ltd (UK) and Blackwell Scientific Publications (UK).

Example 1 Vector Construction: TAP Vectors

Construction of N- and C-terminal GS-tagged GFP and AN3 under the control of the 35S (CaMV) promoter was obtained by Multisite Gateway LR reactions. The coding regions, without (−) and with (+) stopcodon, were amplified by polymerase chain reaction (PCR) and cloned into the Gateway pDONR221 vector (Invitrogen) resulting in pEntryL1L2-GFP(−), pEntryL1L2-GFP(+), pEntryL1L2-AN3(−) and pEntryL1L2-AN3(+). The Pros:GFP-GS- and Pro_(35S):AN3-GS-containing plant transformation vectors were obtained by Multisite Gateway LR reaction between pEntryL4R1-Pro, pEntryL1L2-GFP(−) or pEntryL1L2-AN3(−), and pEntryR2L3-GS and the destination vector pKCTAP, respectively (Van Leene et al., 2007). To obtain the Pro35S:GS-GFP and Pro35S:GS-AN3 vectors Multisite LR recombination between pEntryL4L3-Pross and pEntryL1L2-GFP(+) or pEntryL1L2-AN3(+) with pKNGSTAP occurred.

All entry and destination vectors were checked by sequence analysis. Expression vectors were transformed to Agrobacterium tumefaciens strain C58C1Rif^(R) (pMP90) by electroporation. Transformed bacteria were selected on yeast extract broth plates containing 100 μg/mL rifampicin, 40 μg/mL gentamicin, and 100 μg/mL spectinomycin.

Example 2 Cell Suspension Cultivation

Wild-type and transgenic Arabidopsis thaliana cell suspension PSB-D cultures were maintained in 50 mL MSMO medium (4.43 g/L MSMO, Sigma-Aldrich), 30 g/L sucrose, 0.5 mg/L NAA, 0.05 mg/L kinetin, pH 5.7 adjusted with 1M KOH) at 25° C. in the dark, by gentle agitation (130 rpm). Every 7 days the cells were subcultured in fresh medium at a 1/10 dilution.

Example 3 Cell Culture Transformation

The Arabidopsis culture was transformed by Agrobacterium co-cultivation as described previously (Van Leene et al., 2007). The Agrobacterium culture exponentially growing in YEB (OD₆₀₀ between 1.0 and 1.5) was washed three times by centrifugation (10 min at 5000 rpm) with an equal volume MSMO medium and resuspended in cell suspension growing medium until an OD₆₀₀ of 1.0. Two days after subcultivation, 3 mL suspension culture was incubated with 200 μL washed Agrobacteria and 200 μM acetoseringone, for 48 h in the dark at 25° C. with gentle agitation (130 rpm). Two days after co-cultivation, 7 mL MSMO containing a mix of three antibiotics (25 μg/mL kanamycin, 500 μg/mL carbenicellin, and 500 μg/mL vancomycin) was added to the cell cultures and grown further in suspension under standard conditions (25° C., 130 rpm and continuous darkness). The stable transgenic cultures were selected by sequential dilution in a 1:5 and 1:10 ratio in 50 mL fresh MSMO medium containing the antibiotics mix, respectively at 11, and 18 days post co-cultivation. After counter selecting the bacteria, the transgenic plant cells were further subcultured weekly in a 1:5 ratio in 50 mL MSMO medium containing 25 μg/mL kanamycin for two more weeks. Thereafter the cells were weekly subcultured in fresh medium at a 1/10 dilution.

Example 4 Expression Analysis of Cell Suspension Cultures

Transgene expression was analyzed in a total protein extract derived from exponentially growing cells, harvested two days after subculturing. Equal amounts of total protein were separated on 12% SDS-PAGE gels and blotted onto Immobilon-P membranes (Millipore, Bedford, Mass.). Protein gel blots were blocked in 3% skim milk in 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, and 0.1% Triton X-100. For detection of GS-tagged proteins, blots were incubated with human blood plasma followed by incubation with anti-human IgG coupled to horseradish peroxidase (HRP; GE-Healthcare). Protein gel blots were developed by Chemiluminiscent detection (Perkin Elmer, Norwalk, Conn.).

Example 5 Protein Extract Preparation

Cell material (15 g) was grinded to homogeneity in liquid nitrogen. Crude protein extract were prepared in an equal volume (w/v) of extraction buffer (25 mM Tris-HCl, pH 7.6, 15 mM MgCl₂, 5 mM EGTA, 150 mM NaCl, 15 mM p-nitrophenylphosphate, 60 mM β-glycerophosphate, 0.1% (v/v) Nonidet P-40 (NP-40), 0.1 mM sodium vanadate, 1 mM NaF, 1 mM DTT, 1 mM PMSF, 10 μg/mL leupeptin, 10 μg/mL aprotinin, 5 μg/mL antipain, 5 μg/mL chymostatin, 5 μg/mL pepstatin, 10 μg/mL soybean trypsin inhibitor, 0.1 mM benzamidine, 1 μM trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane (E64), 5% (v/v) ethylene glycol) using an Ultra-Turrax T25 mixer (IKA Works, Wilmington, N.C.) at 4° C. The soluble protein fraction was obtained by a two-step centrifugation at 36900 g for 20 min and at 178000 g for 45 min, at 4° C. The extract was passed through a 0.45 μm filter (Alltech, Deerfield, Ill.) and the protein content was determined with the Protein Assay kit (Bio-Rad, Hercules, Calif.).

Example 6 Tandem Affinity Purification

Purifications were performed as described by Bürckstümmer et al. (2006), with some modifications. Briefly, 200 mg total protein extract was incubated for 1 h at 4° C. under gentle rotation with 100 μL IgG Sepharose 6 Fast Flow Flow beads (GE-Healthcare, Little Chalfont, UK), pre-equilibrated with 3 mL extraction buffer. The IgG Sepharose beads were transferred to a 1 mL Mobicol column (MoBiTec, Goettingen, Germany) and washed with 10 mL IgG wash buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% NP-40, 5% ethylene glycol) and 5 mL Tobacco (Nicotiana tabacum L) Etch Virus (TEV) buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% (v/v) NP-40, 0.5 mM EDTA, 1 mM PMSF, 1 μM E64, 5% (v/v) ethylene glycol). Bound complexes were eluted via AcTEV digest (2×100 U, Invitrogen) for 1 h at 16° C. The IgG eluted fraction was incubated for 1 h at 4° C. under gentle rotation with 100 μL Streptavidin resin (Stratagene, La Jolla, Calif.), pre-equilibrated with 3 mL TEV buffer. The Streptavidin beads were packed in a Mobicol column, and washed with 10 mL TEV buffer. Bound complexes were eluted with 1 mL streptavidin elution buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% (v/v) NP-40, 0.5 mM EDTA, 1 mM PMSF, 1 μM E64, 5% (v/v) ethylene glycol, 20 mM Desthiobiotin), and precipitated using TCA (25% v/v). The protein pellet was washed twice with ice-cold aceton containing 50 mM HCl, redissolved in sample buffer and separated on 4-12% gradient NuPAGE gels (Invitrogen). Proteins were visualized with colloidal Coomassie brilliant blue staining.

Example 7 Proteolysis and Peptide Isolation

After destaining, gel slabs were washed for 1 hour in H₂O, polypeptide disulfide bridges were reduced for 40 min in 25 mL of 6.66 mM DTT in 50 mM NH₄HCO₃ and sequentially the thiol groups were alkylated for 30 min in 25 mL 55 mM IAM in 50 mM NH₄HCO₃. After washing the gel slabs 3 times with water, complete lanes from the protein gels were cut into slices, collected in microtiter plates and treated essentially as described before with minor modifications (Van Leene et al., 2007). Per microtiter plate well, dehydrated gel particles were rehydrated in 20 μL digest buffer containing 250 ng trypsin (MS Gold; Promega, Madison, Wis.), 50 mM NH₄HCO₃ and 10% CH₃CN (v/v) for 30 min at 4° C. After adding 10 μL of a buffer containing 50 mM NH₄HCO₃ and 10% CH₃CN (v/v), proteins were digested at 37° C. for 3 hours. The resulting peptides were concentrated and desalted with microcolumn solid phase tips (PerfectPure™ C18 tip, 200 nL bed volume; Eppendorf, Hamburg, Germany) and eluted directly onto a MALDI target plate (Opti-TOF™384 Well Insert Applied Biosystems, Foster City, Calif.) using 1.2 μL of 50% CH₃CN: 0.1% CF₃COOH solution saturated with α-cyano-4-hydroxycinnamic acid and spiked with 20 fmole/μL Glu1-Fibrinopeptide B (Sigma-Aldrich), 20 fmole/μL des-Pro2-Bradykinin (Sigma-Aldrich), and 20 fmole/μL Adrenocorticotropic Hormone Fragment 18-39 human (Sigma-Aldrich).

Example 8 Acquisition of Mass Spectra

A MALDI-tandem MS instrument (4800 Proteomics Analyzer, Applied Biosystems) was used to acquire peptide mass fingerprints and subsequent 1 kV CID fragmentation spectra of selected peptides. Peptide mass spectra and peptide sequence spectra were obtained using the settings essentially as presented in Van Leene et al. (2007). Each MALDI plate was calibrated according to the manufacturers' specifications. All peptide mass fingerprinting (PMF) spectra were internally calibrated with three internal standards at m/z 963.516 (des-Pro2-Bradykinin), m/z 1570.677 (Glu1-Fibrinopeptide B), and m/z 2465,198 (Adrenocorticotropic Hormone Fragment 18-39) resulting in an average mass accuracy of 5 ppm±10 ppm for each analyzed peptide spot on the analyzed MALDI targets. Using the Individual PMF spectra, up to sixteen peptides, exceeding a signal-to-noise ratio of 20 that passed through a mass exclusion filter were submitted to fragmentation analysis.

Example 9 MS-Based Protein Homology Identification

PMF spectra and the peptide sequence spectra of each sample were processed using the accompanied software suite (GPS Explorer 3.6, Applied Biosystems) with parameter settings essentially as described in Van Leone et al. (2007). Data search files were generated and submitted for protein homology identification by using a local database search engine (Mascot 2.1, Matrix Science). An in-house nonredundant Arabidopsis protein database called SNAPS Arabidopsis thaliana version 0.4 (SNAPS=Simple Nonredundant Assembly of Protein Sequences, 77488 sequence entries, 30468560 residues; available at ptools.ua.ac.be/snaps) was compiled from nine public databases. Protein homology identifications of the top hit (first rank) with a relative score exceeding 95% probability were retained. Additional positive identifications (second rank and more) were retained when the score exceeded the 98% probability threshold.

Example 10 Expression Analysis of GS-Tagged GFP and AN3 Overexpressing Cell Lies

Before performing TAP purifications stably transformed cell suspension cultures were screened on the protein expression level of the transgenes. Protein gel blotting of equal amounts of total protein extract derived from wild-type (PSB-D) cultures and GS-GFP, GFP-GS, GS-AN3, and AN3-GS overexpressing cell lines showed clear expression of the GS-tagged proteins (FIG. 1).

Example 11 TAP Purification of Wild-Type and GS-Tagged GFP Overexpress AN3 Cultures

Despite the two successive purification steps performed within TAP purifications, background proteins co-purified by non-specific binding are an issue. Contaminating proteins due to experimental background were determined by purifications on wild-type and transgenic cultures overexpressing N- and C-terminal GS-tagged nuclear localized green fluorescent protein (GFP). Non-specific co-purified proteins were precipitated, separated on gel, stained (FIG. 2), trypsin digested and identified unambiguously by MALDI-TOF/TOF. Most contaminants are high abundant proteins, such as chaperones, cytoskeleton proteins, ribosomal proteins, metabolic enzymes, or protein translation factors (Table 0). Identical or similar proteins were found as common contaminants in other plant protein-protein interaction studies (Rohila et al., 2006; Van Leone et al., 2007).

Example 12 TAP Isolation and MS Identification of AN3 Interacting Proteins

In order to identify the interaction partners of AN3 in vivo, we performed tandem affinity (TAP) purifications on N- and C-terminal GS-fusions of AN3 ectopically expressed under control of the constitutive 35SCaMV promoter in transgenic Arabidopsis suspension cultures. Two independent TAP purifications were performed on extracts from AN3-GS and GS-AN3 lines, harvested two days after sub-culturing into fresh medium. The affinity purified proteins were separated on a 4-12% NuPAGE gel and stained with Coomassie Brilliant Blue. The purification profiles from transgenic cultures overexpressing AN3 is shown in FIG. 2. Protein bands were cut, in-gel digested with trypsin and subjected to MALDI-TOF/TOF mass spectrometry for protein identification. After subtracting background proteins, identified by the control purifications described in example 2 and in other analyses (GUS and cytosolic GFP, Van Leene et al., 2007), from the obtained hit list we identified 25 AN3 Interacting proteins (Table A). These can be divided into two groups: 14 proteins were confirmed experimentally and 11 proteins were identified only in one out of four TAP experiments.

Example 13 Isolation and Subunit Identification of AN3 Interacting SWI/SNF Chromatin Remodeling Complexes in Plants

Among the experimentally confirmed AN3 interactors six proteins act as subunits of macromolecular machines that remodel chromatin structure. A database survey (ChromDB, Gendler et al., 2008) Illustrates that all of them belong to the SWI/SNF ATPase family. SWI/SNF chromatin remodeling ATPases are conserved in the animal and the plant kingdom and regulate transcriptional programs in response to endogenous and exogenous cues. This suggests that the transcriptional activity of AN3 is regulated through chromatin remodeling. In agreement, the human AN3 homolog SYT was also shown to interact with the SWI/SNF complex components BRM and Brg1 (Thaete et al., 1999; Perani at al., 2003; Ishida et al., 2004).

Although the functional role of several putative SWI/SNF complex components has been studied in Arabidopsis, so far no complete plant chromatin remodeling complex has been isolated and characterized. The co-purification with AN3 gives for the first time proof of the in vivo physical composition of plant SWI/SNF complexes which before was based solely on homology analyses and the interpretation of genetic and in vitro interactions.

A literature survey illustrates that SWI/SNF ATPase subunits control multiple developmental pathways in Arabidopsis. Null mutants of the two isolated ATPases SYD (At2g28290) and BRM (SNF2) (At2g46020) display pleiotropic developmental defects. Both mutants are slow growing and dwarfed, have defects in cotyledon separation, and exhibit reduced apical dominance (Wagner & Meyerowitz, 2002; Farrona et al., 2004; Hurtado et al., 2006; Kwon et al., 2006; Su et al., 2006). Null mutants in BRM (SNF2) also have unique root growth defects and are male sterile (Wagner & Meyerowitz, 2002; Hurtado et al., 2006; Kwon et al., 2006). Core complex Swi3c (At1g21700) mutants closely resemble brm mutants (Sarnowski et al., 2005). Mutants of the accessory components ARP4 and ARP7 display pleiotropic defects with less resemblance to the syd, brm and swi3c phenotypes (Meagher et al., 2005). Down-regulation of ARP4 resulted in phenotypes including altered organization of plant organs, early flowering, delayed flower senescence and partial sterility (Kandasamy et al., 2005a). ARP7 knockdown results in dwarfed plants with small rosette leaves, highly retarded root growth, altered flower development and reduced fertility (Kandasamy et al., 2005b). Finally, RNAi-mediated silencing of the accessory SWI/SNF complex component SWP73B (At5g14170) resulted in dwarfed plants with shorter roots (Crane & Gelvin, 2007).

Example 14 Isolation and Identification of AN3 Interactors

With the exception of the SWI/SNF chromatin remodeling complex subunits all other 19 identified AN3 interactors are not or poorly characterized. Table B gives an overview of their GO biological process and molecular function.

Among them four interactors (At4g16143, At1g09270, At3g06720 and At5g53480) are involved in nucleocytoplasmic trafficking which identifies AN3 as one of the targets of plant nuclear transporters. Indeed a precise cellular localization is essential for protein function and nuclear localization is a key to the function of transcription factors. In plants, nucleocytoplasmic trafficking plays a critical role in various biological processes (Meier, 2007; Xu & Meier, 2008) and nuclear transporters have been shown to be involved in regulating different signal transduction pathways during plant development (Bollman et al., 2003) and in plant responses to biotic (Palma et al., 2005) and abiotic stresses (Verslues et al., 2006).

Another AN3 interactor, that is yet not characterized, is the trehalose phosphatase/synthase 4 (TPS4). Several studies in plants imply an important role of trehalose biosynthesis for plant growth, development and stress tolerance (Grennan, 2007). In the case of Arabidopsis TPS1, knockout mutants display an embryo lethal phenotype, suggesting a role of this gene in plant development (Eastmond et al., 2002). In addition, overexpression of TPS1 shed light on its role as a regulator of glucose, abscisic acid, and stress signalling (Avonce et al., 2004). The latter study, together with a recent analysis of a rice TPS triggering abiotic stress response gene induction when overexpressed (Ge et al., 2008), suggests a possible role for TPS genes in regulating transcriptional signaling pathways.

The other identified interactors indicate links of AN3 function in multiple processes. Several studies demonstrate the involvement of sphingosine kinases in plant cell signaling (Coursol et al., 2003; Coursol et al., 2005; Worral et al., 2008), whereas reports on myosin homologues (Peremyslov et al., 2008; Jiang et al., 2007) implicate roles of protein and organelle trafficking in plant development. The connections between these genes, the other identified interactors and AN3 will be interesting to study in the future.

TABLE 0 List of co-purifying proteins during TAP experiments of untransformed cell cultures, and of cultures ectopically expressing nuclear localized GFP Accession number Protein name Mock GFP At1g06780 glycosyl transferase family 8 protein + At1g07930 elongation factor 1-alpha + At1g09080 luminal binding protein 3 (BiP3) (BP3) + At1g13440 glyceraldehyde 3-phosphate dehydrogenase, cytosolic, + At1g31230 bifunctional aspartate kinase/homoserine dehydrogenase + At1g34610 Ulp1 protease family protein + At1g50010 tubulin alpha chain + At1g61210 WD-40 repeat family protein/katanin p80 subunit, putative + At1g75010 MORN repeat-containing protein + At1g79920 heat shock protein 70, putative + At1g79930 heat shock protein, putative + At2g07620 putative helicase + At2g21410 vacuolar proton ATPase, putative + At2g26570 expressed protein + At3g07160 glycosyl transferase family 48 protein + At3g09170 Ulp1 protease family protein + At3g09440 heat shock cognate 70 kDa protein 3 + At3g11950 ATHST; prenyltransferase + At3g12580 heat shock protein 70, putative + At3g17390 S-adenosylmethionine synthetase, putative + At3g18530 expressed protein + At3g26020 serine/threonine protein phosphatase 2A regulatory subunit B′ + At3g42100 AT hook motif-containing protein-related + At3g48870 ATP-dependent Clp protease ATP-binding subunit (ClpC) + At3g49640 nitrogen regulation family protein + At3g54940 cysteine proteinase, putative + At4g00020 BRCA2A (breast cancer 2 like 2A) + At4g09800 40S ribosomal protein S18 + At4g14960 tubulin alpha chain + At4g18080 hypothetical protein + At4g20160 expressed protein + At4g20890 tubulin beta chain + At4g31820 phototropic-responsive NPH3 family protein + At4g33200 myosin, putative + At5g02490 heat shock cognate 70 kDa protein 2 + At5g02500 heat shock cognate 70 kDa protein 1 + At5g08670 ATP synthase beta chain, mitochondrial + At5g08680 ATP synthase beta chain, mitochondrial + At5g08690 ATP synthase beta chain, mitochondrial + At5g09810 actin 7 (ACT7)/actin 2 + + At5g18110 Novel cap-binding protein (nCBP) + At5g28540 luminal binding protein 1 (BiP-1) (BP1) + + At5g35360 acetyl-CoA carboxylase, biotin carboxylase subunit (CAC2) + At5g40060 disease resistance protein (TIR-NBS-LRR class), putative + At5g42020 luminal binding protein 2 (BiP-2) (BP2) + At5g44340 tubulin beta chain + At5g60390 elongation factor 1-alpha + At5g62700 tubulin beta chain +

TABLE A AN3 and List of AN3-copurified proteins identified by MS. The last column tells in how many of the four independent experiments an interactor was identified. Peptide Protein Best ion AGI code Description MW (kDa) count score/threshold score/threshold AT5G28640 AN3, SYT1, SYT, GIF1 AT4G16143 importin alpha-2, putative (IMPA2) 49.5 13 388/61 84/28 2 AT1G09270 importin alpha-1 subunit, putative (IMPA4) 59.4 6  74/61 37/31 1 AT3G06720 importin alpha-1 subunit, putative (IMPA1) 58.6 8 160/61 62/28 2 AT5G53480 importin beta-2, putative 96.2 16 295/61 50/32 2 AT3G60830 actin-related protein 7 (ARP7) 39.9 12 285/61 53/28 3 AT1G18450 actin-related protein 4 (ARP4) 48.9 12 230/61 44/28 2 AT2G46020 transcription regulatory protein SNF2 245.4 31 351/61 57/31 2 (ATPase) AT2G28290 chromatin remodeling protein, SYD ATPase 389.8 22 118/61 53/31 4 AT1G21700 SWIRM domain-containing protein/DNA- 88.2 5 32/32 2 binding family protein AT5G14170 SWIB complex BAF60b domain-containing 59.2 18 302/61 43/31 2 protein AT4G17330 G2484-1, agenet (tudor-like) domain- 113.3 25 317/61 61/32 3 containing protein AT4G27550 trehalose phosphatase/synthase 4 89.4 15  68/61 2 AT1G65980 thioredoxin-dependent peroxidase 17.4 8  80/61 2 AT5G55210 expressed protein 18.5 4 105/61 49/31 2 AT3G15000 expressed protein similar to DAG protein 42.8 3 38/30 2 AT4G35550 homeobox-leucine zipper protein (HB-2)/ 29.6 3 33/28 1 HD-ZIP protein AT1G20670 DNA-binding bromodomain-containing 72.9 16  75/61 1 protein AT1G08730 myosin heavy chain (PCR43) (Fragment) 174.6 18  70/61 1 AT5G13030 expressed protein 71.1 3 31/29 1 AT2G18876 expressed protein 43.5 11  67/61 1 AT5G17510 expressed protein 42.5 3 37/28 1 AT1G05370 expressed protein 49.9 12  66/61 1 AT4G21540 putative sphingosine kinase (SphK) 141.7 9  69/61 1 AT1G23900 gamma-adaptin 96.4 19  78/61 1 AT5G23690 polynucleotide adenylyltransferase family 59.6 11  66/61 1 protein

TABLE B GO Molecular AGI Code Name/Description GO Biological Process Function At4g16143 Importin alpha-2 Protein import into nucleus Protein transporter (IMP2) activity At1g09270 Importin alpha-1 Intracellular protein Protein transporter (IMPA4) transport activity At3g06720 Importin alpha-1 Intracellular protein Protein transporter (IMPA1) transport activity At5g53480 Importin beta-2 Protein import into nucleus Protein transporter activity At4g17330 G2484-1 protein unknown RNA binding At4g27550 Trehalose Trehalose biosynthesis Trehalose phosphate phosphatase/synthase synthase activity 4 (TPS4) At1g65980 Thioredoxin- unknown Antioxidant activity dependent peroxidase 1 (TPX1) At5g55210 Expressed protein unknown unknown At3g15000 Expressed protein unknown unknown similar to DAG protein At4g35550 Wuschel-related Regulation of transcription DNA binding homeobox 13 (WOX13) At1g20670 Bromodomain- unknown DNA binding containing protein At1g08730 Myosin-like protein Actin filament-based Protein binding XIC movement At5g13030 Expressed protein unknown unknown At2g18876 Expressed protein unknown unknown At5g17510 Expressed protein unknown unknown At1g05370 Expressed protein unknown unknown At4g21540 Putative sphingosine Activation of protein kinase Kinase activity kinase C activity At1g23900 Gamma-adaptin Vesicle-mediated transport Clathrin binding At5g23690 Polynucleotide RNA processing RNA binding adenylyltransferase protein

Example 15 Identification of Sequences Related to iSYT

Sequences (full length cDNA, ESTs or genomic) related to iSYT nucleic acid and polypeptides were identified amongst those maintained in the Entrez Nucleotides database at the National Center for Biotechnology Information (NCBI) and other sequence databases using database sequence search tools, such as the Basic Local Alignment Tool (BLAST) (Altschul et al. (1990) J. Mol. Biol. 215:403-410; and Altschul et al. (1997) Nucleic Acids Res. 25:3389-3402). The program is used to find regions of local similarity between sequences by comparing nucleic acid or polypeptide sequences to sequence databases and by calculating the statistical significance of matches. For example, the polypeptide encoded by the nucleic acid of SYT was used for the TBLASTN algorithm, with default settings and the filter to ignore low complexity sequences set off. The output of the analysis was viewed by pairwise comparison, and ranked according to the probability score (E-value), where the score reflect the probability that a particular alignment occurs by chance (the lower the E-value, the more significant the hit). In addition to E-values, comparisons were also scored by percentage identity. Percentage identity refers to the number of identical nucleotides (or amino acids) between the two compared nucleic acid (or polypeptide) sequences over a particular length. In some Instances, the default parameters may be adjusted to modify the stringency of the search. For example the E-value may be increased to show less stringent matches. This way, short nearly exact matches may be identified.

Tables A2 to A26 provides a list of polypeptide sequences related to the polypeptides of Table A.

Sequences have been tentatively assembled and publicly disclosed by research institutions, such as The Institute for Genomic Research (TIGR; beginning with TA). The Eukaryotic Gene Orthologs (EGO) database may be used to identify such related sequences, either by keyword search or by using the BLAST algorithm with the nucleic acid sequence or polypeptide sequence of interest. Special nucleic acid sequence databases have been created for particular organisms, such as by the Joint Genome Institute. Furthermore, access to proprietary databases, has allowed the identification of novel nucleic acid and polypeptide sequences.

Concerning SYT

TABLE A2 Preferred homologous polypeptides of SYT Name Source organism Database accession number Arath_SYT2 Arabidopsis thaliana AY102640.1 Arath_SYT3 Arabidopsis thaliana AY102641.1 Alice_SYT2 Allium cepa CF437485 Aqufo_SYT1 Aquilegia formosa x Aquilegia pubescens DT758802.1 Aqufo_SYT2 Aquilegia formosa x Aquilegia pubescens TA15831_338618 T25K16.15 Aspof_SYT1 Aspergillus officinalis CV287542 Betvu_SYT2 Beta vulgaris BQ594749.1 BQ594658.1 Bradi_SYT3 Brachypodium distachyon DV480064.1 Brana_SYT1 Brassica napus CD823592 Brana_SYT2 Brassica napa CN732814 Chlre_SYT Chlamydomonas reinhardtii BQ814858, jgi_Chlre3_194013_estExt_fgenesh2_pg. C_510025 Citsi_SYT1 Citrus sinensis CB290588 Citsi_SYT2 Citrus sinensis CV717501 Cryja_SYT1 Cryptomeria japonica TA3001_3369_2 Curlo_SYT2 Curcuma longa TA2676_136217 Eupes_SYT2 Euphorbia esula DV144834 Frave_SYT2 Fragaria vesca DY668312 Glyma_SYT1.1 Glycine max TA55102_3847 Glyma_SYT1.2 Glycine max TA51451_3847 Glyma_SYT2.1 Glycine max BQ612648 Glyma_SYT2.2 Glycine max TA48452_3847 Glyso_SYT2 Glycine soya CA799921 Gosar_SYT1 Gossypium arboreum BM359324 Goshi_SYT1 Gossypium hirsutum DT558852 Goshi_SYT2 Gossypium hirsutum DT563805 Helan_SYT1 Helianthus annuus TA12738_4232 Horvu_SYT2 Hordeum vulgare CA032350 Lacse_SYT2 Lactuca serriola DW110765 Lyces_SYT1 Lycopersicon esculentum AW934450.1 BP893155.1 Maldo_SYT2 Malus domestica CV084230 DR997566 Medtr_SYT1 Medicago trunculata CA858507.1 Medtr_SYT2 Medicago trunculata CA858743 BI310799.1 AL382135.1 Orysa_SYT1 Oryza sativa AK058575 Orysa_SYT2 Oryza sativa AK105366 Orysa_SYT3 Oryza sativa BP185008 Panvi_SYT3 Panicum virgatum DN152517 Phypa_SYT1.1 Physcomitrella patens TA28566_3218 Phypa_SYT1.2 Physcomitrella patens TA21282_3218 Phypa_SYT1.3 Physcomitrella patens TA20922_3218 Phypa_SYT1.4 Physcomitrella patens TA29452_3218 Picsi_SYT1 Picea sitchensis DR484100 DR478464.1 Pinta_SYT1 Pinus taeda DT625916 Poptr_SYT1 Populus trichocarpa DT476906 Poptr_SYT2 Populus trichocarpa scaff_XIV.493 Poptr_SYT1.2 Populus trichocarpa CV257942.1 Prupe_SYT2 Prunus DT454880.1 persica DT455286.1 Sacof_SYT1 Saccharum officinarum CA078249.1 CA078630 CA082679 CA234526 CA239244 CA083312 Sacof_SYT2 Saccharum officinarum CA110367 Sacof_SYT3 Saccharum officinarum CA161933.1 CA265085 Soltu_SYT1.1 Solanum tuberosum CK265597 Soltu_SYT1.2 Solanum tuberosum BG590990 Soltu_SYT3 Solanum tuberosum CK272804 Sorbi_SYT1 Sorghum bicolor TA40712_4558 Sorbi_SYT2 Sorghum bicolor CF482417 CW376917 Sorbi_SYT3 Sorghum bicolor CX611128 Taxof_SYT2 Taraxacum officinale TA1299_50225 Taxof_SYT3 Taraxacum officinale TA5000_50225 Triae_SYT1 Triticum aestivum TA105893_4565 Triae_SYT2 Triticum aestivum CD901951 Triae_SYT3 Triticum aestivum BJ246754 BJ252709 Vitvi_SYT1.1 Vitis vinifera DV219834 Vitvi_SYT1.2 Vitis vinifera EE108079 Vitvi_SYT2.1 Vitis vinifera EC939550 Vitvi_SYT2.2 Vitis vinifera EE094148.1 EC964169.1 Volca_SYT Volvox carteri JGI_CBHO11121.fwdJGI_CBHO11121. rev Welmi_SYT Welwitschia mirabilis DT598761 Zeama_SYT1 Zea mays BG874129.1 CA409022.1 Zeama_SYT2 Zea mays AY106697 Zeama_SYT3 Zea mays CO468901 Homsa_SYT Homo sapiens CR542103

Concerning the AT1G05370 Polypeptide

TABLE A2 Preferred homologous polypeptides, of AT1G05370 polypeptide iSYT Name homologue AT1G05370.1 G. max_Glyma20g28380.3#1 AT1G05370.1 M. truncatula_AC161569_9.5#1 AT1G05370.1 O. sativa_Os03g0219100#1 AT1G05370.1 P. patens_NP13131528#1 AT1G05370.1 P. trichocarpa_scaff_X.810#1 AT1G05370.1 Z. mays_ZM07MC22382_BFb0062G18@22320#1

Concerning AT1G8730 Polypeptide

TABLE A3 Preferred homologous polypeptides, of AT1G08730 polypeptide iSYT Name homologue AT1G08730.1 >G. max_Glyma13g16710.1#1 AT1G08730.1 >M. truncatula_CU041231_65.4#1 AT1G08730.1 >O. sativa_Os06g0488200#1 AT1G08730.1 >P. patens_TC53472#1 AT1G08730.1 >P. trichocarpa_scaff_201.14#1 AT1G08730.1 >T. aestivum_TC339658#1 AT1G08730.1 >Z. mays_TC526723#1

Concerning the AT1G09270 Polypeptide

TABLE A4 Preferred homologous polypeptides, of AT1G09270 polypeptide iSYT Name homologue AT1G09270.1 >B. napus_TC77714#1 AT1G09270.1 >G. max_Glyma09g04430.1#1 AT1G09270.1 >G. hirsutum_ES800234#1 AT1G09270.1 >H. vulgare_TC178368#1 AT1G09270.1 >M. truncatula_AC191599_15.4#1 AT1G09270.1 >O. sativa_Os05g0155500#1 AT1G09270.1 >P. patens_TC29288#1 AT1G09270.1 >P. trichocarpa_scaff_XIII.64#1 AT1G09270.1 >S. lycopersicum_TC192018#1 AT1G09270.1 >T. aestivum_TC326489#1 AT1G09270.1 >Z. mays_ZM07MC09815_62040840@9797#1

Concerning the AT1G18540 Polypeptide

TABLE A5 Preferred homologous polypeptides, of AT1G18450 polypeptide iSYT Name homologue AT1G18450.1 >B. napus_BN06MC30721_51397463@30594#1 AT1G18450.1 >G. max_TC298093#1 AT1G18450.1 >G. hirsutum_TC140956#1 AT1G18450.1 >H. vulgare_c62682376hv270303@11037#1 AT1G18450.1 >M. truncatula_CU179920_30.3#1 AT1G18450.1 >O. sativa_Os08g0137200#1 AT1G18450.1 >P. patens_TC46936#1 AT1G18450.1 >P. trichocarpa_scaff_XII.526#1 AT1G18450.1 >S. lycopersicum_TC191897#1 AT1G18450.1 >T. aestivum_TC318743#1 AT1G18450.1 >Z. mays_ZM07MC12195_62264430@12170#1

Concerning the AT1G20670 Polypeptide

TABLE A6 Preferred homologous polypeptides, of AT1G20670 polypeptide. iSYT Name homologue AT1G20670 >G. max_Glyma04g01850.1#1 AT1G20670 >O. sativa_LOC_Os09g37760.1#1 AT1G20670 >P. patens_TC29124#1 AT1G20670 >P. trichocarpa_scaff_II.76#1

Concerning the AT1G20670 Polypeptide

TABLE A7 Preferred homologous polypeptides, of AT1G20670 polypeptide. iSYT Name homologue AT1G21700 >O. sativa_LOC_Os11g08080.1#1 AT1G21700 >P. trichocarpa_scaff_V.882#1

Concerning the AT1G23900 Polypeptide

TABLE A8 Preferred homologous polypeptides, of AT1G23900 polypeptide. iSYT Name homologue AT1G23900 >B. napus_TC72705#1 AT1G23900 >G. max_Glyma01g03890.1#1 AT1G23900 >M. truncatula_CT025838_33.5#1 AT1G23900 >O. sativa_LOC_Os06g07090.2#1 AT1G23900 >P. patens_TC30541#1 AT1G23900 >P. trichocarpa_831911#1

Concerning the AT1G65980 Polypeptide

TABLE A10 Preferred homologous polypeptides, of AT1G65980 polypeptide. iSYT Name homologue AT1G65980 >B. napus_TC67111#1 AT1G65980 >G. hirsutum_BE055703#1 AT1G65980 >G. max_TC283792#1 AT1G65980 >H. vulgare_TC156915#1 AT1G65980 >M. truncatula_TC127082#1 AT1G65980 >O. sativa_TC321488#1 AT1G65980 >P. patens_TC40270#1 AT1G65980 >P. trichocarpa_scaff_XIII.916#1 AT1G65980 >S. lycopersicum_TC196845#1 AT1G65980 >T. aestivum_TC288115#1 AT1G65980 >Z. mays_TC535995#1

Concerning the AT2G18876 Polypeptide

TABLE A11 Preferred homologous polypeptides, of AT2G18876 polypeptide. iSYT Name homologue AT2G18876 >B. napus_TC73647#1 AT2G18876 >G. max_Glyma17g07040.1#1 AT2G18876 >M. truncatula_TC118724#1 AT2G18876 >O. sativa_Os08g0242900#1 AT2G18876 >P. patens_186245#1 AT2G18876 >P. trichocarpa_825889#1 AT2G18876 >Z. mays_TC516387#1

Concerning the AT2G28290 Polypeptide

TABLE A12 Preferred homologous polypeptides, of AT2G28290 polypeptide. iSYT Name homologue AT2G28290 >B. napus_TC67556#1 AT2G28290 >G. hirsutum_TC164446#1 AT2G28290 >G. max_Glyma17g02540.2#1 AT2G28290 >M. truncatula_NP7265773#1 AT2G28290 >O. sativa_LOC_Os06g14406.1#1 AT2G28290 >P. trichocarpa_565765#1 AT2G28290 >Z. mays_TC537619#1

Concerning AT2G46020 Polypeptide

TABLE A13 Preferred homologous polypeptides, of AT2G46020 polypeptide. iSYT Name homologue AT2G46020 >G. max_Glyma18g46930.1#1 AT2G46020 >M. truncatula_TC112587#1 AT2G46020 >P. trichocarpa_scaff_XIV.322#1

Concerning the AT3G06720 Polypeptide

TABLE A14 Preferred homologous polypeptides.. ISYT Name homologue AT3G06720 >B. napus_TC67085#1 AT3G06720 >G. hirsutum_ES815460#1 AT3G06720 >G. max_Glyma17g03430.1#1 AT3G06720 >H. vulgare_TC178368#1 AT3G06720 >M. truncatula_AC191599_15.4#1 AT3G06720 >O. Sativa_LOC_Os01g14950.1#1 AT3G06720 >P. patens_218909#1 AT3G06720 >P. trichocarpa_833349#1 AT3G06720 >S. lycopersicum_TC192018#1 AT3G06720 >T. aestivum_TC285294#1 AT3G06720 >Z. mays_TC468320#1

Concerning the AT3G15000 Polypeptide

TABLE A15 Preferred homologous polypeptides.. ISYT Name homologue AT3G15000 >B. napus_TC99775#1 AT3G15000 >G. hirsutum_TC130654#1 AT3G15000 >G. max_Glyma13g034670.1#1 AT3G15000 >H. vulgare_TC171299#1 AT3G15000 >M. truncatula_TC121620#1 AT3G15000 >O. Sativa_LOC_Os09g33480.1#1 AT3G15000 >P. trichocarpa_scaff_146.21#1 AT3G15000 >S. lycopersicum_TC212195#1 AT3G15000 >T. aestivum_TC287172#1 AT3G15000 >Z. mays_TC476358#1

Concerning the AT3G60830 Polypeptide

TABLE A16 Preferred homologous polypeptides.. ISYT Name homologue AT3G60830 >B. napus_TC83795#1 AT3G60830 >G. hirsutum_ES802301#1 AT3G60830 >G. max_Glyma12g01010.1#1 AT3G60830 >M. truncatula_TC123694#1 AT3G60830 >O. Sativa_TC300228#1 AT3G60830 >P. patens_TC39330#1 AT3G60830 >P. trichocarpa_TC89949#1 AT3G60830 >S. lycopersicum_TC194794#1 AT3G60830 >T. aestivum_TC308484#1 AT3G60830 >Z. mays_TC515322#1

Concerning the AT3G60830 Polypeptide

TABLE A17 Preferred homologous polypeptides. ISYT Name homologue AT4G16143 >B. napus_TC67085#1 AT4G16143 >G. max_Glyma15g15480.1#1 AT4G16143 >G. hirsutum_ES815460#1 AT4G16143 >H. vulgare_TC178368#1 AT4G16143 >M. truncatula_AC191599_15.4#1 AT4G16143 >O. Sativa_Os01g0253300#1 AT4G16143 >P. patens_TC52982#1 AT4G16143 >P. trichocarpa_833349#1 AT4G16143 >S. lycopersicum_TC192018#1 AT4G16143 >T. aestivum_TC285294#1 AT4G16143 >Z. mays_c62040840gm030403@6670#1

Concerning the AT4G17330 Polypeptide

TABLE A18 Preferred homologous polypeptides. iSYT Name homologue AT4G17330 >B. napus_EE448802#1 AT4G17330 >G. max_TC316889#1 AT4G17330 >M. truncatula_TC114019#1 AT4G17330 >O. Sativa_LOC_Os10g41030.3#1 AT4G17330 >P. trichocarpa_scaff_29.51#1

Concerning the AT4G21540 Polypeptide

TABLE A19 Preferred homologous polypeptides. iSYT Name homologue AT4G21540 >G. max_Glyma07g30980.1#1 AT4G21540 >M. truncatula_AC175090_33.4#1 AT4G21540 >O. Sativa_LOC_Os02g54490.1#1 AT4G21540 >P. patens_TC39605#1 AT4G21540 >P. trichocarpa_scaff_IV.215#1 AT4G21540 >Z. mays_TC484353#1

Concerning the AT4G27550 Polypeptide

TABLE A20 Preferred homologous polypeptides. iSYT Name homologue AT4G27550 >B. napus_BN06MC19686_46389379@19622#1 AT4G27550 >G. max_Glyma12g36280.1#1 AT4G27550 >M. hirsutum_TC168377#1 AT4G27550 >M. truncatula_AC153460_26.4#1 AT4G27550 >O. sativa_LOC_Os05g44210.1#1 AT4G27550 >P. patens_TC45371#1 AT4G27550 >P. trichocarpa_scaff_168.14#1 AT4G27550 >S. lycopersicum_TC197800#1 AT4G27550 >T. aestivum_TC314116#1 AT4G27550 >Z. mays_ZM07MC29609_BFb0010E24@29519#1

Concerning the AT4G35550 Polypeptide

TABLE A21 Preferred homologous polypeptides. iSYT Name homologue AT4G35550 >B. napus_BN06MC07552_42595637@7533#1 AT4G35550 >G. max_Glyma18g52490.1#1 AT4G35550 >G. hirsutum_TC148918#1 AT4G35550 >M. truncatula_TC115228#1 AT4G35550 >O. sativa_TC326307#1 AT4G35550 >P. patens_TC45997#1 AT4G35550 >P. trichocarpa_scaff_V.401#1 AT4G35550 >T. aestivum_CJ574771#1 AT4G35550 >Z. mays_TA9709_4577999#1

Concerning the AT5G13030 Polypeptide

TABLE A21 Preferred homologous polypeptides. iSYT Name homologue AT5G13030 >B. napus_TC91422#1 AT5G13030 >G. max_Glyma20g39090.1#1 AT5G13030 >G. hirsutum_TC174829#1 AT5G13030 >M. truncatula_AC149471_14.5#1 AT5G13030 >O. sativa_TC288127#1 AT5G13030 >P. patens_TC30567#1 AT5G13030 >P. trichocarpa_scaff_I.133#1 AT5G13030 >T. aestivum_c54479201@7744#1 AT5G13030 >Z. mays_ZM07MC31636_BFb0358L02@31542#1

Concerning the AT5G14170 Polypeptide

TABLE A22 Preferred homologous polypeptides. iSYT Name homologue AT5G14170 >AT5G141701|Symbols: CHC1|CHC1|chr5: 4568696-4570444 REVERSE AT5G14170 >A. thaliana_AT3G01890.1#1 AT5G14170 >AC189564.2 Brassica rapa subsp. pekinensis clone KBrH009B23 AT5G14170 >XM_002273713 Vitis vinifera hypothetical protein LOC100261825 AT5G14170 >O. sativa_LOC_Os04g31320.1#1 AT5G14170 >Oryza sativa AL662977 AT5G14170 >P. patens_113811#1 AT5G14170 >P. trichocarpa_scaff_XII.899#1 AT5G14170 >P. trichocarpa_scaff_88.108#1 AT5G14170 >P. trichocarpa_scaff_I.2133#1 AT5G14170 >T. aestivum_c59835991@17741#1 AT5G14170 >Triticum aestivum AK335297 AT5G14170 >Z. mays_ZM07MC18894_BFb0157J03@ 18844#1_FL467690.1|

Concerning the AT5G17510 Polypeptide

TABLE A23 Preferred homologous polypeptides. iSYT Name homologue AT5G17510 >A. thaliana putative glutamine-rich protein (At5g17510) mRNA, complete cds gi_17979156_gb_AY070079.1_(—) AT5G17510 >Vitis vinifera hypothetical protein LOC100249418 (LOC100249418), mRNAgi_225454840_ref_XM_002267054.1_(—) AT5G17510 >Ricinus communis conserved hypothetical protein, mRNAgi_255566123_ref_XM_002524004.1_(—) AT5G17510 >Solanum lycopersicum cDNA, clone: LEFL1007BC07, HTC in leafgi_225312930_dbj_AK320272.1_(—) AT5G17510 >Sorghum bicolor hypothetical protein, mRNAgi_242085467_ref_XM_002443114.1_(—) AT5G17510 >Triticum aestivum cDNA, clone: WT002_P07, cultivar: Chinese Spring gi_241984762_dbj_AK332022.1_(—) AT5G17510 >Zea mays hypothetical protein LOC100276166 (LOC100276166), mRNAgi_226508721_ref_NM_001150017.1_(—)

Concerning the AT5G23690 Polypeptide

TABLE A24 Preferred homologous polypeptides. iSYT Name homologue AT5G23690 >A. thaliana_AT5G23690.1#1 AT5G23690 >A. thaliana_AT1G28090.1#1 AT5G23690 >A. thaliana_AT3G48830.1#1 AT5G23690 >M. truncatula_AC151817_35.4#1 AT5G23690 >O. sativa_TC289531#1 AT5G23690 >O. sativa_TC310376#1 AT5G23690 >P. petens_161847#1 AT5G23690 >P. trichocarpa_scaff_XII.984#1 AT5G23690 >P. trichocarpa_scaff_XV.833#1 AT5G23690 >V. viniferaXM_02266778.1 hypothetical protein LOC100259104 (LOC100259104) AT5G23690 >Z. mays_TC467699#1 AT5023690 >Z. mays_TC473496#1

Concerning the AT5G53480 Polypeptide

TABLE A25 Preferred homologous polypeptides. iSYT Name homologue AT5G53480 >AT5G53480.1 Symbols; importin beta-2, putative chr5 21731242-21733935 FORWARD AT5G53480 A. thaliana_AT3G08943.1#1 AT5G53480 A. thaliana_AT3G08947.1#1 AT5G53480 >G. max_Glyma04g41230.1#1 AT5G53480 >G. max_Glyma05g36630.1#1 AT5G53480 >G. max_Glyma06g13620.1#1 AT5G53480 >G. max_Glyma08g02930.1#1 AT5G53480 >H. vulgare_c62767390hv270303@6375#1 AT5G53480 >H. vulgare AK249047 AT5G53480 >O. sativa_LOC_Os12g38110.1#1 AT5G53480 >P. patens_TC30184#1 AT5G53480 >P. patens_TC31822#1 AT5G53480 >P. trichocarpa_scaff_VI.900#1 AT5G53480 >P. trichocarpa_scaff_XII.230#1 AT5G53480 >P. trichocarpa_scaff_XV.118#1 AT5G53480 >P. trichocarpa_scaff_XVI.1174#1 AT5G53480 >S. bicolor_XM_002442302.1

Concerning the AT5G55210 Polypeptide

TABLE A26 Preferred homologous polypeptides. iSYT Name homologue AT5G55210 >A. thaliana_AT5G55210.1#1 AT5G55210 >A. thaliana_AT4G22320.1#1 AT5G55210 >B. napus_EV025360#1 AT5G55210 >B. napus_TC65291#1 AT5G55210 >B. napus_TC67583#1 AT5G55210 >B. napus_TC68897#1 AT5G55210 >B. napus_TC93468#1 AT5G55210 >G. max_Glyma08g43440.1#1 AT5G55210 >G. max_Glyma09g01220.1#1 AT5G55210 >G. max_Glyma15g12050.1#1 AT5G55210 >G. max_Glyme18g10110.1#1 AT5G55210 >H. vulgare_BG342941#1 AT5G55210 >H. vulgare_TC167448#1 AT5G55210 >M. truncatula_TC122534#1 AT5G55210 >M. truncatula_TC127795#1 AT5G55210 >O. sativa_LOC_Os08g25080.1#1 AT5G55210 >O. sativa_LOC_Os08g25080.2#1 AT5G55210 >O. sativa_LOC_Os09g11240.1#1 AT5G55210 >P. patens_167013#1 AT5G55210 >P. trichocarpa_scaff_166.68#1 AT5G55210 >P. trichocarpa_scaff_I.2546#1 AT5G55210 >P. trichocarpa_scaff_XI.195#1 AT5G55210 >T. aestivum_CK204604#1 AT5G55210 >T. aestivum_TC293410#1 AT5G55210 >Z. mays_FL309643#1 AT5G55210 >Z. mays_TC479416#1

Example 16 Alignment of an iSYT Polypeptide and Homologues Thereof

Alignment of polypeptide sequences is performed using the ClustalW 2.0 algorithm of progressive alignment (Thompson et al. (1997) Nucleic Acids Res 25:4876-4882; Chenna et al. (2003). Nucleic Acids Res 31:3497-3500) with standard setting (slow alignment, similarity matrix: or Blosum 62 (if polypeptides are aligned), gap opening penalty 10, gap extension penalty: 0.2). Minor manual editing is done to further optimise the alignment. A phylogenetic tree of an iSYT polypeptide and homologues thereof is constructed using a neighbour-joining clustering algorithm as provided in the AlignX programme from the Vector NTI (Invitrogen).

Example 17 Calculation of Global Percentage Identity Between Polypeptide Sequences

Global percentages of similarity and identity between full length polypeptide sequences useful in performing the methods of the Invention were determined using one of the methods available in the art, the MatGAT (Matrix Global Alignment Tool) software (BMC Bioinformatics. 2003 4:29. MatGAT: an application that generates similarity/identity matrices using protein or DNA sequences. Campanella J J, Bitincka L, Smalley J; software hosted by Ledion Bitincka). MatGAT software generates similarity/identity matrices for DNA or protein sequences without needing pre-alignment of the data. The program performs a series of pair-wise alignments using the Myers and Miller global alignment algorithm (with a gap opening penalty of 12, and a gap extension penalty of 2), calculates similarity and identity using for example Blosum 62 (for polypeptides), and then places the results in a distance matrix. Sequence similarity is shown in the bottom half of the dividing line and sequence identity is shown in the top half of the diagonal dividing line.

Parameters used in the comparison are: Scoring matrix: Blosum62, First Gap: 12, Extending Gap: 2.

Example 18 Identification of Domains Comprised in Polypeptide Sequences Useful in Performing the Methods of the Invention

The Integrated Resource of Protein Families, Domains and Sites (InterPro) database is an integrated interface for the commonly used signature databases for text- and sequence-based searches. The InterPro database combines these databases, which use different methodologies and varying degrees of biological information about well-characterized proteins to derive protein signatures. Collaborating databases include SWISS-PROT, PROSITE, TrEMBL, PRINTS, ProDom and Pfam, Smart and TIGRFAMs. Pfam is a large collection of multiple sequence alignments and hidden Markov models covering many common protein domains and families. Pfam is hosted at the Sanger Institute server in the United Kingdom. Interpro is hosted at the European Bioinformatics Institute in the United Kingdom.

The results of the InterPro scan of the polypeptide sequence representing the iSYT polypeptides of Table A are presented in Tables C1 to C20.

The term iSYT (Interactor of SYT) and “AN3 interactor” as used herein are interchangeable.

TABLE C1 InterPro scan results (major accession numbers) of the AT1G05370 polypeptide. AN3 InterPro amino acid start amino acid end interactor Database Domain accession Domain name accession coordinate coordinate AT1G05370.1 TMHMM tmhmm transmembrane_regions NULL 170 191 AT1G05370.1 TMHMM tmhmm transmembrane_regions NULL 144 166 AT1G05370.1 Seg seg seg NULL 318 330 AT1G05370.1 Seg seg seg NULL 235 256 AT1G05370.1 Seg seg seg NULL 150 163 AT1G05370.1 HMMPanther PTHR10174 RETINALDEHYDE BINDING NULL 18 150 PROTEIN-RELATED AT1G05370.1 superfamily SSF46938 CRAL/TRIO N-terminal domain IPR011074 14 83 AT1G05370.1 superfamily SSF52087 CRAL/TRIO domain IPR001251 82 149 AT1G05370.1 ProfileScan PS50191 CRAL_TRIO IPR001251 80 262 AT1G05370.1 HMMSmart SM00516 no description IPR001251 86 229 AT1G05370.1 Gene3D G3DSA:3.40.525.10 description IPR001251 70 149 no AT1G08730.1 superfamily SSF54849 GroEL-intermediate domain like NULL 940 1017

TABLE C2 InterPro scan results (major accession numbers) of the AT1G08730 polypeptide. AN3 InterPro amino acid amino acid interactor Database Domain accession Domain name accession start coordinate end coordinate AT1G08730.1 superfamily SSF54849 GroEL-intermediate domain like NULL 940 1017 AT1G08730.1 superfamily SSF52540 P-loop containing nucleoside NULL 798 893 triphosphate hydrolases AT1G08730.1 superfamily SSF52540 P-loop containing nucleoside NULL 38 797 triphosphate hydrolases AT1G08730.1 SignalPHMM signalp signal-peptide NULL 1 23 AT1G08730.1 Seg seg seg NULL 1191 1208 AT1G08730.1 Seg seg seg NULL 1015 1037 AT1G08730.1 Seg seg seg NULL 950 966 AT1G08730.1 Seg seg seg NULL 605 618 AT1G08730.1 HMMPanther PTHR13140:SF36 MYOSIN XI NULL 1130 1517 AT1G08730.1 HMMPanther PTHR13140:SF36 MYOSIN XI NULL 870 925 AT1G08730.1 HMMPanther PTHR13140:SF36 MYOSIN XI NULL 312 840 AT1G08730.1 HMMPanther PTHR13140:SF36 MYOSIN XI NULL 17 292 AT1G08730.1 HMMPanther PTHR13140 MYOSIN NULL 1130 1517 AT1G08730.1 HMMPanther PTHR13140 MYOSIN NULL 870 925 AT1G08730.1 HMMPanther PTHR13140 MYOSIN NULL 312 840 AT1G08730.1 HMMPanther PTHR13140 MYOSIN NULL 17 292 AT1G08730.1 Gene3D G3DSA:4.10.270.20no description NULL 726 771 AT1G08730.1 Gene3D G3DSA:3.30.538.10no description NULL 71 304 AT1G08730.1 Gene3D G3DSA:3.30.1370.40no description NULL 655 721 AT1G08730.1 Gene3D G3DSA:1.10.465.10no description NULL 446 628 AT1G08730.1 Gene3D G3DSA:1.10.183.10no description NULL 320 428 AT1G08730.1 superfamily SSF50084 Myosin S1 fragment, N-terminal domain IPR008989 13 37 AT1G08730.1 HMMPfam PF02736 Myosin_N IPR004009 18 59 AT1G08730.1 ProfileScan PS51126 DILUTE IPR002710 1168 1481 AT1G08730.1 HMMPfam PF01843 DIL IPR002710 1356 1463 AT1G08730.1 BlastProDom PD003376 Q6ZGC5_EEEEE_Q6ZGC5; IPR002710 1287 1434 AT1G08730.1 HMMSmart SM00242 no description IPR001609 64 741 AT1G08730.1 HMMPfam PF00063 Myosin_head IPR001609 72 728 AT1G08730.1 FPrintScan PR00193 MYOSINHEAVY IPR001609 490 518 AT1G08730.1 FPrintScan PR00193 MYOSINHEAVY IPR001609 437 465 AT1G08730.1 FPrintScan PR00193 MYOSINHEAVY IPR001609 204 231 AT1G08730.1 FPrintScan PR00193 MYOSINHEAVY IPR001609 157 182 AT1G08730.1 FPrintScan PR00193 MYOSINHEAVY IPR001609 100 119 AT1G08730.1 BlastProDom PD000355 Q9ZVN3_ARATH_Q9ZVN3; IPR001609 196 226 AT1G08730.1 ProfileScan PS50096 IQ IPR000048 862 891 AT1G08730.1 ProfileScan PS50096 IQ IPR000048 839 866 AT1G08730.1 ProfileScan PS50096 IQ IPR000048 814 843 AT1G08730.1 ProfileScan PS50096 IQ IPR000048 791 818 AT1G08730.1 ProfileScan PS50096 IQ IPR000048 766 795 AT1G08730.1 ProfileScan PS50096 IQ IPR000048 743 772 AT1G08730.1 HMMSmart SM00015 no description IPR000048 861 883 AT1G08730.1 HMMSmart SM00015 no description IPR000048 838 860 AT1G08730.1 HMMSmart SM00015 no description IPR000048 813 835 AT1G08730.1 HMMSmart SM00015 no description IPR000048 790 812 AT1G08730.1 HMMSmart SM00015 no description IPR000048 765 787 AT1G08730.1 HMMSmart SM00015 no description IPR000048 742 764 AT1G08730.1 HMMPfam PF00612 IQ IPR000048 840 860 AT1G08730.1 HMMPfam PF00612 IQ IPR000048 815 835 AT1G08730.1 HMMPfam PF00612 IQ IPR000048 792 812 AT1G08730.1 HMMPfam PF00612 IQ IPR000048 767 787 AT1G08730.1 HMMPfam PF00612 IQ IPR000048 744 764

TABLE C3 InterPro scan results (major accession numbers) of the AT1G09270 polypeptide. AN3 InterPro amino acid amino acid interactor Database Domain accession Domain name accession start coordinate end coordinate AT1G09270.1 HMMPanther PTHR23316 PTHR23316 NULL 1 537 AT1G09270.1 HMMPanther PTHR23316 PTHR23316 NULL 1 537 AT1G09270.1 superfamily SSF48371 ARM-type_fold IPR016024 49 501 AT1G09270.1 Gene3D G3DSA:1.25.10.10ARM-like IPR011989 81 501 AT1G09270.1 ProfileScan PS51214 IBB IPR002652 1 58 AT1G09270.1 HMMPfam PF01749 IBB IPR002652 4 102 AT1G09270.1 Gene3D G3DSA:1.20.5.690Importin-a-like_IBB- IPR002652 9 52 bd AT1G09270.1 ProfileScan PS50176 ARM_REPEAT IPR000225 333 376 AT1G09270.1 ProfileScan PS50176 ARM_REPEAT IPR000225 165 207 AT1G09270.1 ProfileScan PS50176 ARM_REPEAT IPR000225 122 165 AT1G09270.1 HMMSmart SM00185 ARM IPR000225 408 448 AT1G09270.1 HMMSmart SM00185 ARM IPR000225 365 405 AT1G09270.1 HMMSmart SM00185 ARM IPR000225 322 363 AT1G09270.1 HMMSmart SM00185 ARM IPR000225 280 320 AT1G09270.1 HMMSmart SM00185 ARM IPR000225 239 278 AT1G09270.1 HMMSmart SM00185 ARM IPR000225 195 237 AT1G09270.1 HMMSmart SM00185 ARM IPR000225 154 194 AT1G09270.1 HMMSmart SM00185 ARM IPR000225 111 152 AT1G09270.1 HMMPfam PF00514 Arm IPR000225 408 448 AT1G09270.1 HMMPfam PF00514 Arm IPR000225 365 405 AT1G09270.1 HMMPfam PF00514 Arm IPR000225 322 363 AT1G09270.1 HMMPfam PF00514 Arm IPR000225 280 320 AT1G09270.1 HMMPfam PF00514 Arm IPR000225 239 278 AT1G09270.1 HMMPfam PF00514 Arm IPR000225 196 237 AT1G09270.1 HMMPfam PF00514 Arm IPR000225 154 194 AT1G09270.1 HMMPfam PF00514 Arm IPR000225 111 152

TABLE C4 InterPro scan results (major accession numbers) of the AT1G18450. polypeptide. AN3 InterPro amino acid amino acid interactor Database Domain accession Domain name accession start coordinate end coordinate AT1G18450.1 superfamily SSF53067 SSF53067 NULL 170 441 AT1G18450.1 HMMPanther PTHR11937:SF32 PTHR11937:SF32 NULL 254 441 AT1G18450.1 superfamily SSF53067 SSF53067 NULL 3 170 AT1G18450.1 HMMPanther PTHR11937:SF32 PTHR11937:SF32 NULL 74 223 AT1G18450.1 HMMPanther PTHR11937:SF32 PTHR11937:SF32 NULL 31 441 AT1G18450.1 HMMPanther PTHR11937:SF32 PTHR11937:SF32 NULL 31 52 AT1G18450.1 Gene3D G3DSA:3.30.420.40G3DSA:3.30.420.40 NULL 404 441 AT1G18450.1 Gene3D G3DSA:3.30.420.40G3DSA:3.30.420.40 NULL 296 387 AT1G18450.1 Gene3D G3DSA:3.30.420.40G3DSA:3.30.420.40 NULL 3 164 AT1G18450.1 HMMSmart SM00268 ACTIN IPR004000 7 441 AT1G18450.1 HMMPfam PF00022 Actin IPR004000 4 441 AT1G18450.1 HMMPanther PTHR11937 Actin_like IPR004000 31 441

TABLE C5 InterPro scan results (major accession numbers) of the AT1G20670 polypeptide. AN3 InterPro amino acid amino acid interactor Database Domain accession Domain name accession start coordinate end coordinate AT1G20670.1 HMMPanther PTHR22881:SF3 PTHR22881:SF3 NULL 173 652 AT1G20670.1 HMMPanther PTHR22881:SF3 PTHR22881:SF3 NULL 173 652 AT1G20670.1 HMMPanther PTHR22881 PTHR22881 NULL 173 652 AT1G20670.1 HMMPanther PTHR22881 PTHR22881 NULL 173 652 AT1G20670.1 superfamily SSF47370 Bromodomain IPR001487 145 288 AT1G20670.1 ProfileScan PS50014 BROMODOMAIN_2 IPR001487 188 258 AT1G20670.1 ProfileScan PS00633 BROMODOMAIN_1 IPR001487 194 250 AT1G20670.1 HMMSmart SM00297 BROMO IPR001487 169 277 AT1G20670.1 HMMPfam PF00439 Bromodomain IPR001487 176 263 AT1G20670.1 Gene3D G3DSA:1.20.920.10Bromodomain IPR001487 152 306 AT1G20670.1 FPrintScan PR00503 BROMODOMAIN IPR001487 239 258 AT1G20670.1 FPrintScan PR00503 BROMODOMAIN IPR001487 221 239 AT1G20670.1 FPrintScan PR00503 BROMODOMAIN IPR001487 205 221

TABLE C6 InterPro scan results (major accession numbers) of the AT1G21700 polypeptide. AN3 InterPro amino acid amino acid interactor Database Domain accession Domain name accession start coordinate end coordinate AT1G21700.1 HMMPanther PTHR12802:SF4 PTHR12802:SF4 NULL 175 807 AT1G21700.1 HMMPanther PTHR12802:SF4 PTHR12802:SF4 NULL 175 807 AT1G21700.1 HMMPanther PTHR12802 PTHR12802 NULL 175 807 AT1G21700.1 HMMPanther PTHR12802 PTHR12802 NULL 175 807 AT1G21700.1 HMMPfam PF00249 Myb_DNA-binding IPR014778 400 445 AT1G21700.1 superfamily SSF46689 Homeodomain_like IPR009057 394 447 AT1G21700.1 ProfileScan PS50934 SWIRM IPR007526 176 274 AT1G21700.1 HMMPfam PF04433 SWIRM IPR007526 176 265 AT1G21700.1 ProfileScan PS50090 MYB_3 IPR001005 402 445 AT1G21700.1 HMMSmart SM00717 SANT IPR001005 399 447

TABLE C7 InterPro scan results (major accession numbers) of the AT1G23900 polypeptide. AN3 InterPro amino acid amino acid interactor Database Domain accession Domain name accession start coordinate end coordinate AT1G23900.2 HMMPanther PTHR22780:SF5 PTHR22780:SF5 NULL 10 876 AT1G23900.2 HMMPanther PTHR22780:SF5 PTHR22780:SF5 NULL 10 876 AT1G23900.2 HMMPanther PTHR22780 PTHR22780 NULL 10 876 AT1G23900.2 HMMPanther PTHR22780 PTHR22780 NULL 10 876 AT1G23900.2 HMMPIR PIRSF037094 AP1 _complex_gamma IPR017107 1 876 AT1G23900.2 superfamily SSF48371 ARM-type_fold IPR016024 6 591 AT1G23900.2 superfamily SSF49348 Clath_adapt IPR013041 726 873 AT1G23900.2 Gene3D G3DSA:1.25.10.10ARM-like IPR011989 9 572 AT1G23900.2 ProfileScan PS50180 GAE IPR008153 756 873 AT1G23900.2 Gene3D G3DSA:2.60.40.1230 IPR008153 757 873 Clathrin g-adaptin_app AT1G23900.2 BlastProDom PD021457 Gamma_adaptin_C IPR008153 760 873 AT1G23900.2 HMMSmart SM00809 Alpha_adaptinC2 IPR008152 753 873 AT1G23900.2 HMMPfam PF02883 Alpha_adaptinC2 IPR008152 753 873 AT1G23900.2 HMMPfam PF01602 Adaptin_N IPR002553 26 580

TABLE C8 InterPro scan results (major accession numbers) of the AT1G65980 polypeptide. AN3 InterPro amino acid amino acid interactor Database Domain accession Domain name accession start coordinate end coordinate AT1G65980.2 HMMPanther PTHR10430:SF4 PTHR10430:SF4 NULL 1 104 AT1G65980.2 HMMPanther PTHR10430:SF4 PTHR10430:SF4 NULL 1 104 AT1G65980.2 HMMPanther PTHR10430 PTHR10430 NULL 1 104 AT1G65980.2 HMMPanther PTHR10430 PTHR10430 NULL 1 104 AT1G65980.2 HMMPfam PF08534 Redoxin IPR013740 5 120 AT1G65980.2 superfamily SSF52833 Thiordxn-like_fd IPR012336 4 103 AT1G65980.2 Gene3D G3DSA:3.40.30.10Thioredoxin_fold IPR012335 2 104

TABLE C9 InterPro scan results (major accession numbers) of the AT2G18876 polypeptide. AN3 InterPro amino acid amino acid interactor Database Domain accession Domain name accession start coordinate end coordinate AT2G18876.2 HMMPanther PTHR21736:SF12 PTHR21736:SF12 NULL 64 284 AT2G18876.2 HMMPanther PTHR21736:SF12 PTHR21736:SF12 NULL 64 284 AT2G18876.2 HMMPanther PTHR21736 PTHR21736 NULL 64 284 AT2G18876.2 HMMPanther PTHR21736 PTHR21736 NULL 64 284

TABLE C10 InterPro scan results (major accession numbers) of the AT2G46020 polypeptide. AN3 InterPro amino acid amino acid interactor Database Domain accession Domain name accession start coordinate end coordinate AT2G46020.2 superfamily SSF52540 SSF52540 NULL 1300 1434 AT2G46020.2 superfamily SSF52540 SSF52540 NULL 758 1157 AT2G46020.2 HMMPanther PTHR10799:SF76 PTHR10799:SF76 NULL 1465 1721 AT2G46020.2 HMMPanther PTHR10799:SF76 PTHR10799:SF76 NULL 965 1430 AT2G46020.2 HMMPanther PTHR10799:SF76 PTHR10799:SF76 NULL 202 217 AT2G46020.2 HMMPanther PTHR10799:SF76 PTHR10799:SF76 NULL 24 1721 AT2G46020.2 HMMPanther PTHR10799:SF76 PTHR10799:SF76 NULL 24 74 AT2G46020.2 HMMPanther PTHR10799 PTHR10799 NULL 1465 1721 AT2G46020.2 HMMPanther PTHR10799 PTHR10799 NULL 965 1430 AT2G46020.2 HMMPanther PTHR10799 PTHR10799 NULL 202 217 AT2G46020.2 HMMPanther PTHR10799 PTHR10799 NULL 24 1721 AT2G46020.2 HMMPanther PTHR10799 PTHR10799 NULL 24 74 AT2G46020.2 Gene3D G3DSA:3.40.50.300G3DSA:3.40.50.300 NULL 1309 1444 AT2G46020.2 HMMPfam PF08880 QLQ IPR014978 462 499 AT2G46020.2 ProfileScan PS51192 HELICASE_ATP_(—) IPR014021 993 1158 BIND_1 AT2G46020.2 HMMSmart SM00487 DEXDc IPR014001 977 1166 AT2G46020.2 ProfileScan PS51194 HELICASE_CTER IPR001650 1312 1489 AT2G46020.2 HMMSmart SM00490 HELICc IPR001650 1338 1422 AT2G46020.2 HMMPfam PF00271 Helicase_C IPR001650 1343 1422 AT2G46020.2 superfamily SSF47370 Bromodomain IPR001487 1890 2010 AT2G46020.2 HMMSmart SM00297 BROMO IPR001487 1900 2007 AT2G46020.2 Gene3D G3DSA:1.20.920.10Bromodomain IPR001487 1889 2003 AT2G46020.2 HMMPfam PF00176 SNF2_N IPR000330 984 1291

TABLE C11 InterPro scan results (major accession numbers) of the AT3G06720 polypeptide. AN3 InterPro amino acid amino acid interactor Database Domain accession Domain name accession start coordinate end coordinate AT3G06720.1 HMMPanther PTHR23316 PTHR23316 NULL 1 531 AT3G06720.1 HMMPanther PTHR23316 PTHR23316 NULL 1 531 AT3G06720.1 superfamily SSF48371 ARM-type_fold IPR016024 43 494 AT3G06720.1 Gene3D G3DSA:1.25.10.10ARM- IPR011989 72 494 like AT3G06720.1 ProfileScan PS51214 IBB IPR002652 1 58 AT3G06720.1 HMMPfam PF01749 IBB IPR002652 4 95 AT3G06720.1 ProfileScan PS50176 ARM_REPEAT IPR000225 326 361 AT3G06720.1 ProfileScan PS50176 ARM_REPEAT IPR000225 242 284 AT3G06720.1 ProfileScan PS50176 ARM_REPEAT IPR000225 158 186 AT3G06720.1 ProfileScan PS50176 ARM_REPEAT IPR000225 115 154 AT3G06720.1 HMMSmart SM00185 ARM IPR000225 401 441 AT3G06720.1 HMMSmart SM00185 ARM IPR000225 358 398 AT3G06720.1 HMMSmart SM00185 ARM IPR000225 315 356 AT3G06720.1 HMMSmart SM00185 ARM IPR000225 273 313 AT3G06720.1 HMMSmart SM00185 ARM IPR000225 232 271 AT3G06720.1 HMMSmart SM00185 ARM IPR000225 188 230 AT3G06720.1 HMMSmart SM00185 ARM IPR000225 147 187 AT3G06720.1 HMMSmart SM00185 ARM IPR000225 104 145 AT3G06720.1 HMMPfam PF00514 Arm IPR000225 401 441 AT3G06720.1 HMMPfam PF00514 Arm IPR000225 358 398 AT3G06720.1 HMMPfam PF00514 Arm IPR000225 315 356 AT3G06720.1 HMMPfam PF00514 Arm IPR000225 273 313 AT3G06720.1 HMMPfam PF00514 Arm IPR000225 232 271 AT3G06720.1 HMMPfam PF00514 Arm IPR000225 189 230 AT3G06720.1 HMMPfam PF00514 Arm IPR000225 147 187 AT3G06720.1 HMMPfam PF00514 Arm IPR000225 104 145

TABLE C12 InterPro scan results (major accession numbers) of the AT3G15000 polypeptide. AN3 InterPro amino acid amino acid interactor Database Domain accession Domain name accession start coordinate end coordinate AT3G15000.1 Seg seg seg NULL 311 385 AT3G15000.1 Seg seg seg NULL 280 302 AT3G15000.1 Seg seg seg NULL 239 278 AT3G15000.1 Seg seg seg NULL 206 229 AT3G15000.1 Seg seg seg NULL 25 50

TABLE C13 InterPro scan results (major accession numbers) of the AT3G60830 polypeptide. AN3 InterPro amino acid amino acid interactor Database Domain accession Domain name accession start coordinate end coordinate AT3G60830.1 superfamily SSF53067 SSF53067 NULL 135 363 AT3G60830.1 superfamily SSF53067 SSF53067 NULL 1 141 AT3G60830.1 HMMPanther PTHR11937:SF26 PTHR11937:SF26 NULL 20 363 AT3G60830.1 HMMPanther PTHR11937:SF26 PTHR11937:SF26 NULL 20 363 AT3G60830.1 Gene3D G3DSA:3.30.420.40G3DSA:3.30.420.40 NULL 325 363 AT3G60830.1 Gene3D G3DSA:3.30.420.40G3DSA:3.30.420.40 NULL 228 300 AT3G60830.1 Gene3D G3DSA:3.30.420.40G3DSA:3.30.420.40 NULL 3 128 AT3G60830.1 HMMSmart SM00268 ACTIN IPR004000 1 363 AT3G60830.1 HMMPfam PF00022 Actin IPR004000 3 363 AT3G60830.1 HMMPanther PTHR11937 Actin_like IPR004000 20 363 AT3G60830.1 FPrintScan PR00190 ACTIN IPR004000 219 235 AT3G60830.1 FPrintScan PR00190 ACTIN IPR004000 128 147 AT3G60830.1 FPrintScan PR00190 ACTIN IPR004000 103 116 AT3G60830.1 FPrintScan PR00190 ACTIN IPR004000 23 32

TABLE C14 InterPro scan results (major accession numbers) of the AT4G16143 polypeptide. AN3 InterPro amino acid amino acid interactor Database Domain accession Domain name accession start coordinate end coordinate AT4G16143.1 Seg seg seg NULL 333 340 AT4G16143.1 HMMPanther PTHR23316 IMPORTIN NULL 1 534 ALPHA AT4G16143.1 superfamily SSF48371 ARM repeat IPR016024 77 499 AT4G16143.1 Gene3D G3DSA:1.25.10.10no description IPR011989 77 499 AT4G16143.1 ProfileScan PS51214 IBB IPR002652 1 58 AT4G16143.1 HMMPfam PF01749 IBB IPR002652 4 100 AT4G16143.1 ProfileScan PS50176 ARM_REPEAT IPR000225 331 374 AT4G16143.1 ProfileScan PS50176 ARM_REPEAT IPR000225 289 331 AT4G16143.1 ProfileScan PS50176 ARM_REPEAT IPR000225 247 289 AT4G16143.1 ProfileScan PS50176 ARM_REPEAT IPR000225 163 205 AT4G16143.1 ProfileScan PS50176 ARM_REPEAT IPR000225 120 163 AT4G16143.1 HMMSmart SM00185 no description IPR000225 406 446 AT4G16143.1 HMMSmart SM00185 no description IPR000225 363 403 AT4G16143.1 HMMSmart SM00185 no description IPR000225 320 361 AT4G16143.1 HMMSmart SM00185 no description IPR000225 278 318 AT4G16143.1 HMMSmart SM00185 no description IPR000225 237 276 AT4G16143.1 HMMSmart SM00185 no description IPR000225 193 235 AT4G16143.1 HMMSmart SM00185 no description IPR000225 152 192 AT4G16143.1 HMMSmart SM00185 no description IPR000225 109 150 AT4G16143.1 HMMPfam PF00514 Arm IPR000225 406 446 AT4G16143.1 HMMPfam PF00514 Arm IPR000225 363 403 AT4G16143.1 HMMPfam PF00514 Arm IPR000225 320 361 AT4G16143.1 HMMPfam PF00514 Arm IPR000225 278 318 AT4G16143.1 HMMPfam PF00514 Arm IPR000225 237 276 AT4G16143.1 HMMPfam PF00514 Arm IPR000225 194 235 AT4G16143.1 HMMPfam PF00514 Arm IPR000225 152 192 AT4G16143.1 HMMPfam PF00514 Arm IPR000225 109 150

TABLE C15 InterPro scan results (major accession numbers) of the AT4G21540 polypeptide. AN3 InterPro amino acid amino acid interactor Database Domain accession Domain name accession start coordinate end coordinate AT4G21540.1 SignalPHMM signalp signal-peptide NULL 1 30 AT4G21540.1 Seg seg seg NULL 226 236 AT4G21540.1 Seg seg seg NULL 19 37 AT4G21540.1 HMMPanther PTHR12358:SF10 SPHINGOSINE KINASE- NULL 373 747 RELATED AT4G21540.1 HMMPanther PTHR12358 SPHINGOSINE KINASE NULL 373 747 AT4G21540.1 HMMSmart SM00046 no description IPR001206 909 1041 AT4G21540.1 HMMSmart SM00046 no description IPR001206 379 515 AT4G21540.1 HMMPfam PF00781 DAGK_cat IPR001206 909 1041 AT4G21540.1 HMMPfam PF00781 DAGK_cat IPR001206 379 515 AT4G21540.1 BlastProDom PD005043 O65419_ARATH_O65419; IPR001206 908 1018 AT4G21540.1 BlastProDom PD005043 O65419_ARATH_O65419; IPR001206 378 488

TABLE C16 InterPro scan results (major accession numbers) of the AT4G27550 polypeptide. AN3 InterPro amino acid amino acid interactor Database Domain accession Domain name accession start coordinate end coordinate AT4G27550.1 superfamily SSF56784 SSF56784 NULL 511 790 AT4G27550.1 superfamily SSF53756 SSF53756 NULL 4 467 AT4G27550.1 HMMPanther PTHR10788 PTHR10788 NULL 68 730 AT4G27550.1 HMMPanther PTHR10788 PTHR10788 NULL 68 730 AT4G27550.1 Gene3D G3DSA:3.40.50.2000G3DSA:3.40.50.2000 NULL 247 452 AT4G27550.1 HMMTigr TIGR00685 T6PP IPR003337 508 791 AT4G27550.1 HMMPfam PF02358 Trehalose_PPase IPR003337 514 758 AT4G27550.1 HMMPfam PF00982 Glyco_transf_20 IPR001830 4 469

TABLE C17 InterPro scan results (major accession numbers) of the AT5G13030 polypeptide. AN3 InterPro amino acid amino acid interactor Database Domain accession Domain name accession start coordinate end coordinate AT5G13030.1 HMMPfam PF02696 UPF0061 IPR003846 108 604 AT5G14170.1 HMMPanther PTHR13844 PTHR13844 NULL 250 523 AT5G14170.1 HMMPanther PTHR13844 PTHR13844 NULL 250 523 AT5G14170.1 superfamily SSF47592 MDM2 IPR003121 308 400 AT5G14170.1 HMMPfam PF02201 SWIB IPR003121 315 390 AT5G14170.1 Gene3D G3DSA:1.10.245.10SWIB_MDM2 IPR003121 308 400

TABLE C18 InterPro scan results (major accession numbers) of the AT5G17510 polypeptide. AN3 InterPro amino acid amino acid interactor Database Domain accession Domain name accession start coordinate end coordinate AT5G17510.1 Seg seg seg NULL 343 357 AT5G17510.1 Seg seg seg NULL 70 121 AT5G17510.1 Seg seg seg NULL 15 51 AT5G17510.1 superfamily SSF47175 Cytochromes IPR010980 12 151

TABLE C19 InterPro scan results (major accession numbers) of the AT5G23690 polypeptide. AN3 InterPro amino acid amino acid interactor Database Domain accession Domain name accession start coordinate end coordinate AT5G23690.1 superfamily SSF81891 Poly A polymerase C-terminal NULL 224 443 region-like AT5G23690.1 superfamily SSF81301 Nucleotidyltransferase NULL 76 223 AT5G23690.1 Seg seg seg NULL 240 252 AT5G23690.1 HMMPanther PTHR13734:SF12 POLY(A) POLYMERASE, NULL 112 523 ARABIDOPSIS AT5G23690.1 HMMPanther PTHR13734 TRNA-NUCLEO- NULL 112 523 TIDYLTRANSFERASE/POLY(A) POLYMERASE FAMILY MEMBER AT5G23690.1 Gene3D G3DSA:3.30.460.10no description NULL 66 223 AT5G23690.1 Gene3D G3DSA:1.10.3090.10no description NULL 224 316 AT5G23690.1 ScanRegExp PS00012 PHOSPHOPANTETHEINE IPR006162 71 86 AT5G23690.1 HMMPfam PF01743 PolyA_pol IPR002646 97 226 AT5G23690.1 ScanRegExp PS00014 ER_TARGET IPR000886 524 527

TABLE C20 InterPro scan results (major accession numbers) of the AT5G53480 polypeptide. AN3 InterPro amino acid amino acid interactor Database Domain accession Domain name accession start coordinate end coordinate AT5G53480.1 HMMPanther PTHR10527:SF1 PTHR10527:SF1 NULL 217 869 AT5G53480.1 HMMPanther PTHR10527:SF1 PTHR10527:SF1 NULL 217 869 AT5G53480.1 HMMPanther PTHR10527 PTHR10527 NULL 217 869 AT5G53480.1 HMMPanther PTHR10527 PTHR10527 NULL 217 869 AT5G53480.1 superfamily SSF48371 ARM-type_fold IPR016024 3 864 AT5G53480.1 Gene3D G3DSA:1.25.10.10ARM- IPR011989 3 866 like AT5G53480.1 ProfileScan PS50166 IMPORTIN_B_NT IPR001494 23 103 AT5G53480.1 HMMPfam PF03810 IBN_N IPR001494 23 103 AT5G53480.1 HMMPfam PF02985 HEAT IPR000357 404 441 AT5G53480.1 HMMPfam PF02985 HEAT IPR000357 362 398 AT5G53480.1 HMMPfam PF02985 HEAT IPR000357 214 250

Example 19 Topology Prediction of the iSYT Polypeptide Sequences

TargetP 1.1 predicts the subcellular location of eukaryotic proteins. The location assignment is based on the predicted presence of any of the N-terminal pre-sequences: chloroplast transit peptide (cTP), mitochondrial targeting peptide (mTP) or secretory pathway signal peptide (SP). Scores on which the final prediction is based are not really probabilities, and they do not necessarily add to one. However, the location with the highest score is the most likely according to TargetP, and the relationship between the scores (the reliability class) may be an indication of how certain the prediction is. The reliability class (RC) ranges from 1 to 5, where 1 indicates the strongest prediction. TargetP is maintained at the server of the Technical University of Denmark.

For the sequences predicted to contain an N-terminal presequence a potential cleavage site can also be predicted.

A number of parameters is selected, such as organism group (non-plant or plant), cutoff sets (none, predefined set of cutoffs, or user-specified set of cutoffs), and the calculation of prediction of cleavage sites (yes or no).

Many other algorithms can be used to perform such analyses, including:

-   -   ChloroP 1.1 hosted on the server of the Technical University of         Denmark;     -   Protein Prowler Subcellular Localisation Predictor version 1.2         hosted on the server of the Institute for Molecular Bioscience,         University of Queensland, Brisbane, Australia;     -   PENCE Proteome Analyst PA-GOSUB 2.5 hosted on the server of the         University of Alberta, Edmonton, Alberta, Canada;     -   TMHMM, hosted on the server of the Technical University of         Denmark     -   PSORT (URL: psort.org)     -   PLOC (Park and Kanehisa, Bloinformatics, 19, 1656-1663, 2003).

Example 20 Cloning of the iSYT Encoding Nucleic Acid Sequence

The method was adapted from the Multisite Gateway® Pro (Invitrogen™).

Each plant transformation vector was constructed in two steps: First, the two coding sequences of gene of interest were amplified from the cDNA obtained from the appropriate source using a high-fidelity PCR. To this end primers were designed and synthesized using standard methods. Then the sequences were cloned in pDONR201 P1-P4 and pDONR201 P3-P2 (Invitrogen™), respectively, using the Gateway™ BP (Invitrogen™) standard reaction method. The resulting clone was called the Entry Clone (EC), in accordance with Gateway method terminology. The other entry clone that carried a terminator and a promoter was produced by using pDONR201 P4r-P3r. The identity of the clone was verified by restriction digestion analysis and complete sequencing of the insert. After verification, the clone (EC) went through a second Gateway method step which allows transfer of the inserts of all 3 ECs to the so-called Destination Vector (DV) using the Gateway LR (Invitrogen™) standard reaction method. On the destination vector, a promoter and a terminator designed for stacking genes were already in place. The identity of the resulting clone was verified by restriction digestion analysis and then by sequencing. After this verification, this binary vector was used as plant transformation vector. The plant transformation vector contains following functional cassettes in its t-DNA region: the selectable marker gene, the visual (reporter) marker gene, and two genes of interest. Each of these genes was driven by its corresponding promoter and terminator. The binary vector is then cloned into a disarmed Agrobacterium tumefaciens which Is used to transform rice.

Example 21 Plant Transformation Rice Transformation

The Agrobacterium containing the expression vector is used to transform Oryza sativa plants. Mature dry seeds of the rice Japonica cultivar Nipponbare are dehusked. Sterilization is carried out by Incubating for one minute in 70% ethanol, followed by 30 minutes in 0.2% HgCl₂, followed by a 6 times 15 minutes wash with sterile distilled water. The sterile seeds are then germinated on a medium containing 2,4-D (callus Induction medium). After incubation in the dark for four weeks, embryogenic, scutellum-derived calli are excised and propagated on the same medium. After two weeks, the calli are multiplied or propagated by subculture on the same medium for another 2 weeks. Embryogenic callus pieces are sub-cultured on fresh medium 3 days before co-cultivation (to boost cell division activity).

Agrobacterium strain LBA4404 containing the expression vector is used for co-cultivation. Agrobacterium was inoculated on AB medium with the appropriate antibiotics and cultured for 3 days at 28° C. The bacteria are then collected and suspended in liquid co-cultivation medium to a density (OD₆₀₀) of about 1. The suspension is then transferred to a Petri dish and the calli immersed in the suspension for 15 minutes. The callus tissues are then blotted dry on a filter paper and transferred to solidified, co-cultivation medium and incubated for 3 days in the dark at 25° C. Co-cultivated calli are grown on 2,4-D-containing medium for 4 weeks in the dark at 28° C. in the presence of a selection agent. During this period, rapidly growing resistant callus islands developed. After transfer of this material to a regeneration medium and incubation in the light, the embryogenic potential is released and shoots developed in the next four to five weeks. Shoots are excised from the calli and incubated for 2 to 3 weeks on an auxin-containing medium from which they are transferred to soil. Hardened shoots era grown under high humidity and short days in a greenhouse.

Approximately 35 independent T0 rice transformants are generated for one construct. The primary transformants are transferred from a tissue culture chamber to a greenhouse. After a quantitative PCR analysis to verify copy number of the T-DNA insert, only single copy transgenic plants that exhibit tolerance to the selection agent are kept for harvest of T1 seed. Seeds are then harvested three to five months after transplanting. The method yielded single locus transformants at a rate of over 50% (Aldemita and Hodges 1996, Chan et al. 1993, Hiei et al. 1994).

Example 22 Transformation of Other Crops Corn Transformation

Transformation of maize (Zea mays) is performed with a modification of the method described by Ishida et al. (1996) Nature Biotech 14(6): 745-50. Transformation is genotype-dependent in corn and only specific genotypes are amenable to transformation and regeneration. The inbred line A188 (University of Minnesota) or hybrids with A188 as a parent are good sources of donor material for transformation, but other genotypes can be used successfully as well. Ears are harvested from corn plant approximately 11 days after pollination (DAP) when the length of the immature embryo is about 1 to 1.2 mm. Immature embryos are cocultivated with Agrobacterium tumefaciens containing the expression vector, and transgenic plants are recovered through organogenesis. Excised embryos are grown on callus induction medium, then maize regeneration medium, containing the selection agent (for example imidazolinone but various selection markers can be used). The Petri plates are incubated in the light at 25° C. for 2-3 weeks, or until shoots develop. The green shoots are transferred from each embryo to maize rooting medium and incubated at 25° C. for 2-3 weeks, until roots develop. The rooted shoots are transplanted to soil in the greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent and that contain a single copy of the T-DNA insert.

Wheat Transformation

Transformation of wheat is performed with the method described by Ishida et al. (1996) Nature Biotech 14(6): 745-50. The cultivar Bobwhite (available from CIMMYT, Mexico) is commonly used in transformation. Immature embryos are co-cultivated with Agrobacterium tumefaciens containing the expression vector, and transgenic plants are recovered through organogenesis. After incubation with Agrobacterium, the embryos are grown in vitro on callus induction medium, then regeneration medium, containing the selection agent (for example imidazolinone but various selection markers can be used). The Petri plates are incubated in the light at 25° C. for 2-3 weeks, or until shoots develop. The green shoots are transferred from each embryo to rooting medium and incubated at 25° C. for 2-3 weeks, until roots develop. The rooted shoots are transplanted to soil in the greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent and that contain a single copy of the T-DNA insert.

Soybean Transformation

Soybean is transformed according to a modification of the method described in the Texas A&M patent U.S. Pat. No. 5,164,310. Several commercial soybean varieties are amenable to transformation by this method. The cultivar Jack (available from the Illinois Seed foundation) is commonly used for transformation. Soybean seeds are sterilised for in vitro sowing. The hypocotyl, the radicle and one cotyledon are excised from seven-day old young seedlings. The epicotyl and the remaining cotyledon are further grown to develop axillary nodes. These axillary nodes are excised and incubated with Agrobacterium tumefaciens containing the expression vector. After the cocultivation treatment, the explants are washed and transferred to selection media. Regenerated shoots are excised and placed on a shoot elongation medium. Shoots no longer than 1 cm are placed on rooting medium until roots develop. The rooted shoots are transplanted to soil in the greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent and that contain a single copy of the T-DNA insert.

Rapeseed/Canola Transformation

Cotyledonary petioles and hypocotyls of 5-6 day old young seedling are used as explants for tissue culture and transformed according to Babic et al. (1998, Plant Cell Rep 17: 183-188). The commercial cultivar Westar (Agriculture Canada) is the standard variety used for transformation, but other varieties can also be used. Canola seeds are surface-sterilized for in vitro sowing. The cotyledon petiole explants with the cotyledon attached are excised from the in vitro seedlings, and inoculated with Agrobacterium (containing the expression vector) by dipping the cut end of the petiole explant into the bacterial suspension. The explants are then cultured for 2 days on MSBAP-3 medium containing 3 mg/l BAP, 3% sucrose, 0.7% Phytagar at 23° C., 16 hr light. After two days of co-cultivation with Agrobacterium, the petiole explants are transferred to MSBAP-3 medium containing 3 mg/l BAP, cefotaxime, carbenicillin, or timentin (300 mg/l) for 7 days, and then cultured on MSBAP-3 medium with cefotaxime, carbenicillin, or timentin and selection agent until shoot regeneration. When the shoots are 5-10 mm in length, they are cut and transferred to shoot elongation medium (MSBAP-0.5, containing 0.5 mg/l BAP). Shoots of about 2 cm in length are transferred to the rooting medium (MS0) for root induction. The rooted shoots are transplanted to soil in the greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent and that contain a single copy of the T-DNA insert.

Alfalfa Transformation

A regenerating clone of alfalfa (Medicago sativa) is transformed using the method of (McKersie et al., 1999 Plant Physiol 119: 839-847). Regeneration and transformation of alfalfa is genotype dependent and therefore a regenerating plant is required. Methods to obtain regenerating plants have been described. For example, these can be selected from the cultivar Rangelander (Agriculture Canada) or any other commercial alfalfa variety as described by Brown DCW and A Atanassov (1985. Plant Cell Tissue Organ Culture 4: 111-112). Alternatively, the RA3 variety (University of Wisconsin) has been selected for use in tissue culture (Walker et al., 1978 Am J Bot 65:654-659). Petiole explants are cocultivated with an overnight culture of Agrobacterium tumefaciens C58C1 pMP90 (McKersie at al., 1999 Plant Physiol 119: 839-847) or LBA4404 containing the expression vector. The explants are cocultivated for 3 d in the dark on SH induction medium containing 288 mg/L Pro, 53 mg/L thioproline, 4.35 g/L K2SO4, and 100 μm acetosyringinone. The explants are washed in half-strength Murashige-Skoog medium (Murashige and Skoog, 1962) and plated on the same SH induction medium without acetosyringinone but with a suitable selection agent and suitable antibiotic to inhibit Agrobacterium growth. After several weeks, somatic embryos are transferred to BOi2Y development medium containing no growth regulators, no antibiotics, and 50 g/L sucrose. Somatic embryos are subsequently germinated on half-strength Murashige-Skoog medium. Rooted seedlings were transplanted into pots and grown in a greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent and that contain a single copy of the T-DNA insert.

Cotton Transformation

Cotton is transformed using Agrobacterium tumefaciens according to the method described in U.S. Pat. No. 5,159,135. Cotton seeds are surface sterilised in 3% sodium hypochlorite solution during 20 minutes and washed in distilled water with 500 μg/ml cefotaxime. The seeds are then transferred to SH-medium with 50 μg/ml benomyl for germination. Hypocotyls of 4 to 6 days old seedlings are removed, cut into 0.5 cm pieces and are placed on 0.8% agar. An Agrobacterium suspension (approx. 108 cells per ml, diluted from an overnight culture transformed with the gene of interest and suitable selection markers) is used for inoculation of the hypocotyl explants. After 3 days at room temperature and lighting, the tissues are transferred to a solid medium (1.6 g/l Geirite) with Murashige and Skoog salts with B5 vitamins (Gamborg et al., Exp. Cell Res. 50:151-158 (1968)), 0.1 mg/l 2,4-0, 0.1 mg/l 6-furfurylaminopurine and 750 μg/ml MgCL2, and with 50 to 100 μg/ml cefotaxime and 400-500 μg/ml carbenicillin to kill residual bacteria. Individual cell lines are isolated after two to three months (with subcultures every four to six weeks) and are further cultivated on selective medium for tissue amplification (30° C., 16 hr photoperiod). Transformed tissues are subsequently further cultivated on non-selective medium during 2 to 3 months to give rise to somatic embryos. Healthy looking embryos of at least 4 mm length are transferred to tubes with SH medium in fine vermiculite, supplemented with 0.1 mg/l indole acetic acid, 6 furfurylaminopurine and gibberellic acid. The embryos are cultivated at 30° C. with a photoperiod of 16 hrs, and plantlets at the 2 to 3 leaf stage are transferred to pots with vermiculite and nutrients. The plants are hardened and subsequently moved to the greenhouse for further cultivation.

Example 23 Phenotypic Evaluation Procedure 23.1 Evaluation Setup

Approximately 35 independent T0 rice transformants are generated. The primary transformants are transferred from a tissue culture chamber to a greenhouse for growing and harvest of T1 seed. Events, of which the T1 progeny segregated 3:1 for presence/absence of the transgene, are retained. For each of these events, approximately 10 T1 seedlings containing the transgene (hetero- and homo-zygotes) and approximately 10 T1 seedlings lacking the transgene (nullizygotes) are selected by monitoring visual marker expression. The transgenic plants and the corresponding nullizygotes are grown side-by-side at random positions. Greenhouse conditions are of shorts days (12 hours light), 28° C. in the light and 22° C. in the dark, and a relative humidity of 70%. Plants grown under non-stress conditions are watered at regular intervals to ensure that water and nutrients are not limiting and to satisfy plant needs to complete growth and development.

T1 events are further evaluated in the T2 generation following the same evaluation procedure as for the T1 generation but with more individuals per event. From the stage of sowing until the stage of maturity the plants are passed several times through a digital imaging cabinet. At each time point digital images (2048×1536 pixels, 16 million colours) are taken of each plant from at least 6 different angles.

Drought Screen

Plants from T2 seeds are grown in potting soil under normal conditions until they approached the heading stage. They are then transferred to a “dry” section where irrigation is withheld. Humidity probes are inserted in randomly chosen pots to monitor the soil water content (SWC). When SWC goes below certain thresholds, the plants are automatically re-watered continuously until a normal level is reached again. The plants are then re-transferred again to normal conditions. The rest of the cultivation (plant maturation, seed harvest) is the same as for plants not grown under abiotic stress conditions. Growth and yield parameters are recorded as detailed for growth under normal conditions.

Nitrogen Use Efficiency Screen

Rice plants from T2 seeds are grown in potting soil under normal conditions except for the nutrient solution. The pots are watered from transplantation to maturation with a specific nutrient solution containing reduced N nitrogen (N) content, usually between 7 to 8 times less. The rest of the cultivation (plant maturation, seed harvest) is the same as for plants not grown under abiotic stress. Growth and yield parameters are recorded as detailed for growth under normal conditions.

Salt Stress Screen

Plants are grown on a substrate made of coco fibers and argex (3 to 1 ratio). A normal nutrient solution is used during the first two weeks after transplanting the plantlets in the greenhouse. After the first two weeks, 25 mM of salt (NaCl) is added to the nutrient solution, until the plants are harvested. Seed-related parameters are then measured.

23.2 Statistical Analysis: F Test

A two factor ANOVA (analysis of variants) is used as a statistical model for the overall evaluation of plant phenotypic characteristics. An F test is carried out on all the parameters measured of all the plants of all the events transformed with the gene of the present invention. The F test is carried out to check for an effect of the gene over all the transformation events and to verify for an overall effect of the gene, also known as a global gene effect. The threshold for significance for a true global gene effect is set at a 5% probability level for the F test. A significant F test value points to a gene effect, meaning that it is not only the mere presence or position of the gene that is causing the differences in phenotype.

23.3 Parameters Measured

Biomass-Related Parameter Measurement

From the stage of sowing until the stage of maturity the plants are passed several times through a digital imaging cabinet. At each time point digital images (2048×1536 pixels, 16 million colours) are taken of each plant from at least 6 different angles.

The plant aboveground area (or leafy biomass) is determined by counting the total number of pixels on the digital images from aboveground plant parts discriminated from the background. This value is averaged for the pictures taken on the same time point from the different angles and was converted to a physical surface value expressed in square mm by calibration. Experiments show that the aboveground plant area measured this way correlates with the biomass of plant parts above ground. The above ground area is the area measured at the time point at which the plant had reached its maximal leafy biomass.

The early vigour is the plant (seedling) aboveground area three weeks post-germination. Increase in root biomass is expressed as an increase in total root biomass (measured as maximum biomass of roots observed during the lifespan of a plant); or as an increase in the root/shoot index (measured as the ratio between root mass and shoot mass in the period of active growth of root and shoot).

Early vigour is determined by counting the total number of pixels from aboveground plant parts discriminated from the background. This value was averaged for the pictures taken on the same time point from different angles and was converted to a physical surface value expressed in square mm by calibration. The results described below are for plants three weeks post-germination.

Seed-Related Parameter Measurements

The mature primary panicles are harvested, counted, bagged, barcode-labeled and then dried for three days in an oven at 37° C. The panicles are then threshed and all the seeds are collected and counted. The filled husks are separated from the empty ones using an air-blowing device. The empty husks are discarded and the remaining fraction was counted again. The filled husks were weighed on an analytical balance. The number of filled seeds is determined by counting the number of filled husks that remained after the separation step. The total seed yield is measured by weighing all filled husks harvested from a plant. Total seed number per plant is measured by counting the number of husks harvested from a plant. Thousand Kernel Weight (TKW) is extrapolated from the number of filled seeds counted and their total weight. The Harvest Index (HI) in the present invention is defined as the ratio between the total seed yield and the above ground area (mm²), multiplied by a factor 10⁶. The total number of flowers per panicle as defined in the present invention is the ratio between the total number of seeds and the number of mature primary panicles. The seed fill rate as defined in the present invention is the proportion (expressed as a %) of the number of filled seeds over the total number of seeds (or florets).

Examples 24 Results of the Phenotypic Evaluation of the Transgenic Plants

Transgenic rice plants expressing a nucleic acid comprising the Open Reading Frame of at least two genes encoding an iSYT polypeptide are evaluated under one or more of the conditions abovementioned (non-stress conditions, drought stress, Nitrogene deficiency). The performance of the transgenic plants outperform the control plants in one or more yield-related traits selected from aboveground biomass (AreaMax), root biomass (RootMax and RootThickMax), and for seed yield (total weight of seeds, number of filled seeds, fill rate, harvest index) and thousand kernel weight in addition, plants expressing in addition, the transgenic plants comprising recombinant nucleic acids expressing at least two iSYT polypeptides or homologues thereof or fusions of the same show a faster growth rate (a shorter time (in days) needed between sowing and the day the plant reaches 90% of its final biomass (AreaCycle) and an earlier start of flowering (TimetoFlower: time (in days) between sowing and the emergence of the first panicle). 

1. A method for enhancing a yield-related trait in a plant relative to a control plant, comprising increasing expression in a plant of: (i) any two or three nucleic acids encoding the corresponding two or three interactor of synovial sarcoma translocation (iSYT)-like polypeptides; (ii) two or three nucleic acids, each encoding a single iSYT-like polypeptide; or (iii) the nucleic acids of (i) and the nucleic acids of (ii), wherein said iSYT-like polypeptide is selected from the group consisting of any of the polypeptides of Table A, homologues thereof, and fusions of the same.
 2. The method of claim 1 wherein at least one of the polypeptides is a synovial sarcoma translocation (SYT) polypeptide or a homologue thereof, said SYT polypeptide or homologue thereof comprising an SNH domain having at least 40% sequence identity to the SNH domain of SEQ ID NO:
 670. 3. The method of claim 1 wherein the nucleic acids encode the corresponding polypeptides selected from the group consisting of the polypeptides listed in Table
 3. 4. The method of claim 1, wherein the expression of the nucleic acids is increased by introducing and expressing the nucleic acids in said plant.
 5. The method of claim 1, wherein the nucleic acids are selected from the group consisting of the nucleic acids encoding any of the polypeptides listed in Table A and Tables A2 to Table A26, or is a portion of such a nucleic acid, or a nucleic acid capable of hybridising with such a nucleic acid.
 6. The method of claim 1, comprising increasing expression in said plant of: (i) a first nucleic acid encoding a polypeptide having at least 80% sequence identity to the amino acid sequence of SEQ ID NO: 2; and (ii) a second nucleic acid encoding a polypeptide having at least 80% sequence identity to the amino acid sequence of SEQ ID NO:
 120. 7. The method of claim 1, wherein the enhanced yield-related trait comprises increased yield, increased biomass and/or increased seed yield relative to a control plant.
 8. The method of claim 1, wherein the enhanced yield-related trait is obtained under non-stress conditions.
 9. The method of claim 1, wherein the enhanced yield-related trait is obtained under conditions of drought stress, salt stress or nitrogen deficiency.
 10. The method of claim 4, wherein the nucleic acids are operably linked to a plant promoter, a constitutive promoter, a GOS2 promoter, or a GOS2 promoter from rice.
 11. A construct comprising: (i) any two or three nucleic acids encoding the corresponding two or three polypeptides selected from the group consisting of any of the polypeptides listed in of Table A or homologues thereof and fusions of the same; (ii) one or more control sequences capable of driving expression of the nucleic acid of (i); and optionally (iii) a transcription termination sequence.
 12. The construct of claim 11, wherein one of the control sequences is a plant promoter, a constitutive promoter, a GOS2 promoter, or a GOS2 promoter from rice.
 13. A plant, plant part or plant cell comprising the construct of claim
 11. 14. A method for making a plant having increased yield, increased biomass, and/or increased seed yield relative to a control plant, comprising transforming a plant, plant part, or plant cell with the construct of claim
 11. 15. A method for the production of a transgenic plant having increased yield, increased biomass, and/or increased seed yield relative to a control plant, comprising: (i) introducing and expressing in a plant or plant cell any two or three nucleic acids encoding the corresponding polypeptides selected from the group consisting of any of the polypeptides of Table A or homologues thereof and fusions of the same; and (ii) cultivating the plant or plant cell under conditions promoting plant growth and development.
 16. A transgenic plant obtained by the method of claim 15, or a plant cell, plant part, seed, or progeny of said plant, wherein said plant, or said plant cell, plant part, seed, or progeny, comprises any two or three nucleic acids encoding the corresponding two or three polypeptides selected from the group consisting of the polypeptides listed in Table A, homologues thereof, and fusions of the same.
 17. A transgenic plant having increased yield, increased biomass, and/or increased seed yield relative to a control plant, resulting from increased expression of any two or three nucleic acids encoding the corresponding polypeptides selected from the group consisting of any of the polypeptides of Table A or homologues thereof and fusions of the same, or a transgenic plant cell derived from said transgenic plant.
 18. The transgenic plant of claim 17, wherein said plant is a crop plant, a monocot, or a cereal, or wherein said plant is rice, maize, wheat, barley, millet, rye, triticale, sorghum, emmer, spelt, secale, einkom, teff, milo, or oats.
 19. Harvestable parts of the transgenic plant of claim 17, wherein said harvestable parts are shoot biomass and/or seeds, and wherein said harvestable parts comprise any two or three nucleic acids encoding the corresponding two or three polypeptides selected from the group consisting of the polypeptides listed in Table A, homologues thereof, and fusions of the same
 20. Products derived from the transgenic plant of claim 17 and/or from harvestable parts of said plant, wherein said products comprise any two or three nucleic acids encoding the corresponding two or three polypeptides selected from the group consisting of the polypeptides listed in Table A, homologues thereof, and fusions of the same. 